Header Logo

CHRISTIE BALLANTYNE

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
AddressOne Baylor Plaza
Houston, TX 77030
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Molecular & Human Genetics
    DivisionMolecular & Human Genetics


    Collapse Research 
    Collapse research activities and funding
    R01HL148050     (BALLANTYNE, CHRISTIE MITCHELL ;NATARAJAN, PRADEEP)Jul 19, 2019 - Jun 30, 2023
    NIH
    Clonal hematopoiesis in humans: determinants of development and progression
    Role: Principal Investigator
    R01HL134320     (BALLANTYNE, CHRISTIE MITCHELL)Sep 1, 2016 - Jun 30, 2021
    NIH
    Profiling Cardiovascular Events and Biomarkers in the Very Old to Improve Personalized Approaches for the Prevention of Cardiac and Vascular Disease
    Role: Principal Investigator
    P30HL101255     (BALLANTYNE, CHRISTIE MITCHELL)Sep 30, 2009 - Oct 31, 2012
    NIH
    Genetics and Personalized Medicine: From Population Studies to Clinical Therapy
    Role: Principal Investigator
    R01DK078847     (BALLANTYNE, CHRISTIE MITCHELL)May 5, 2009 - Mar 31, 2015
    NIH
    T Cells, Macrophages, Chemokines, and Adiposopathy in Diet-Induced Obesity
    Role: Principal Investigator
    R01HL090514     (BALLANTYNE, CHRISTIE MITCHELL)May 1, 2007 - Apr 30, 2012
    NIH
    Obesity, Inflammation and Thrombosis: LOOK AHEAD
    Role: Principal Investigator
    R01HL075824     (BALLANTYNE, CHRISTIE M)Sep 22, 2003 - Jun 30, 2010
    NIH
    Effect of lipid modification on peripheral arterial disease (PAD)
    Role: Principal Investigator
    R01HL062243     (BALLANTYNE, CHRISTIE M)Apr 1, 1999 - Mar 31, 2004
    NIH
    MAC 1/LFA 1/P150 95 AND PMN LEUKOCYTE FUNCTION
    Role: Principal Investigator
    T32HL007812     (BALLANTYNE, CHRISTIE MITCHELL)Jul 1, 1997 - Jun 30, 2014
    NIH
    Atherosclerosis and Vascular Biology Training Center
    Role: Principal Investigator
    K08HL002537     (BALLANTYNE, CHRISTIE M)Jul 1, 1990 - Jun 30, 1995
    NIH
    MOLECULAR STUDIES OF ENDOTHELIAL ADHESION MOLECULES
    Role: Principal Investigator
    N01HC055016     (BALLANTYNE, CHRISTIE M)Sep 1, 1985 - Jan 31, 2007
    NIH/NHLBI
    COMMUNITY AND COHORT SURVEILLANCE PROGRAM
    Role: Principal Investigator
    N01HC55016-38-0-1     (BALLANTYNE, CHRISTIE M)Jul 1, 1985 - Jan 31, 2012
    NIH/NHLBI
    Atherosclerosis Risk in Communities Study (ARIC)
    Role: Principal Investigator
    N01HC55016-40-0-1     (BALLANTYNE, CHRISTIE M)Jul 1, 1985 - Jan 31, 2012
    NIH/NHLBI
    Atherosclerosis Risk in Communities Study (ARIC)
    Role: Principal Investigator
    P50HL027341     (BALLANTYNE, CHRISTIE M)Sep 1, 1981 - Jun 30, 1997
    NIH
    SCOR IN ARTERIOSCLEROSIS
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Saadatagah S, Naderian M, Uddin M, Dikilitas O, Niroula A, Schuermans A, Selvin E, Hoogeveen RC, Matsushita K, Nambi V, Yu B, Chen LY, Bick AG, Ebert BL, Honigberg MC, Li N, Shah A, Natarajan P, Kullo IJ, Ballantyne CM. Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1. JAMA Cardiol. 2024 Apr 10. PMID: 38598228; PMCID: PMC11007653.
      Citations:    
    2. Minhas AMK, Sedhom R, Jean ED, Shapiro MD, Panza JA, Alam M, Virani SS, Ballantyne CM, Abramov D. Global burden of cardiovascular disease attributable to smoking, 1990-2019: an analysis of the 2019 Global Burden of Disease Study. Eur J Prev Cardiol. 2024 Apr 09. PMID: 38589018.
      Citations:    
    3. Gaudet D, Pall D, Watts GF, Nicholls SJ, Rosenson RS, Modesto K, San Martin J, Hellawell J, Ballantyne CM. Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia: The SHASTA-2 Randomized Clinical Trial. JAMA Cardiol. 2024 Apr 07. PMID: 38583092; PMCID: PMC11000138.
      Citations:    
    4. Stroes ESG, Alexander VJ, Karwatowska-Prokopczuk E, Hegele RA, Arca M, Ballantyne CM, Soran H, Prohaska TA, Xia S, Ginsberg HN, Witztum JL, Tsimikas S, Balance Investigators. Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome. N Engl J Med. 2024 Apr 07. PMID: 38587247.
      Citations:    
    5. Ballantyne CM, Nambi V. HDL Therapeutics - Time for a Curtain Call or Time to Reconceptualize? N Engl J Med. 2024 Apr 06. PMID: 38587250.
      Citations:    
    6. Nissen SE, Hutchinson HG, Wolski K, Watson K, Martin SS, Michos ED, Weintraub WS, Morris M, Cho L, Laffin L, Jacoby D, Ballantyne CM, Ekelund J, Birve F, Menon V, Strzelecki M, Ridker PM. A Technology-Assisted Web Application for Consumer Access to a Nonprescription Statin Medication. J Am Coll Cardiol. 2024 Apr 01. PMID: 38599257.
      Citations:    
    7. Sayah N, Bhatt DL, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Jiao L, Pineda AL, Doyle RT, Tardif JC, Ballantyne CM, Steg PG. Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial. Eur Heart J. 2024 Apr 01; 45(13):1173-1176. PMID: 38252107; PMCID: PMC10984562.
      Citations:    Fields:    Translation:Humans
    8. Venishetty N, Berry JD, de Lemos JA, Wu E, Lee MJ, Drawz PE, Nambi V, Ballantyne CM, Killeen AA, Ix JH, Shlipak MG, Ascher SB. Associations of ambulatory blood pressure measurements with high-sensitivity troponin and natriuretic peptide levels in SPRINT. Am J Hypertens. 2024 Mar 30. PMID: 38554284.
      Citations:    Fields:    
    9. Koschinsky ML, Bajaj A, Boffa MB, Dixon DL, Ferdinand KC, Gidding SS, Gill EA, Jacobson TA, Michos ED, Safarova MS, Soffer DE, Taub PR, Wilkinson MJ, Wilson DP, Ballantyne CM. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. J Clin Lipidol. 2024 Mar 29. PMID: 38565461.
      Citations:    Fields:    
    10. Agarwala A, Asim R, Ballantyne CM. Oral PCSK9 Inhibitors. Curr Atheroscler Rep. 2024 Mar 27. PMID: 38536608.
      Citations:    Fields:    
    11. Smith C, Berry JD, Scherzer R, de Lemos JA, Nambi V, Ballantyne CM, Kravitz RL, Killeen AA, Ix JH, Shlipak MG, Ascher SB. Intensive Blood Pressure Lowering in Individuals With Low Diastolic Blood Pressure and Elevated Troponin Levels in SPRINT. J Am Heart Assoc. 2024 Mar 19; 13(6):e032493. PMID: 38497469.
      Citations:    Fields:    Translation:Humans
    12. Szarek M, Bhatt DL, Miller M, Brinton EA, Jacobson TA, Tardif JC, Ballantyne CM, Mason RP, Ketchum SB, Lira Pineda A, Doyle RT, Steg PG, REDUCE-IT Investigators. Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl. J Am Coll Cardiol. 2024 Mar 15. PMID: 38530686.
      Citations:    Fields:    
    13. Echouffo-Tcheugui JB, Zhang S, Florido R, Pankow JS, Michos ED, Goldberg RB, Nambi V, Gerstenblith G, Post WS, Blumenthal RS, Ballantyne CM, Coresh J, Selvin E, Ndumele CE. Galectin-3, Metabolic Risk, and Incident Heart Failure: The ARIC Study. J Am Heart Assoc. 2024 Mar 19; 13(6):e031607. PMID: 38471823.
      Citations:    Fields:    Translation:Humans
    14. Murugan M, Yuan B, Venner E, Ballantyne CM, Robinson KM, Coons JC, Wang L, Empey PE, Gibbs RA. Empowering personalized pharmacogenomics with generative AI solutions. J Am Med Inform Assoc. 2024 Mar 06. PMID: 38447590.
      Citations:    Fields:    
    15. Zhang Y, Dron JS, Bellows BK, Khera AV, Liu J, Balte PP, Oelsner EC, Amr SS, Lebo MS, Nagy A, Peloso GM, Natarajan P, Rotter JI, Willer C, Boerwinkle E, Ballantyne CM, Lutsey PL, Fornage M, Lloyd-Jones DM, Hou L, Psaty BM, Bis JC, Floyd JS, Vasan RS, Heard-Costa NL, Carson AP, Hall ME, Rich SS, Guo X, Kazi DS, de Ferranti SD, Moran AE. Familial Hypercholesterolemia Variant and Cardiovascular Risk in Individuals With Elevated Cholesterol. JAMA Cardiol. 2024 Mar 01; 9(3):263-271. PMID: 38294787; PMCID: PMC10831623.
      Citations:    Fields:    Translation:Humans
    16. El-Serag H, Kanwal F, Ning J, Powell H, Khaderi S, Singal AG, Asrani S, Marrero JA, Amos CI, Thrift AP, Luster M, Alsarraj A, Olivares L, Skapura D, Deng J, Salem E, Najjar O, Yu X, Duong H, Scheurer ME, Ballantyne CM, Kaochar S. Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis. Gut. 2024 Feb 16. PMID: 38365278.
      Citations:    Fields:    
    17. Minhas AMK, Talha KM, Abramov D, Johnson HM, Antoine S, Rodriguez F, Fudim M, Michos ED, Misra A, Abushamat L, Nambi V, Fonarow GC, Ballantyne CM, Virani SS. Racial and ethnic disparities in cardiovascular disease - analysis across major US national databases. J Natl Med Assoc. 2024 Feb 10. PMID: 38342731.
      Citations:    Fields:    
    18. Jia X, Nambi V, Berry JD, Dalmacy D, Ascher SB, Taylor AA, Hoogeveen RC, de Lemos JA, Ballantyne CM. High-Sensitivity Cardiac Troponins I and T and Cardiovascular Outcomes: Findings from the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Chem. 2024 02 07; 70(2):414-424. PMID: 38084941.
      Citations:    Fields:    
    19. Shelbaya K, Arthur V, Yang Y, Dorbala P, Buckley L, Claggett B, Skali H, Dufresne L, Yang TY, Engert JC, Thanassoulis G, Floyd J, Austin TR, Bortnick A, Kizer J, Freitas RCC, Singh SA, Aikawa E, Hoogeveen RC, Ballantyne C, Yu B, Coresh J, Blaha MJ, Matsushita K, Shah AM. Large-Scale Proteomics Identifies Novel Biomarkers and Circulating Risk Factors for Aortic Stenosis. J Am Coll Cardiol. 2024 Feb 06; 83(5):577-591. PMID: 38296402.
      Citations:    Fields:    Translation:Humans
    20. Mok Y, Dardari Z, Sang Y, Hu X, Bancks MP, Mathews L, Hoogeveen RC, Koton S, Blaha MJ, Post WS, Ballantyne CM, Coresh J, Rosamond W, Matsushita K. Universal Risk Prediction for Individuals With and Without Atherosclerotic Cardiovascular Disease. J Am Coll Cardiol. 2024 Feb 06; 83(5):562-573. PMID: 38296400.
      Citations:    Fields:    Translation:Humans
    21. Alkis T, Luo X, Wall K, Brody J, Bartz T, Chang PP, Norby FL, Hoogeveen RC, Morrison AC, Ballantyne CM, Coresh J, Boerwinkle E, Psaty BM, Shah AM, Yu B. A polygenic risk score of atrial fibrillation improves prediction of lifetime risk for heart failure. ESC Heart Fail. 2024 Apr; 11(2):1086-1096. PMID: 38258344; PMCID: PMC10966276.
      Citations: 1     Fields:    Translation:Humans
    22. Hartig S, Felix J, Saha P, de Groot E, Tan L, Sharp R, Anaya E, Li Y, Quang H, Saidi N, Abushamat L, Ballantyne C, Amos C, Lorenzi P, Klein S, Gao X, Felix JB, Saha PK, de Groot E, Tan L, Sharp R, Anaya ES, Li Y, Quang H, Saidi N, Abushamat L, Ballantyne CM, Amos CI, Lorenzi PL, Klein S, Gao X, Hartig SM. N-acetylaspartate from fat cells regulates postprandial body temperature. Res Sq. 2024 Jan 09. PMID: 38260478; PMCID: PMC10802732.
      Citations:    
    23. Saadatagah S, Uddin MM, Weeks LD, Niroula A, Ru M, Takahashi K, Gondek L, Yu B, Bick AG, Ebert BL, Platz EA, Natarajan P, Ballantyne CM. Clonal Hematopoiesis Risk Score and All-Cause and Cardiovascular Mortality in Older Adults. JAMA Netw Open. 2024 Jan 02; 7(1):e2351927. PMID: 38231513; PMCID: PMC10794939.
      Citations:    Fields:    Translation:Humans
    24. Asghar A, Talha KM, Waqar E, Sperling LS, DiNino EK, Sharafkhaneh A, Virani SS, Ballantyne CM, Nambi V, Minhas AMK, Asghar A, Sperling LS, Sharafkhaneh A, Virani SS, Ballantyne CM, Nambi V, Minhas AMK. Trends in sleep apnea and heart failure related mortality in the United States from 1999 to 2019. Curr Probl Cardiol. 2024 Feb; 49(2):102342. PMID: 38103816.
      Citations:    Fields:    Translation:Humans
    25. Ballantyne CM, Minhas AMK, Orringer CE. Inclisiran: Where Are We on Safety, Efficacy, and Clinical Effectiveness of?siRNA Therapies for Prevention? J Am Coll Cardiol. 2023 12 12; 82(24):2262-2264. PMID: 38057067.
      Citations:    Fields:    Translation:Humans
    26. Khagi B, Belousova T, Short CM, Taylor A, Nambi V, Ballantyne CM, Bismuth J, Shah DJ, Brunner G. A machine learning-based approach to identify peripheral artery disease using texture features from contrast-enhanced magnetic resonance imaging. Magn Reson Imaging. 2024 Feb; 106:31-42. PMID: 38065273.
      Citations:    Fields:    Translation:Humans
    27. Sayed A, Navar AM, Slipczuk L, Ballantyne CM, Samad Z, Lavie CJ, Virani SS. Prevalence, Awareness, and Treatment of Elevated LDL Cholesterol in US Adults, 1999-2020. JAMA Cardiol. 2023 12 01; 8(12):1185-1187. PMID: 37910086; PMCID: PMC10620668.
      Citations:    Fields:    Translation:Humans
    28. Minhas AMK, Parwani P, Fudim M, Virani SS, Khan SS, Cullen MW, Misra A, Ballantyne C, Nambi V, Abramov D. County-Level Cardiologist Density and Mortality in the United States. J Am Heart Assoc. 2023 Dec 05; 12(23):e031686. PMID: 38014694; PMCID: PMC10727342.
      Citations: 1     Fields:    Translation:Humans
    29. Sinharoy A, Reddy N, Lin JK, Nambi V, Yang EY, Kougias P, Taylor AA, Lumsden AB, Ballantyne CM, Brunner G. Longitudinal Magnetic Resonance Imaging-Based Superficial Femoral Artery Velocity Measurements in Diabetic and Nondiabetic Patients With Peripheral Artery Disease. Top Magn Reson Imaging. 2023 Dec 01; 32(6):57-65. PMID: 38051028.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    30. Varughese MG, Ballantyne CM. The 2022 American College of Cardiology Expert Consensus on the Role of Nonstatin Therapies: An Expert-Guided Tour. Tex Heart Inst J. 2023 11 17; 50(6). PMID: 38013588; PMCID: PMC10751478.
      Citations:    Fields:    Translation:Humans
    31. Jia X, Buckley L, Sun C, Al Rifai M, Yu B, Nambi V, Virani SS, Selvin E, Matsushita K, Hoogeveen RC, Coresh J, Shah AM, Ballantyne CM, Jia X, Buckley L, Sun C, Al Rifai M, Yu B, Nambi V, Virani SS, Selvin E, Matsushita K, Hoogeveen RC, Coresh J, Shah AM, Ballantyne CM. Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study. Eur J Prev Cardiol. 2023 11 09; 30(16):1731-1740. PMID: 37306504; PMCID: PMC10637765.
      Citations:    Fields:    
    32. Deets A, Joshi PH, Chandra A, Singh K, Khera A, Virani SS, Ballantyne CM, Otvos JD, Dullaart RPF, Gruppen EG, Connelly MA, Ayers C, Navar AM, Pandey A, Wilkins JT, Rohatgi A. Novel Size-Based High-Density Lipoprotein Subspecies and Incident Vascular Events. J Am Heart Assoc. 2023 11 07; 12(21):e031160. PMID: 37929707; PMCID: PMC10727395.
      Citations: 3     Fields:    Translation:Humans
    33. Khan Minhas AM, Kobo O, Mamas MA, Al-Kindi SG, Abushamat LA, Nambi V, Michos ED, Ballantyne C, Abramov D, Minhas AMK, Al-Kindi SG, Abushamat LA, Nambi V, Michos ED, Ballantyne C, Abramov D. Social Vulnerability and Cardiovascular-Related Mortality Among Older Adults in the United States. Am J Med. 2024 Feb; 137(2):122-127.e1. PMID: 37879590.
      Citations:    Fields:    Translation:Humans
    34. Minhas AMK, Cullen MW, Mamas MA, Fudim M, Virani SS, Khan SS, Misra A, Ballantyne CM, Nambi V, Abramov D. Association Between Cardiologist Density and Mortality in Urban and Rural Counties in the United States. Am J Cardiol. 2024 Jan 01; 210:279-282. PMID: 37844717.
      Citations:    Fields:    
    35. Goldberg AC, Soffer D, Ballantyne C, Gulati M, Shapiro M. NLA/ASPC response to the USPSTF recommendation statement on screening lipid panel in children and adolescents. J Clin Lipidol. 2023 Sep-Oct; 17(5):559-560. PMID: 37806802.
      Citations:    Fields:    Translation:HumansPHPublic Health
    36. Buckley LF, Agha AM, Dorbala P, Claggett BL, Yu B, Hussain A, Nambi V, Chen LY, Matsushita K, Hoogeveen RC, Ballantyne CM, Shah AM, Buckley LF, Dorbala P, Claggett BL. MMP-2 Associates With Incident Heart Failure and Atrial Fibrillation: The ARIC Study. Circ Heart Fail. 2023 11; 16(11):e010849. PMID: 37753653; PMCID: PMC10842537.
      Citations:    Fields:    Translation:Humans
    37. Marriott RJ, Murray K, Adams RJ, Antonio L, Ballantyne CM, Bauer DC, Bhasin S, Biggs ML, Cawthon PM, Couper DJ, Dobs AS, Flicker L, Handelsman DJ, Hankey GJ, Hannemann A, Haring R, Hsu B, Karlsson M, Martin SA, Matsumoto AM, Mellstr?m D, Ohlsson C, O'Neill TW, Orwoll ES, Quartagno M, Shores MM, Steveling A, Tivesten ?, Travison TG, Vanderschueren D, Wittert GA, Wu FCW, Yeap BB. Factors Associated With Circulating Sex Hormones in Men : Individual Participant Data Meta-analyses. Ann Intern Med. 2023 09; 176(9):1221-1234. PMID: 37639720; PMCID: PMC10995451.
      Citations: 1     Fields:    
    38. Global Cardiovascular Risk Consortium, Magnussen C, Ojeda FM, Leong DP, Alegre-Diaz J, Amouyel P, Aviles-Santa L, De Bacquer D, Ballantyne CM, Bernab?-Ortiz A, Bobak M, Brenner H, Carrillo-Larco RM, de Lemos J, Dobson A, D?rr M, Donfrancesco C, Drygas W, Dullaart RP, Engstr?m G, Ferrario MM, Ferri?res J, de Gaetano G, Goldbourt U, Gonzalez C, Grassi G, Hodge AM, Hveem K, Iacoviello L, Ikram MK, Irazola V, Jobe M, Jousilahti P, Kaleebu P, Kavousi M, Kee F, Khalili D, Koenig W, Kontsevaya A, Kuulasmaa K, Lackner KJ, Leistner DM, Lind L, Linneberg A, Lorenz T, Lyngbakken MN, Malekzadeh R, Malyutina S, Mathiesen EB, Melander O, Metspalu A, Miranda JJ, Moitry M, Mugisha J, Nalini M, Nambi V, Ninomiya T, Oppermann K, d'Orsi E, Pajak A, Palmieri L, Panagiotakos D, Perianayagam A, Peters A, Poustchi H, Prentice AM, Prescott E, Ris?rus U, Salomaa V, Sans S, Sakata S, Sch?ttker B, Schutte AE, Sepanlou SG, Sharma SK, Shaw JE, Simons LA, S?derberg S, Tamosiunas A, Thorand B, Tunstall-Pedoe H, Twerenbold R, Vanuzzo D, Veronesi G, Waibel J, Wannamethee SG, Watanabe M, Wild PS, Yao Y, Zeng Y, Ziegler A, Blankenberg S. Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality. N Engl J Med. 2023 10 05; 389(14):1273-1285. PMID: 37632466; PMCID: PMC10589462.
      Citations: 16     Fields:    Translation:Humans
    39. Al Rifai M, Taffet GE, Matsushita K, Virani SS, De Lemos J, Khera A, Berry J, Ndumele C, Aguilar D, Sun C, Hoogeveen RC, Selvin E, Ballantyne CM, Nambi V. Age-Related Differences in the Contribution of Systolic Blood Pressure and Biomarkers to Cardiovascular Disease Risk Prediction: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Cardiol. 2023 10 01; 204:295-301. PMID: 37567021; PMCID: PMC10528351.
      Citations:    Fields:    Translation:Humans
    40. Ballantyne CM, Jia X. Omega-3 Fatty Acids and Risk for Atrial?Fibrillation: Big Fish or Small Fry? J Am Coll Cardiol. 2023 07 25; 82(4):350-352. PMID: 37468190.
      Citations: 3     Fields:    Translation:Animals
    41. Shapiro MD, Taub PR, Louie MJ, Lei L, Ballantyne CM. Efficacy and safety of bempedoic acid in patients with and without metabolic syndrome: Pooled analysis of data from four phase 3 clinical trials. Atherosclerosis. 2023 08; 378:117182. PMID: 37517922.
      Citations: 2     Fields:    Translation:Humans
    42. Bebo A, Jarmul JA, Pletcher MJ, Hasbani NR, Couper D, Nambi V, Ballantyne CM, Fornage M, Morrison AC, Avery CL, de Vries PS. Coronary heart disease and ischemic stroke polygenic risk scores and atherosclerotic cardiovascular disease in a diverse, population-based cohort study. PLoS One. 2023; 18(6):e0285259. PMID: 37327218; PMCID: PMC10275447.
      Citations:    Fields:    Translation:Humans
    43. Ballantyne CM, Ditmarsch M, Kastelein JJ, Nelson AJ, Kling D, Hsieh A, Curcio DL, Maki KC, Davidson MH, Nicholls SJ. Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial. J Clin Lipidol. 2023 Jul-Aug; 17(4):491-503. PMID: 37277261.
      Citations:    Fields:    
    44. Hussain A, Ramsey D, Lee M, Mahtta D, Khan MS, Nambi V, Ballantyne CM, Petersen LA, Walker AD, Kayani WT, Butler J, Slipczuk L, Rogers JG, Bozkurt B, Navaneethan SD, Virani SS. Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs. JACC Heart Fail. 2023 08; 11(8 Pt 1):933-942. PMID: 37204363.
      Citations: 1     Fields:    Translation:Humans
    45. Zhang Y, Dron JS, Bellows BK, Khera AV, Liu J, Balte PP, Oelsner EC, Amr SS, Lebo MS, Nagy A, Peloso GM, Natarajan P, Rotter JI, Willer C, Boerwinkle E, Ballantyne CM, Lutsey PL, Fornage M, Lloyd-Jones DM, Hou L, Psaty BM, Bis JC, Floyd JS, Vasan RS, Heard-Costa NL, Carson AP, Hall ME, Rich SS, Guo X, Kazi DS, de Ferranti SD, Moran AE. Association of Severe Hypercholesterolemia and Familial Hypercholesterolemia Genotype With Risk of Coronary Heart Disease. Circulation. 2023 05 16; 147(20):1556-1559. PMID: 37186683; PMCID: PMC10188204.
      Citations:    Fields:    Translation:Humans
    46. Cuchel M, Lee PC, Hudgins LC, Duell PB, Ahmad Z, Baum SJ, Linton MF, de Ferranti SD, Ballantyne CM, Larry JA, Hemphill LC, Kindt I, Gidding SS, Martin SS, Moriarty PM, Thompson PP, Underberg JA, Guyton JR, Andersen RL, Whellan DJ, Benuck I, Kane JP, Myers K, Howard W, Staszak D, Jamison A, Card MC, Bourbon M, Chora JR, Rader DJ, Knowles JW, Wilemon K, McGowan MP. Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry. J Am Heart Assoc. 2023 05 02; 12(9):e029175. PMID: 37119068; PMCID: PMC10227232.
      Citations:    Fields:    Translation:Humans
    47. Behera S, Belyeu JR, Chen X, Paulin LF, Nguyen NQH, Newman E, Mahmoud M, Menon VK, Qi Q, Joshi P, Marcovina S, Rossi M, Roller E, Han J, Onuchic V, Avery CL, Ballantyne CM, Rodriguez CJ, Kaplan RC, Muzny DM, Metcalf GA, Gibbs R, Yu B, Boerwinkle E, Eberle MA, Sedlazeck FJ. Identification of allele-specific KIV-2 repeats and impact on Lp(a) measurements for cardiovascular disease risk. bioRxiv. 2023 Apr 27. PMID: 37163057; PMCID: PMC10168217.
      Citations:    
    48. Lian Z, Perrard XD, Antony AK, Peng X, Xu L, Ni J, Zhang B, O'Brien V, Saeed A, Jia X, Hussain A, Yu B, Simon SI, Sacks FM, Hoogeveen RC, Ballantyne CM, Wu H. Dietary Effects on Monocyte Phenotypes in Subjects With Hypertriglyceridemia and Metabolic Syndrome. JACC Basic Transl Sci. 2023 May; 8(5):460-475. PMID: 37325398; PMCID: PMC10264566.
      Citations:    
    49. Ballantyne CM, Varughese MG, Abushamat LA. Lipid-Lowering Therapy in the Elderly: Are Current Guidelines a Sign of Ageism in Medical Care? J Am Coll Cardiol. 2023 04 11; 81(14):1350-1352. PMID: 37019581.
      Citations:    Fields:    Translation:Humans
    50. GOULD Investigators, Arnold SV, de Lemos JA, Zheng L, Rosenson RS, Ballantyne CM, Alam S, Bhatt DL, Cannon CP, Kosiborod M. Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study. Diabetes Obes Metab. 2023 06; 25(6):1750-1757. PMID: 36843558.
      Citations: 2     Fields:    Translation:Humans
    51. Ballantyne CM, Mendez G, Garcia R, Banka P, Rosenstock J, Rodgers A, Mendizabal G, Mitchel Y, Catapano AL. Phase 2b Randomized Trial of the Oral PCSK9 Inhibitor MK-0616. J Am Coll Cardiol. 2023 04 25; 81(16):1553-1564. PMID: 36889610.
      Citations: 7     Fields:    Translation:Humans
    52. Rosenson RS, Gaudet D, Ballantyne CM, Baum SJ, Bergeron J, Kershaw EE, Moriarty PM, Rubba P, Whitcomb DC, Banerjee P, Gewitz A, Gonzaga-Jauregui C, McGinniss J, Ponda MP, Pordy R, Zhao J, Rader DJ. Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial. Nat Med. 2023 03; 29(3):729-737. PMID: 36879129; PMCID: PMC10033404.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    53. Virani SS, Ramsey DJ, Westerman D, Kuebeler MK, Chen L, Akeroyd JM, Gobbel GT, Ballantyne CM, Petersen LA, Turchin A, Matheny ME. Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease. Circulation. 2023 05 02; 147(18):1411-1413. PMID: 36871214.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    54. Peterson BE, Bhatt DL, Ballantyne CM, de Lemos JA, Rosenson RS, Kosiborod MN, Cannon CP, GOULD Investigators. Intensity of Lipid-Lowering Therapy Among Patients With Polyvascular Disease. JAMA Netw Open. 2023 03 01; 6(3):e234709. PMID: 36972054; PMCID: PMC10043744.
      Citations:    Fields:    Translation:Humans
    55. Jia X, Al Rifai M, Hoogeveen R, Echouffo-Tcheugui JB, Shah AM, Ndumele CE, Virani SS, Bozkurt B, Selvin E, Ballantyne CM, Nambi V. Association of Long-term Change in N-Terminal Pro-B-Type Natriuretic Peptide With Incident Heart Failure and Death. JAMA Cardiol. 2023 03 01; 8(3):222-230. PMID: 36753229; PMCID: PMC9909572.
      Citations: 1     Fields:    Translation:Humans
    56. Agarwala A, Ballantyne C, Goldberg A. Reply: Sex-related differences in premature cardiovascular disease in familial hypercholesterolemia. J Clin Lipidol. 2023 Mar-Apr; 17(2):304-305. PMID: 36965960.
      Citations:    Fields:    Translation:Humans
    57. Virani SS, Aspry K, Dixon DL, Ferdinand KC, Heidenreich PA, Jackson EJ, Jacobson TA, McAlister JL, Neff DR, Gulati M, Ballantyne CM. The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint Clinical Perspective from the National Lipid Association and the American Society for Preventive Cardiology. J Clin Lipidol. 2023 Mar-Apr; 17(2):208-218. PMID: 36965958.
      Citations:    Fields:    Translation:Humans
    58. Virani SS, Aspry K, Dixon DL, Ferdinand KC, Heidenreich PA, Jackson EJ, Jacobson TA, McAlister JL, Neff DR, Gulati M, Ballantyne CM. The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint clinical perspective from the National Lipid Association and the American Society for Preventive Cardiology. Am J Prev Cardiol. 2023 Mar; 13:100472. PMID: 36970638; PMCID: PMC10037190.
      Citations: 1     
    59. Ridker PM, Lei L, Ray KK, Ballantyne CM, Bradwin G, Rifai N. Effects of bempedoic acid on CRP, IL-6, fibrinogen and lipoprotein(a) in patients with residual inflammatory risk: A secondary analysis of the CLEAR harmony trial. J Clin Lipidol. 2023 Mar-Apr; 17(2):297-302. PMID: 36813656.
      Citations: 2     Fields:    Translation:Humans
    60. Jia X, Al Rifai M, Ndumele CE, Virani SS, de Lemos JA, Lee E, Shah AM, Echouffo-Tcheugui JB, Bozkurt B, Hoogeveen R, Selvin E, Ballantyne CM, Nambi V. Reclassification of Pre-Heart Failure Stages Using Cardiac Biomarkers: The ARIC Study. JACC Heart Fail. 2023 04; 11(4):440-450. PMID: 36881398; PMCID: PMC10248756.
      Citations: 1     Fields:    Translation:Humans
    61. Gimnich OA, Belousova T, Short CM, Taylor AA, Nambi V, Morrisett JD, Ballantyne CM, Bismuth J, Shah DJ, Brunner G. Magnetic Resonance Imaging-Derived Microvascular Perfusion Modeling to Assess Peripheral Artery Disease. J Am Heart Assoc. 2023 02 07; 12(3):e027649. PMID: 36688362; PMCID: PMC9973623.
      Citations:    Fields:    Translation:Humans
    62. Schaefer EJ, Ikezaki H, Diffenderfer MR, Lim E, Liu CT, Hoogeveen RC, Guan W, Tsai MY, Ballantyne CM. Atherosclerotic cardiovascular disease risk and small dense low-density lipoprotein cholesterol in men, women, African Americans and non-African Americans: The pooling project. Atherosclerosis. 2023 02; 367:15-23. PMID: 36724690.
      Citations:    Fields:    Translation:Humans
    63. Agarwala A, Ballantyne C, Stone NJ. Primary Prevention Management of Elevated Lipoprotein(a). JAMA Cardiol. 2023 01 01; 8(1):96-97. PMID: 36383356.
      Citations:    Fields:    Translation:HumansPHPublic Health
    64. Berry JD, Ascher SB, Shlipak MG, Ix JH, Gupta R, Killeen A, Toto RD, Ballantyne CM, de Lemos JA, Chen H, Nambi V, Ambrosius WT, Kitzman DW. Effect of Intensive Blood Pressure Control on Troponin and Natriuretic Peptide Levels: Findings From SPRINT. Circulation. 2023 Jan 24; 147(4):310-323. PMID: 36533535.
      Citations:    Fields:    Translation:Humans
    65. Bohn B, Lutsey PL, Tang W, Pankow JS, Norby FL, Yu B, Ballantyne CM, Whitsel EA, Matsushita K, Demmer RT. A proteomic approach for investigating the pleiotropic effects of statins in the atherosclerosis risk in communities (ARIC) study. J Proteomics. 2023 02 10; 272:104788. PMID: 36470581; PMCID: PMC9819193.
      Citations:    Fields:    Translation:Humans
    66. Agarwala A, Deych E, Jones LK, Sturm AC, Aspry K, Ahmad Z, Ballantyne CM, Goldberg AC. Sex-related differences in premature cardiovascular disease in familial hypercholesterolemia. J Clin Lipidol. 2023 Jan-Feb; 17(1):150-156. PMID: 36470719.
      Citations: 1     Fields:    Translation:Humans
    67. Varughese MG, Deshotels MR, Zhang L, Ballantyne CM. Severe hypercholesterolemia in a patient with very low albumin and normal renal function. J Clin Lipidol. 2023 Jan-Feb; 17(1):64-67. PMID: 36411186.
      Citations:    Fields:    Translation:Humans
    68. Deshotels MR, Hadley TD, Roth M, Agha AM, Pulipati VP, Nugent AK, Virani SS, Nambi V, Moriarty PM, Davidson MH, Ballantyne CM. Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics: Implications for Precision Medicine-Brief Report. Arterioscler Thromb Vasc Biol. 2022 Dec; 42(12):1461-1467. PMID: 36325899.
      Citations: 1     Fields:    Translation:Humans
    69. Deshotels MR, Sun C, Nambi V, Virani SS, Matsushita K, Yu B, Ballantyne CM, Hoogeveen RC. Temporal Trends in Lipoprotein(a) Concentrations: The Atherosclerosis Risk in Communities Study. J Am Heart Assoc. 2022 Nov; 11(21):e026762. PMID: 36285784; PMCID: PMC9673625.
      Citations:    Fields:    Translation:Humans
    70. Smith HS, Sanchez CE, Maag R, Buentello A, Murdock DR, Metcalf GA, Hadley TD, Riconda DL, Boerwinkle E, Wehrens XHT, Ballantyne CM, Gibbs RA, McGuire AL, Pereira S. Patient and Clinician Perceptions of Precision Cardiology Care: Findings From the HeartCare Study. Circ Genom Precis Med. 2022 12; 15(6):e003605. PMID: 36282588; PMCID: PMC10163837.
      Citations:    Fields:    Translation:Humans
    71. Ascher SB, de Lemos JA, Lee M, Wu E, Soliman EZ, Neeland IJ, Kitzman DW, Ballantyne CM, Nambi V, Killeen AA, Ix JH, Shlipak MG, Berry JD. Intensive Blood Pressure Lowering in?Patients With Malignant Left?Ventricular?Hypertrophy. J Am Coll Cardiol. 2022 10 18; 80(16):1516-1525. PMID: 36229087; PMCID: PMC9982833.
      Citations: 2     Fields:    Translation:Humans
    72. Hamo CE, Echouffo-Tcheugui JB, Zhang S, Florido R, Pankow JS, Michos ED, Goldberg R, Nambi V, Gerstenblith G, Post WS, Blumenthal RS, Ballantyne C, Selvin E, Coresh J, Ndumele CE. Diabetes Duration and Subclinical Myocardial Injury: The Atherosclerosis Risk in Communities Study (ARIC). Clin Chem. 2022 10 06; 68(10):1272-1280. PMID: 35904048; PMCID: PMC9766881.
      Citations:    Fields:    
    73. Al Rifai M, Szklo M, Patel J, Blaha MJ, Ballantyne CM, Bittner V, Morris P, McEvoy JW, Shapiro MD, Al-Mallah MH, Greenland P, Virani SS. Statin Use and Risk of Diabetes by Subclinical Atherosclerosis Burden (from a Multi-Ethnic Study of Atherosclerosis Report). Am J Cardiol. 2022 12 01; 184:7-13. PMID: 36192199; PMCID: PMC10458502.
      Citations:    Fields:    Translation:Humans
    74. Shaik A, Kosiborod M, de Lemos JA, Gao Q, Mues KE, Alam S, Bhatt DL, Cannon CP, Ballantyne CM, Rosenson RS, GOULD Investigators. Use of lipid-lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2-year results from Getting to an imprOved Understanding of Low-Density lipoprotein cholesterol and dyslipidemia management (GOULD). Clin Cardiol. 2022 Sep 19. PMID: 36124341.
      Citations:    
    75. Saadatagah S, Ballantyne CM. Clonal hematopoiesis of indeterminate potential and cardiovascular disease. Transl Res. 2023 05; 255:152-158. PMID: 36067904.
      Citations:    
    76. Writing Committee, Lloyd-Jones DM, Morris PB, Ballantyne CM, Birtcher KK, Covington AM, DePalma SM, Minissian MB, Orringer CE, Smith SC, Waring AA, Wilkins JT. 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2022 10 04; 80(14):1366-1418. PMID: 36031461.
      Citations:    
    77. Gimnich OA, Ortiz CB, Yang EY, Chen C, Virani SS, Kougias P, Lumsden AB, Morrisett JD, Ballantyne CM, Nambi V, Brunner G. Comparison of Longitudinal Skeletal Thigh Muscle Findings With Magnetic Resonance Imaging in Patients With Peripheral Artery Disease With-Versus-Without Diabetes Mellitus. Am J Cardiol. 2022 10 15; 181:130-138. PMID: 35999068.
      Citations:    
    78. Al Rifai M, Yao J, Guo X, Post WS, Malik S, Blumenthal RS, Ballantyne CM, Budoff M, Taylor KD, Lin HJ, Rich SS, Hajek C, Greenland P, Rotter JI, Virani SS. Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosis. Prog Cardiovasc Dis. 2022 Sep-Oct; 74:19-27. PMID: 35952728; PMCID: PMC10240572.
      Citations:    
    79. Sinharoy A, Reddy N, Lin JK, Nambi V, Yang EY, Kougias P, Taylor AA, Lumsden AB, Ballantyne CM, Morrisett JD, Brunner G. Magnetic resonance imaging based superficial femoral artery velocity measurements in peripheral artery disease. Magn Reson Imaging. 2022 11; 93:128-134. PMID: 35940380.
      Citations:    
    80. Ballantyne CM, Bays HE, Louie MJ, Smart J, Zhang Y, Ray KK. Factors Associated With Enhanced Low-Density Lipoprotein Cholesterol Lowering With Bempedoic Acid. J Am Heart Assoc. 2022 08 02; 11(15):e024531. PMID: 35916348; PMCID: PMC9375471.
      Citations:    
    81. Jia X, Al Rifai M, Saeed A, Ballantyne CM, Virani SS. PCSK9 Inhibitors in the Management of Cardiovascular Risk: A Practical Guidance. Vasc Health Risk Manag. 2022; 18:555-566. PMID: 35898405; PMCID: PMC9309324.
      Citations:    Fields:    Translation:Humans
    82. Abushamat LA, Ballantyne CM. Lowering LDL cholesterol in clinical practice: time for change? Lancet. 2022 07 30; 400(10349):341-343. PMID: 35863368.
      Citations:    Fields:    
    83. Ridker PM, Rifai N, MacFadyen J, Glynn RJ, Jiao L, Miller M, Brinton EA, Jacobson TA, Ballantyne CM, Mason RP, Bhatt DL, Steg PG, Tardif JC. Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1?, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy. Circulation. 2022 Aug 02; 146(5):372-379. PMID: 35762321.
      Citations:    Fields:    
    84. Karwatowska-Prokopczuk E, Tardif JC, Gaudet D, Ballantyne CM, Shapiro MD, Moriarty PM, Baum SJ, Amour ES, Alexander VJ, Xia S, Otvos JD, Witztum JL, Tsimikas S, Olezarsen Trial Investigators. Effect of olezarsen targeting APOC-III on lipoprotein size and particle number measured by NMR in patients with hypertriglyceridemia. J Clin Lipidol. 2022 Sep-Oct; 16(5):617-625. PMID: 35902351.
      Citations:    
    85. Obisesan OH, Kou M, Wang FM, Boakye E, Honda Y, Uddin SMI, Dzaye O, Osei AD, Orimoloye OA, Howard-Claudio CM, Coresh J, Blumenthal RS, Hoogeveen RC, Budoff MJ, Matsushita K, Ballantyne CM, Blaha MJ. Lipoprotein(a) and Subclinical Vascular and Valvular Calcification on Cardiac Computed Tomography: The Atherosclerosis Risk in Communities Study. J Am Heart Assoc. 2022 06 07; 11(11):e024870. PMID: 35656990; PMCID: PMC9238743.
      Citations:    Fields:    Translation:Humans
    86. Peng X, Lian Z, Perrard XD, Xiao Y, Ni J, O'Brien V, Dong H, Pownall HJ, Ballantyne CM, Wu H. Poloxamer 407 Induces Hypertriglyceridemia but Decreases Atherosclerosis in Ldlr-/- Mice. Cells. 2022 05 30; 11(11). PMID: 35681489; PMCID: PMC9179832.
      Citations:    Fields:    Translation:AnimalsCells
    87. Gunn LH, McKay AJ, Feng A, Louie MJ, Ballantyne CM, Ray KK. Estimated cardiovascular benefits of bempedoic acid in patients with established cardiovascular disease. Atheroscler Plus. 2022 Aug; 49:20-27. PMID: 36644205; PMCID: PMC9833227.
      Citations: 1     
    88. Virani SS, Ballantyne CM, Petersen LA. Guideline-Concordant Statin Therapy Use?in Secondary Prevention: Should the Medical Community Wait for Divine Intervention? J Am Coll Cardiol. 2022 05 10; 79(18):1814-1817. PMID: 35512861.
      Citations:    Fields:    Translation:HumansPHPublic Health
    89. Gaba P, Bhatt DL, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Juliano RA, Jiao L, Doyle RT, Granowitz C, Giugliano RP, Martens FMAC, Gibson CM, Ballantyne CM, REDUCE-IT Investigators, Steg PG, Tardif JC. Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior?Myocardial Infarction. J Am Coll Cardiol. 2022 05 03; 79(17):1660-1671. PMID: 35483753.
      Citations:    Fields:    Translation:Humans
    90. Ballantyne CM, Davis JW. Exercise and Mortality in Heart?Disease?Cohorts: Meta-Analysis to Augment Available Evidence. J Am Coll Cardiol. 2022 05 03; 79(17):1701-1703. PMID: 35483758.
      Citations:    Fields:    Translation:Humans
    91. Florido R, Kwak L, Echouffo-Tcheugui JB, Zhang S, Michos ED, Nambi V, Goldberg RB, Hoogeveen RC, Lazo M, Gerstenblith G, Post WS, Blumenthal RS, Coresh J, Folsom AR, Selvin E, Ballantyne C, Ndumele CE. Obesity, Galectin-3, and Incident Heart Failure: The ARIC Study. J Am Heart Assoc. 2022 05 03; 11(9):e023238. PMID: 35491999; PMCID: PMC9238585.
      Citations:    Fields:    Translation:Humans
    92. Schwartz GG, Ballantyne CM. Existing and emerging strategies to lower Lipoprotein(a). Atherosclerosis. 2022 05; 349:110-122. PMID: 35606071.
      Citations:    Fields:    Translation:Humans
    93. Mehta A, Jain V, Saeed A, Saseen JJ, Gulati M, Ballantyne CM, Virani SS. Lipoprotein(a) and ethnicities. Atherosclerosis. 2022 05; 349:42-52. PMID: 35606075.
      Citations:    Fields:    Translation:Humans
    94. Jia X, Sun C, Nambi V, Virani SS, Taffet G, Boerwinkle E, Bressler J, Ndumele C, Windham BG, de Lemos JA, Matsushita K, McEvoy JW, Hoogeveen RC, Selvin E, Ballantyne CM. Midlife determinants of healthy cardiovascular aging: The Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis. 2022 06; 350:82-89. PMID: 35550933; PMCID: PMC9627572.
      Citations:    Fields:    Translation:Humans
    95. Ballantyne CM, Bays HE, Catapano AL, Stroes ESG, Robinson P, Lei L, Ray KK, Banach M, Laufs U. Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension Study). Am J Cardiol. 2022 07 01; 174:1-11. PMID: 35483979.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    96. Tardif JC, Karwatowska-Prokopczuk E, Amour ES, Ballantyne CM, Shapiro MD, Moriarty PM, Baum SJ, Hurh E, Bartlett VJ, Kingsbury J, Figueroa AL, Alexander VJ, Tami J, Witztum JL, Geary RS, O'Dea LSL, Tsimikas S, Gaudet D. Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk. Eur Heart J. 2022 04 06; 43(14):1401-1412. PMID: 35025993; PMCID: PMC8986458.
      Citations: 5     Fields:    Translation:Humans
    97. Selvaraj S, Bhatt DL, Miller M, Brinton EA, Jacobson TA, Juliano RA, Jiao L, Ballantyne CM, REDUCE-IT Investigators, Steg PG, Tardif JC. Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE-IT. J Am Heart Assoc. 2022 04 05; 11(7):e024999. PMID: 35377160; PMCID: PMC9075460.
      Citations:    Fields:    Translation:Humans
    98. Ballantyne CM, Bays H, Catapano AL, Duell PB, Goldberg AC, Gotto AM, Leiter LA, Ray KK, Bloedon LT, MacDougall D, Zhang Y, Mancini GBJ, Laufs U, Banach M. Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials. J Clin Lipidol. 2022 May-Jun; 16(3):286-297. PMID: 35346603.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    99. Hussain A, Sun C, Selvin E, Nambi V, Coresh J, Jia X, Ballantyne CM, Hoogeveen RC. Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study. Eur J Prev Cardiol. 2022 03 11; 29(2):e53-e64. PMID: 33580780; PMCID: PMC8277878.
      Citations: 2     Fields:    Translation:Humans
    100. Peterson BE, Bhatt DL, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Juliano RA, Jiao L, Doyle RT, Granowitz C, Gibson CM, Pinto D, Giugliano RP, Budoff MJ, Verma S, Ballantyne CM, REDUCE-IT Investigators, Steg PG, Tardif JC. Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI. J Am Heart Assoc. 2022 03 15; 11(6):e022937. PMID: 35261279; PMCID: PMC9075300.
      Citations:    Fields:    Translation:Humans
    101. Ascher SB, Scherzer R, de Lemos JA, Estrella MM, Jotwani VK, Garimella PS, Bullen AL, Ambrosius WT, Ballantyne CM, Nambi V, Killeen AA, Ix JH, Shlipak MG, Berry JD. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Serious Adverse Events in SPRINT. J Am Heart Assoc. 2022 03 15; 11(6):e023314. PMID: 35243872; PMCID: PMC9075292.
      Citations:    Fields:    Translation:Humans
    102. Maki KC, Bays HE, Ballantyne CM, Underberg JA, Kastelein JJP, Johnson JB, Ferguson JJ. A Head-to-Head Comparison of a Free Fatty Acid Formulation of Omega-3 Pentaenoic Acids Versus Icosapent Ethyl in Adults With Hypertriglyceridemia: The ENHANCE-IT Study. J Am Heart Assoc. 2022 03 15; 11(6):e024176. PMID: 35232215; PMCID: PMC9075326.
      Citations:    Fields:    Translation:Humans
    103. Kianoush S, Al Rifai M, Patel J, George J, Gulati M, Taub P, Moran T, Shapiro MD, Agarwala A, Ullah W, Lavie CJ, Bittner V, Ballantyne CM, Virani SS. Association of participation in Cardiac Rehabilitation with Social Vulnerability Index: The behavioral risk factor surveillance system. Prog Cardiovasc Dis. 2022 Mar-Apr; 71:86-91. PMID: 35182577.
      Citations:    Fields:    Translation:Humans
    104. Hamo CE, Kwak L, Wang D, Florido R, Echouffo-Tcheugui JB, Blumenthal RS, Loehr L, Matsushita K, Nambi V, Ballantyne CM, Selvin E, Folsom AR, Heiss G, Coresh J, Ndumele CE. Heart Failure Risk Associated With Severity of Modifiable Heart Failure Risk Factors: The ARIC Study. J Am Heart Assoc. 2022 02 15; 11(4):e021583. PMID: 35156388; PMCID: PMC9245814.
      Citations:    Fields:    Translation:Humans
    105. Vaughan EM, Johnson E, Naik AD, Amspoker AB, Balasubramanyam A, Virani SS, Ballantyne CM, Johnston CA, Foreyt JP. Long-Term Effectiveness of the TIME Intervention to Improve Diabetes Outcomes in Low-Income Settings: a 2-Year Follow-Up. J Gen Intern Med. 2022 09; 37(12):3062-3069. PMID: 35132555; PMCID: PMC8821843.
      Citations:    Fields:    
    106. Weintraub WS, Bhatt DL, Zhang Z, Dolman S, Boden WE, Bress AP, King JB, Bellows BK, Tajeu GS, Derington CG, Johnson J, Andrade K, Miller M, Brinton EA, Jacobson TA, Ballantyne CM, Kolm P, Steg PG, Tardif JC. Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment. JAMA Netw Open. 2022 02 01; 5(2):e2148172. PMID: 35157055; PMCID: PMC8844997.
      Citations: 2     Fields:    Translation:Humans
    107. Mahtta D, Ramsey DJ, Lee MT, Chen L, Al Rifai M, Akeroyd JM, Vaughan EM, Matheny ME, Navaneethan SD, Lavie CJ, Birnbaum Y, Ballantyne CM, Petersen LA, Virani SS, Santo KRDE. Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs. Diabetes Care. 2022 02 01; 45(2):372-380. PMID: 35015080; PMCID: PMC8914426.
      Citations:    Fields:    Translation:Humans
    108. Singh N, Bhatt DL, Miller M, Steg PG, Brinton EA, Jacobson TA, Jiao L, Tardif JC, Mason RP, Ballantyne CM, REDUCE-IT Investigators. Consistency of Benefit of Icosapent Ethyl by Background Statin Type in REDUCE-IT. J Am Coll Cardiol. 2022 01 18; 79(2):220-222. PMID: 35027114; PMCID: PMC8972488.
      Citations:    Fields:    Translation:Humans
    109. Norby FL, Tang W, Pankow JS, Lutsey PL, Alonso A, Chen LY, Zhang M, Shippee ND, Ballantyne CM, Boerwinkle E, Coresh J, Folsom AR, Steffen BT. Proteomics and Risk of Atrial Fibrillation in Older Adults (From the Atherosclerosis Risk in Communities [ARIC] Study). Am J Cardiol. 2021 12 15; 161:42-50. PMID: 34794617; PMCID: PMC8608272.
      Citations: 1     Fields:    Translation:Humans
    110. Al Rifai M, Blaha MJ, Nambi V, Shea SJC, Michos ED, Blumenthal RS, Ballantyne CM, Szklo M, Greenland P, Miedema MD, Nasir K, Rotter JI, Guo X, Yao J, Post WS, Virani SS. Determinants of Incident Atherosclerotic Cardiovascular Disease Events Among Those With Absent Coronary Artery Calcium: Multi-Ethnic Study of Atherosclerosis. Circulation. 2022 01 25; 145(4):259-267. PMID: 34879218; PMCID: PMC8792296.
      Citations: 3     Fields:    Translation:Humans
    111. Handelsman Y, Anderson JE, Bakris GL, Ballantyne CM, Beckman JA, Bhatt DL, Bloomgarden ZT, Bozkurt B, Budoff MJ, Butler J, Dagogo-Jack S, de Boer IH, DeFronzo RA, Eckel RH, Einhorn D, Fonseca VA, Green JB, Grunberger G, Guerin C, Inzucchi SE, Jellinger PS, Kosiborod MN, Kushner P, Lepor N, Mende CW, Michos ED, Plutzky J, Taub PR, Umpierrez GE, Vaduganathan M, Weir MR. DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases. J Diabetes Complications. 2022 02; 36(2):108101. PMID: 34922811.
      Citations: 1     Fields:    Translation:Humans
    112. Gobbel GT, Matheny ME, Reeves RR, Akeroyd JM, Turchin A, Ballantyne CM, Petersen LA, Virani SS. Leveraging structured and unstructured electronic health record data to detect reasons for suboptimal statin therapy use in patients with atherosclerotic cardiovascular disease. Am J Prev Cardiol. 2022 Mar; 9:100300. PMID: 34950914; PMCID: PMC8671496.
      Citations:    
    113. Berry JD, Nambi V, Ambrosius WT, Chen H, Killeen AA, Taylor A, Toto RD, Soliman EZ, McEvoy JW, Pandey A, Joshi PH, Blankenberg S, Kitzman DW, Ballantyne CM, de Lemos JA. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering: Findings From the SPRINT Randomized Clinical Trial. JAMA Cardiol. 2021 12 01; 6(12):1397-1405. PMID: 34468696; PMCID: PMC8411355.
      Citations: 1     Fields:    Translation:Humans
    114. Rifai MA, Ballantyne CM. PCSK9-targeted therapies: present and future approaches. Nat Rev Cardiol. 2021 12; 18(12):805-806. PMID: 34663945.
      Citations: 2     Fields:    Translation:Humans
    115. Rana JS, Virani SS, Moffet HH, Liu JY, Coghlan LA, Vasadia J, Ballantyne CM, Karter AJ. Association of Low-Density Lipoprotein Testing After an Atherosclerotic Cardiovascular Event with Subsequent Statin Adherence and Intensification. Am J Med. 2022 05; 135(5):603-606. PMID: 34861203; PMCID: PMC9081243.
      Citations: 1     Fields:    Translation:Humans
    116. Honda Y, Mok Y, Ishigami J, Ashley KE, Hoogeveen RC, Ballantyne CM, Karger AB, Couper D, Selvin E, Matsushita K. The Fifth-Generation Cardiac Troponin T and Cardiovascular Disease in the Community. J Am Coll Cardiol. 2021 11 16; 78(20):2019-2021. PMID: 34763781.
      Citations:    Fields:    Translation:Humans
    117. Quispe R, Martin SS, Michos ED, Lamba I, Blumenthal RS, Saeed A, Lima J, Puri R, Nomura S, Tsai M, Wilkins J, Ballantyne CM, Nicholls S, Jones SR, Elshazly MB. Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study. Eur Heart J. 2021 11 07; 42(42):4324-4332. PMID: 34293083; PMCID: PMC8572557.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    118. Majithia A, Bhatt DL, Friedman AN, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Juliano RA, Jiao L, Doyle RT, Granowitz C, Budoff M, Preston Mason R, Boden WE, Ballantyne CM, Steg PG, Tardif JC. Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL. Circulation. 2021 11 30; 144(22):1750-1759. PMID: 34706555; PMCID: PMC8614567.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    119. Bhatt DL, Miller M, Brinton EA, Jacobson TA, Dhingra NK, Ketchum SB, Juliano RA, Jiao L, Doyle RT, Granowitz C, Gibson CM, Pinto D, Giugliano RP, Budoff MJ, Mason RP, Ballantyne CM, REDUCE-IT Investigators, Verma S, Steg PG, Tardif JC. Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG. Circulation. 2021 12 07; 144(23):1845-1855. PMID: 34710343.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    120. Gaba P, Bhatt DL, Giugliano RP, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Juliano RA, Jiao L, Doyle RT, Granowitz C, Ballantyne CM, Pinto DS, Budoff MJ, Gibson CM, Steg PG, Tardif JC. Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT. J Am Coll Cardiol. 2021 10 12; 78(15):1525-1537. PMID: 34620410.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    121. Bays HE, Baum SJ, Brinton EA, Plutzky J, Hanselman JC, Teng R, Ballantyne CM. Effect of bempedoic acid plus ezetimibe fixed-dose combination vs ezetimibe or placebo on low-density lipoprotein cholesterol in patients with type 2 diabetes and hypercholesterolemia not treated with statins. Am J Prev Cardiol. 2021 Dec; 8:100278. PMID: 34746903; PMCID: PMC8550983.
      Citations: 2     
    122. Jia X, Lee MT, Ramsey DJ, Mahtta D, Akeroyd JM, Turchin A, Navar AM, Matheny ME, Gobbel G, Stone NJ, Nambi V, Ballantyne CM, Petersen LA, Virani SS. Association of patient, provider and facility related characteristics with statin associated side effects and statin use: Insight from the Veteran's Affairs healthcare system. J Clin Lipidol. 2021 Nov-Dec; 15(6):832-839. PMID: 34666951.
      Citations:    Fields:    Translation:Humans
    123. Wilson PWF, Jacobson TA, Martin SS, Jackson EJ, Le NA, Davidson MH, Vesper HW, Frikke-Schmidt R, Ballantyne CM, Remaley AT. Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group. J Clin Lipidol. 2021 Sep-Oct; 15(5):629-648. PMID: 34802986.
      Citations: 5     Fields:    Translation:Humans
    124. Nissen SE, Hutchinson HG, Wang TY, Ballantyne CM, Travis S, Morris M, Miller W, Hynson J, Wolski K, Ridker PM. Technology-Assisted Self-Selection of Candidates for Nonprescription Statin?Therapy. J Am Coll Cardiol. 2021 09 14; 78(11):1114-1123. PMID: 34503680.
      Citations:    Fields:    Translation:Humans
    125. Mao H, Li L, Fan Q, Angelini A, Saha PK, Coarfa C, Rajapakshe K, Perera D, Cheng J, Wu H, Ballantyne CM, Sun Z, Xie L, Pi X. Endothelium-specific depletion of LRP1 improves glucose homeostasis through inducing osteocalcin. Nat Commun. 2021 09 06; 12(1):5296. PMID: 34489478; PMCID: PMC8421392.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    126. Saeed A, Zhu J, Thoma F, Marroquin O, Aiyer A, Agarwala A, Virani SS, Gulati M, Lee JS, Reis S, Saba S, Ballantyne C, Mulukutla S. Cardiovascular Disease Risk-Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network. Circ Cardiovasc Qual Outcomes. 2021 09; 14(9):e007485. PMID: 34455825.
      Citations:    Fields:    Translation:HumansPHPublic Health
    127. Garg PK, Norby FL, Wang W, Krishnappa D, Soliman EZ, Lutsey PL, Selvin E, Ballantyne CM, Alonso A, Chen LY. Association of Longitudinal Changes in Cardiac Biomarkers With Atrial and Ventricular Arrhythmias (from the Atherosclerosis Risk in Communities [ARIC] Study). Am J Cardiol. 2021 11 01; 158:45-52. PMID: 34465464; PMCID: PMC8497411.
      Citations: 1     Fields:    Translation:Humans
    128. Agarwala A, Bekele N, Deych E, Rich MW, Hussain A, Jones LK, Sturm AC, Aspry K, Nowak E, Ahmad Z, Ballantyne CM, Goldberg AC. Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial Hypercholesterolemia. J Am Heart Assoc. 2021 09 07; 10(17):e020890. PMID: 34431361; PMCID: PMC8649284.
      Citations: 1     Fields:    Translation:Humans
    129. Arnold SV, Cannon CP, de Lemos JA, Rosenson RS, Ballantyne CM, Liu Y, Alam S, Mues KE, Bhatt DL, Kosiborod M, GOULD Investigators. What Do US Physicians and Patients Think About Lipid-Lowering Therapy and Goals of Treatment? Results From the GOULD Registry. J Am Heart Assoc. 2021 08 17; 10(16):e020893. PMID: 34369165; PMCID: PMC8475019.
      Citations:    Fields:    Translation:HumansCells
    130. Murdock DR, Venner E, Muzny DM, Metcalf GA, Murugan M, Hadley TD, Chander V, de Vries PS, Jia X, Hussain A, Agha AM, Sabo A, Li S, Meng Q, Hu J, Tian X, Cohen M, Yi V, Kovar CL, Gingras MC, Korchina V, Howard C, Riconda DL, Pereira S, Smith HS, Huda ZA, Buentello A, Marino PR, Leiber L, Balasubramanyam A, Amos CI, Civitello AB, Chelu MG, Maag R, McGuire AL, Boerwinkle E, Wehrens XHT, Ballantyne CM, Gibbs RA. Genetic testing in ambulatory cardiology clinics reveals high rate of findings with clinical management implications. Genet Med. 2021 12; 23(12):2404-2414. PMID: 34363016; PMCID: PMC8931845.
      Citations: 3     Fields:    Translation:Humans
    131. Jia X, Sun C, Tanaka H, Al Rifai M, Aguilar D, Ndumele C, Selvin E, Virani SS, Hoogeveen RC, Heiss G, Ballantyne CM, Nambi V. Association between circulating Galectin-3 and arterial stiffness in older adults. Vasa. 2021 Nov; 50(6):439-445. PMID: 34346252; PMCID: PMC8620155.
      Citations:    Fields:    Translation:Humans
    132. Vaughan EM, Naik AD, Amspoker AB, Johnston CA, Landrum JD, Balasubramanyam A, Virani SS, Ballantyne CM, Foreyt JP. Mentored implementation to initiate a diabetes program in an underserved community: a pilot study. BMJ Open Diabetes Res Care. 2021 08; 9(1). PMID: 34385148; PMCID: PMC8362735.
      Citations: 1     Translation:Humans
    133. Echouffo-Tcheugui JB, Zhang S, Florido R, Hamo C, Pankow JS, Michos ED, Goldberg RB, Nambi V, Gerstenblith G, Post WS, Blumenthal RS, Ballantyne CM, Coresh J, Selvin E, Ndumele CE. Duration of Diabetes and Incident?Heart?Failure: The ARIC (Atherosclerosis Risk In Communities) Study. JACC Heart Fail. 2021 08; 9(8):594-603. PMID: 34325890; PMCID: PMC8629143.
      Citations: 4     Fields:    Translation:Humans
    134. Ballantyne CM, Bays H, Catapano AL, Goldberg A, Ray KK, Saseen JJ. Correction to: Role of Bempedoic Acid in Clinical Practice. Cardiovasc Drugs Ther. 2021 Aug; 35(4):865. PMID: 33871715; PMCID: PMC8266693.
      Citations:    Fields:    
    135. Virani SS, Morris PB, Agarwala A, Ballantyne CM, Birtcher KK, Kris-Etherton PM, Ladden-Stirling AB, Miller M, Orringer CE, Stone NJ. 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2021 08 31; 78(9):960-993. PMID: 34332805.
      Citations: 14     Fields:    Translation:Humans
    136. Cohen AJ, Teramoto K, Claggett B, Buckley L, Solomon S, Ballantyne C, Selvin E, Shah AM. Mid- to Late-Life Inflammation and Risk of Cardiac Dysfunction, HFpEF and HFrEF in Late Life. J Card Fail. 2021 12; 27(12):1382-1392. PMID: 34314823; PMCID: PMC8823406.
      Citations:    Fields:    Translation:Humans
    137. Bansal N, Zelnick LR, Ballantyne CM, Chaves PHM, Christenson RH, Coresh J, deFilippi CR, de Lemos JA, Daniels LB, Go AS, He J, Hedayati SS, Matsushita K, Nambi V, Shlipak MG, Taliercio JJ, Seliger SL, CRIC Study Investigators. Upper Reference Limits for High-Sensitivity Cardiac Troponin T and N-Terminal Fragment of the Prohormone Brain Natriuretic Peptide in Patients With CKD. Am J Kidney Dis. 2022 Mar; 79(3):383-392. PMID: 34293394; PMCID: PMC8766621.
      Citations: 1     Fields:    Translation:Humans
    138. Deshotels MR, Virani SS, Ballantyne CM. Lipid Monitoring After Initiation of Lipid-Lowering Therapies: Return of Performance Measures? Curr Cardiol Rep. 2021 07 16; 23(9):116. PMID: 34269897.
      Citations:    Fields:    Translation:Humans
    139. Agha AM, Jones PH, Ballantyne CM, Virani SS, Nambi V. Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH). J Clin Lipidol. 2021 Sep-Oct; 15(5):649-652. PMID: 34393074.
      Citations: 2     Fields:    Translation:Humans
    140. Khan SU, Lone AN, Khan MS, Virani SS, Blumenthal RS, Nasir K, Miller M, Michos ED, Ballantyne CM, Boden WE, Bhatt DL. Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis. EClinicalMedicine. 2021 Aug; 38:100997. PMID: 34505026; PMCID: PMC8413259.
      Citations: 13     
    141. Yu B, Roberts MB, Raffield LM, Zekavat SM, Nguyen NQH, Biggs ML, Brown MR, Griffin G, Desai P, Correa A, Morrison AC, Shah AM, Niroula A, Uddin MM, Honigberg MC, Ebert BL, Psaty BM, Whitsel EA, Manson JE, Kooperberg C, Bick AG, Ballantyne CM, Reiner AP, Natarajan P, Eaton CB, National Heart, Lung, and Blood Institute TOPMed Consortium. Supplemental Association of Clonal Hematopoiesis With Incident Heart?Failure. J Am Coll Cardiol. 2021 07 06; 78(1):42-52. PMID: 34210413; PMCID: PMC8313294.
      Citations: 9     Fields:    Translation:Humans
    142. Al Rifai M, Mahtta D, Kherallah R, Kianoush S, Liu J, Rodriguez F, Nasir K, Valero J, Khan SU, Ballantyne C, Petersen LA, Virani SS. Prevalence and Determinants of Difficulty in Accessing Medical Care in U.S. Adults. Am J Prev Med. 2021 10; 61(4):492-500. PMID: 34229931.
      Citations: 1     Fields:    Translation:Humans
    143. Lee MT, Mahtta D, Ramsey DJ, Liu J, Misra A, Nasir K, Samad Z, Itchhaporia D, Khan SU, Schofield RS, Ballantyne CM, Petersen LA, Virani SS. Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease. JAMA Cardiol. 2021 07 01; 6(7):782-790. PMID: 33881448; PMCID: PMC8060887.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    144. Agarwala A, Goldberg AC, Ballantyne CM, Guyton JR. JCL Roundtable. Making prevention a priority. J Clin Lipidol. 2021 Jul-Aug; 15(4):530-537. PMID: 34815066.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    145. Ballantyne CM, Nambi V. Statins and Your Memory: "Forget" About It? J Am Coll Cardiol. 2021 06 29; 77(25):3157-3159. PMID: 34167640; PMCID: PMC9090519.
      Citations:    Fields:    Translation:Humans
    146. Cannon CP, de Lemos JA, Rosenson RS, Ballantyne CM, Liu Y, Gao Q, Palagashvilli T, Alam S, Mues KE, Bhatt DL, Kosiborod MN, GOULD Investigators. Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US. JAMA Cardiol. 2021 Jun 16. PMID: 34132735; PMCID: PMC8209562.
      Citations: 3     Fields:    
    147. Wright JD, Folsom AR, Coresh J, Sharrett AR, Couper D, Wagenknecht LE, Mosley TH, Ballantyne CM, Boerwinkle EA, Rosamond WD, Heiss G. The ARIC (Atherosclerosis Risk In Communities) Study: JACC Focus Seminar 3/8. J Am Coll Cardiol. 2021 06 15; 77(23):2939-2959. PMID: 34112321; PMCID: PMC8667593.
      Citations: 16     Fields:    Translation:HumansPHPublic Health
    148. Al Rifai M, Jia X, Pickett J, Hussain A, Navaneethan SD, Birtcher KK, Ballantyne C, Petersen LA, Virani SS. Social Determinants of Health and Comorbidities Among Individuals with Atherosclerotic Cardiovascular Disease: The Behavioral Risk Factor Surveillance System Survey. Popul Health Manag. 2022 02; 25(1):39-45. PMID: 34129402.
      Citations: 1     Fields:    Translation:Humans
    149. Shapiro MD, Ballantyne CM, Santos RD. Glycated Hemoglobin to Detect Subclinical Atherosclerosis in People Without Diabetes. J Am Coll Cardiol. 2021 06 08; 77(22):2792-2795. PMID: 34082908.
      Citations: 3     Fields:    Translation:Humans
    150. Wang Q, Su X, He Y, Wang M, Yang D, Zhang R, Wei J, Ma Q, Zhai W, Pang A, Huang Y, Feng S, Ballantyne CM, Wu H, Pei X, Feng X, Han M, Jiang E. CD11c participates in triggering acute graft-versus-host disease during bone marrow transplantation. Immunology. 2021 09; 164(1):148-160. PMID: 33934334; PMCID: PMC8358721.
      Citations: 1     Fields:    Translation:AnimalsCells
    151. Jia X, Gao F, Pickett JK, Al Rifai M, Birnbaum Y, Nambi V, Virani SS, Ballantyne CM. Association Between Omega-3 Fatty Acid Treatment and Atrial Fibrillation in Cardiovascular Outcome Trials: A Systematic Review and Meta-Analysis. Cardiovasc Drugs Ther. 2021 08; 35(4):793-800. PMID: 34057665.
      Citations:    Fields:    Translation:Humans
    152. Virani SS, Nambi V, Ballantyne CM. Has the 'strength' of fish oil therapy been 'reduced'? Reconciling the results of REDUCE-IT and STRENGTH. Eur Heart J Cardiovasc Pharmacother. 2021 05 23; 7(3):e7-e8. PMID: 33537734.
      Citations:    Fields:    Translation:Humans
    153. Nissen SE, Lincoff AM, Wolski K, Ballantyne CM, Kastelein JJP, Ridker PM, Ray KK, McGuire DK, Mozaffarian D, Davidson MH, Garcia M, Katona BG, Himmelmann A, Loss LE, Poole M, Menon V, Nicholls SJ, Koenig W. Association Between Achieved ?-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk: A Secondary Analysis of the STRENGTH Trial. JAMA Cardiol. 2021 May 16. PMID: 33993205; PMCID: PMC8126992.
      Citations: 5     Fields:    
    154. Schunk SJ, Kleber ME, Zewinger S, Triem S, Ege P, Jaumann I, Schmit D, Sarakpi T, Kramann R, Boerwinkle E, Ballantyne CM, Grove ML, Tragante V, Pilbrow AP, Richards AM, Cameron VA, Doughty RN, Liu C, Ko YA, Quyyumi AA, Hartiala JA, Tang WHW, Hazen SL, Allayee H, McDonough CW, Gong Y, Cooper-DeHoff RM, Johnson JA, Smith JG, Wallentin L, James SK, Eriksson N, White H, Held C, Waterworth D, Trompet S, Jukema JW, Ford I, Stott DJ, Cresci S, Spertus JA, Campbell H, Fliser D, Speer T, eQTLGen consortium, BIOS consortium, M?rz W, Pang S, Reichert MC, Krawczyk M, Weber SN, Wagenpfeil S, Dub? MP, Tardif JC, Feroz-Zada Y, Sun M, Scholz M, Teren A, Burkhardt R, Martinsson A, Sattar N, Tierling S, Walter J, Ampofo E, Niemeyer BA, Lipp P, Schunkert H, B?hm M, Koenig W, Laufs U. Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality. Eur Heart J. 2021 05 07; 42(18):1742-1756. PMID: 33748830; PMCID: PMC8244638.
      Citations: 10     Fields:    Translation:HumansCells
    155. Commodore-Mensah Y, Lazo M, Tang O, Echouffo-Tcheugui JB, Ndumele CE, Nambi V, Wang D, Ballantyne C, Selvin E. High Burden of Subclinical and Cardiovascular Disease Risk in Adults With Metabolically Healthy Obesity: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 2021 07; 44(7):1657-1663. PMID: 33952606; PMCID: PMC8323178.
      Citations: 6     Fields:    Translation:Humans
    156. Elbadawi A, Elgendy IY, Omer M, Abdelazeem M, Nambi V, Krittanawong C, Hira RS, Tamis-Holland J, Ballantyne C, Jneid H. Outcomes of Acute Myocardial Infarction in Patients with Familial Hypercholesteremia. Am J Med. 2021 08; 134(8):992-1001.e4. PMID: 33872584.
      Citations:    Fields:    Translation:Humans
    157. Segar MW, Jaeger BC, Patel KV, Nambi V, Ndumele CE, Correa A, Butler J, Chandra A, Ayers C, Rao S, Lewis AA, Raffield LM, Rodriguez CJ, Michos ED, Ballantyne CM, Hall ME, Mentz RJ, de Lemos JA, Pandey A. Development and Validation of Machine Learning-Based Race-Specific Models to Predict 10-Year Risk of Heart Failure: A Multicohort Analysis. Circulation. 2021 06 15; 143(24):2370-2383. PMID: 33845593; PMCID: PMC9976274.
      Citations: 9     Fields:    Translation:Humans
    158. Ballantyne CM, Bays H, Catapano AL, Goldberg A, Ray KK, Saseen JJ. Role of Bempedoic Acid in Clinical Practice. Cardiovasc Drugs Ther. 2021 08; 35(4):853-864. PMID: 33818688; PMCID: PMC8266788.
      Citations: 9     Fields:    Translation:Humans
    159. Hadley TD, Agha AM, Ballantyne CM. How Do We Incorporate Polygenic Risk Scores in Cardiovascular Disease Risk Assessment and Management? Curr Atheroscler Rep. 2021 04 01; 23(6):28. PMID: 33791884; PMCID: PMC8183125.
      Citations:    Fields:    Translation:Humans
    160. Lee MT, Mahtta D, Chen L, Hussain A, Al Rifai M, Sinh P, Khalid U, Nasir K, Ballantyne CM, Petersen LA, Virani SS. Premature Atherosclerotic Cardiovascular Disease Risk Among Patients with Inflammatory Bowel Disease. Am J Med. 2021 08; 134(8):1047-1051.e2. PMID: 33812865.
      Citations: 3     Fields:    Translation:Humans
    161. Agha AM, Virani SS, Ballantyne CM. Transatlantic guidelines on dyslipidemia and cardiovascular risk: key differences across the pond. Curr Opin Endocrinol Diabetes Obes. 2021 04 01; 28(2):114-121. PMID: 33395089; PMCID: PMC7963270.
      Citations:    Fields:    Translation:Humans
    162. Mao H, Li L, Fan Q, Angelini A, Saha PK, Wu H, Ballantyne CM, Hartig SM, Xie L, Pi X. Loss of bone morphogenetic protein-binding endothelial regulator causes insulin resistance. Nat Commun. 2021 03 26; 12(1):1927. PMID: 33772019; PMCID: PMC7997910.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    163. Agha AM, Ballantyne CM. Management of hyperlipidaemia among statin-intolerant patients after acute coronary syndrome: where do we stand in 2020? Eur J Prev Cardiol. 2021 03 23; 28(1):30-32. PMID: 33624105.
      Citations:    Fields:    Translation:Humans
    164. Mahtta D, Ramsey D, Krittanawong C, Al Rifai M, Khurram N, Samad Z, Jneid H, Ballantyne C, Petersen LA, Virani SS. Recreational substance use among patients with premature atherosclerotic cardiovascular disease. Heart. 2021 04; 107(8):650-656. PMID: 33589427.
      Citations: 4     Fields:    Translation:Humans
    165. Nelson AJ, Puri R, Brennan DM, Anderson TJ, Cho L, Ballantyne CM, Kastelein JJ, Kassahun H, Somaratne RM, Wasserman SM, Nissen SE, Nicholls SJ, Koenig W. Erratum to "C-Reactive Protein Levels and Plaque Regression with Evolocumab: Insights From GLAGOV" [American Journal of Preventive Cardiology 3C (2020) 100091]. Am J Prev Cardiol. 2021 Jun; 6:100153. PMID: 34374706; PMCID: PMC8315629.
      Citations:    
    166. Hussain A, Sun W, Deswal A, de Lemos JA, McEvoy JW, Hoogeveen RC, Matsushita K, Aguilar D, Bozkurt B, Virani SS, Shah AM, Selvin E, Ndumule C, Ballantyne CM, Nambi V. Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study. J Am Coll Cardiol. 2021 02 09; 77(5):559-571. PMID: 33538254; PMCID: PMC7945981.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    167. Hussain A, Tang O, Sun C, Jia X, Selvin E, Nambi V, Folsom A, Heiss G, Mosley T, Virani SS, Coresh J, Boerwinkle E, Yu B, Cunningham JW, Shah AM, Solomon SD, de Lemos JA, Hoogeveen RC, Ballantyne CM, Zannad F. Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (from the Atherosclerosis Risk in Communities Study). Am J Cardiol. 2021 05 01; 146:15-21. PMID: 33539861; PMCID: PMC8038970.
      Citations: 4     Fields:    Translation:Humans
    168. Jia X, Lee MT, Ramsey DJ, Al Rifai M, Mahtta D, Krittanawong C, Akeroyd JM, Matheny ME, Gobbel G, Stone NJ, Ballantyne CM, Petersen LA, Virani SS. Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease-Perspective from the Veterans Affair Healthcare System. Cardiovasc Drugs Ther. 2022 04; 36(2):295-300. PMID: 33523335.
      Citations: 1     Fields:    Translation:Humans
    169. Kou M, Ding N, Ballew SH, Salameh MJ, Martin SS, Selvin E, Heiss G, Ballantyne CM, Matsushita K, Hoogeveen RC. Conventional and Novel Lipid Measures and Risk of Peripheral Artery Disease. Arterioscler Thromb Vasc Biol. 2021 03; 41(3):1229-1238. PMID: 33504178; PMCID: PMC8188625.
      Citations: 4     Fields:    Translation:Humans
    170. Al Rifai M, Khalid U, Misra A, Liu J, Nasir K, Cainzos-Achirica M, Mahtta D, Ballantyne CM, Petersen LA, Virani SS. Racial and geographic disparities in influenza vaccination in the U.S. among individuals with atherosclerotic cardiovascular disease: Renewed importance in the setting of COVID-19. Am J Prev Cardiol. 2021 Mar; 5:100150. PMID: 33521756; PMCID: PMC7826080.
      Citations: 2     
    171. Bays HE, Taub PR, Epstein E, Michos ED, Ferraro RA, Bailey AL, Kelli HM, Ferdinand KC, Echols MR, Weintraub H, Bostrom J, Johnson HM, Hoppe KK, Shapiro MD, German CA, Virani SS, Hussain A, Ballantyne CM, Agha AM, Toth PP. Ten things to know about ten cardiovascular disease risk factors. Am J Prev Cardiol. 2021 Mar; 5:100149. PMID: 34327491; PMCID: PMC8315386.
      Citations: 14     
    172. Agarwala A, Saeed A, Kulkarni S, Goldberg A, Ballantyne C. Prevention: The past, present, and future of medicine and society. J Clin Lipidol. 2021 Mar-Apr; 15(2):245-247. PMID: 33516696.
      Citations: 1     Fields:    
    173. Hoogeveen RC, Ballantyne CM. Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation. Clin Chem. 2021 01 08; 67(1):143-153. PMID: 33257928; PMCID: PMC7793228.
      Citations: 17     Fields:    Translation:Humans
    174. Pandey A, Vaduganathan M, Patel KV, Ayers C, Ballantyne CM, Kosiborod MN, Carnethon M, DeFilippi C, McGuire DK, Khan SS, Caughey MC, de Lemos JA, Everett BM. Biomarker-Based Risk Prediction of Incident Heart?Failure in Pre-Diabetes and?Diabetes. JACC Heart Fail. 2021 03; 9(3):215-223. PMID: 33422434.
      Citations: 9     Fields:    Translation:Humans
    175. Mahtta D, Lee MT, Ramsey DJ, Akeroyd JM, Krittanawong C, Khan SU, Sinh P, Alam M, Garratt KN, Schofield RS, Ballantyne CM, Petersen LA, Virani SS. Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7. Cardiovasc Drugs Ther. 2022 02; 36(1):93-102. PMID: 33400053.
      Citations:    Fields:    Translation:HumansPHPublic Health
    176. Ebong IA, Wilson MD, Bertoni AG, Appiah D, Polonsky T, Michos ED, Ballantyne C, Chang P. High-sensitivity cardiac troponin T and the risk of heart failure in postmenopausal women of the ARIC Study. Menopause. 2021 01 04; 28(3):284-291. PMID: 33399316.
      Citations: 3     Fields:    Translation:Humans
    177. Brunner G, Virani SS, Sun W, Liu L, Dodge RC, Nambi V, Coresh J, Mosley TH, Sharrett AR, Boerwinkle E, Ballantyne CM, Wasserman BA. Associations Between Carotid Artery Plaque Burden, Plaque Characteristics, and Cardiovascular Events: The ARIC Carotid Magnetic Resonance Imaging Study. JAMA Cardiol. 2021 01 01; 6(1):79-86. PMID: 33206125; PMCID: PMC7675218.
      Citations: 6     Fields:    Translation:Humans
    178. Antony A, Lian Z, Perrard XD, Perrard J, Liu H, Cox AR, Saha P, Hennighausen L, Hartig SM, Ballantyne CM, Wu H. Deficiency of Stat1 in CD11c+ Cells Alters Adipose Tissue Inflammation and Improves Metabolic Dysfunctions in Mice Fed a High-Fat Diet. Diabetes. 2021 03; 70(3):720-732. PMID: 33323395; PMCID: PMC7897343.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    179. Al Rifai M, Mirbolouk M, Jia X, Nasir K, Pickett JK, Nambi V, Ballantyne CM, Merchant AT, Blaha MJ, Virani SS. E-cigarette Use and Risk Behaviors among Lesbian, Gay, Bisexual, and Transgender Adults: The Behavioral Risk Factor Surveillance System (BRFSS) Survey. Kans J Med. 2020; 13:318-321. PMID: 33343826; PMCID: PMC7735432.
      Citations: 4     
    180. Nicholls SJ, Lincoff AM, Garcia M, Bash D, Ballantyne CM, Barter PJ, Davidson MH, Kastelein JJP, McGuire DK, Mozaffarian D, Ridker PM, Ray KK, Katona BG, Himmelmann A, Loss LE, Rensfeldt M, Agrawal R, Menon V, Wolski K, Nissen SE, Koenig W, Lundstr?m T. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial. JAMA. 2020 12 08; 324(22):2268-2280. PMID: 33190147; PMCID: PMC7667577.
      Citations: 92     Fields:    Translation:Humans
    181. Jia X, Sun C, Tang O, Gorlov I, Nambi V, Virani SS, Villareal DT, Taffet GE, Yu B, Bressler J, Boerwinkle E, Windham BG, de Lemos JA, Matsushita K, Selvin E, Michos ED, Hoogeveen RC, Ballantyne CM. Plasma Dehydroepiandrosterone Sulfate and Cardiovascular Disease Risk in Older Men and Women. J Clin Endocrinol Metab. 2020 12 01; 105(12). PMID: 32785663; PMCID: PMC7526732.
      Citations: 5     Fields:    Translation:Humans
    182. Hussain A, Ballantyne CM. New Approaches for the Prevention and Treatment of Cardiovascular Disease: Focus on Lipoproteins and Inflammation. Annu Rev Med. 2021 01 27; 72:431-446. PMID: 33217249.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    183. Ahmed ST, Akeroyd JM, Mahtta D, Street R, Slagle J, Navar AM, Stone NJ, Ballantyne CM, Petersen LA, Virani SS. Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin-Associated Side Effects. J Am Heart Assoc. 2020 11 17; 9(22):e017915. PMID: 33170055; PMCID: PMC7763718.
      Citations: 3     Fields:    Translation:Humans
    184. Peterson BE, Bhatt DL, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Juliano RA, Jiao L, Doyle RT, Granowitz C, Gibson CM, Pinto D, Giugliano RP, Budoff MJ, Verma S, Ballantyne CM, REDUCE-IT Investigators, Steg PG, Tardif JC. Reduction in Revascularization With Icosapent Ethyl: Insights From REDUCE-IT Revascularization Analyses. Circulation. 2021 01 05; 143(1):33-44. PMID: 33148016; PMCID: PMC7752247.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    185. Tang O, Matsushita K, Coresh J, Hoogeveen RC, Windham BG, Ballantyne CM, Selvin E. High-Sensitivity Cardiac Troponin I for Risk Stratification in Older Adults. J Am Geriatr Soc. 2021 04; 69(4):986-994. PMID: 33150614; PMCID: PMC8049956.
      Citations: 3     Fields:    Translation:Humans
    186. Gimnich OA, Holbrook J, Belousova T, Short CM, Taylor AA, Nambi V, Morrisett JD, Ballantyne CM, Bismuth J, Shah DJ, Brunner G. Relation of Magnetic Resonance Imaging Based Arterial Signal Enhancement to Markers of Peripheral Artery Disease. Am J Cardiol. 2021 02 01; 140:140-147. PMID: 33144163; PMCID: PMC8210786.
      Citations:    Fields:    Translation:Humans
    187. Ballantyne CM, Virani SS. Real-world data, theoretical application of guidelines, cost, and access: how do we optimize non-statin therapy for LDL-C/non-HDL-C/ApoB? Eur Heart J. 2020 10 21; 41(40):3910-3912. PMID: 32268351.
      Citations: 1     Fields:    Translation:Humans
    188. Krittanawong C, Kumar A, Hahn J, Wang Z, Zhang HJ, Sun T, Bozkurt B, Ballantyne CM, Virani SS, Halperin JL, Jneid H. Cardiovascular risk and complications associated with COVID-19. Am J Cardiovasc Dis. 2020; 10(4):479-489. PMID: 33224599; PMCID: PMC7675166.
      Citations: 8     
    189. Nelson AJ, Puri R, Brennan DM, Anderson TJ, Cho L, Ballantyne CM, Kastelein JJ, Kassahun H, Somaratne RM, Wasserman SM, Nissen SE, Nicholls SJ, Koenig W. C-reactive protein levels and plaque regression with evolocumab: Insights from GLAGOV. Am J Prev Cardiol. 2020 Sep; 3:100091. PMID: 34327467; PMCID: PMC8315612.
      Citations:    
    190. Zhao D, Guallar E, Ballantyne CM, Post WS, Ouyang P, Vaidya D, Jia X, Ying W, Subramanya V, Ndumele CE, Hoogeveen RC, Michos ED. Sex Hormones and Incident Heart Failure in Men and Postmenopausal Women: The Atherosclerosis Risk in Communities Study. J Clin Endocrinol Metab. 2020 10 01; 105(10). PMID: 32770207; PMCID: PMC7455306.
      Citations: 8     Fields:    Translation:Humans
    191. Jia X, Liu J, Mehta A, Ballantyne CM, Virani SS. Lipid-Lowering Biotechnological Drugs: from Monoclonal Antibodies to Antisense Therapies-a Clinical Perspective. Cardiovasc Drugs Ther. 2021 12; 35(6):1269-1279. PMID: 32997212.
      Citations: 6     Fields:    Translation:HumansAnimals
    192. Krittanawong C, Liu Y, Mahtta D, Narasimhan B, Wang Z, Jneid H, Tamis-Holland JE, Mahboob A, Baber U, Mehran R, Wilson Tang WH, Ballantyne CM, Virani SS. Non-traditional risk factors and the risk of myocardial infarction in the young in the US population-based cohort. Int J Cardiol Heart Vasc. 2020 Oct; 30:100634. PMID: 32995474; PMCID: PMC7516292.
      Citations: 3     
    193. Al Rifai M, Merchant AT, Nambi V, Jia X, Gulati M, Mahtta D, Nasir K, Ballantyne CM, Virani SS. Letter to the Editor: Temporal Trends in E-Cigarette and Cigarette Use Among US Adults by US State: Behavioral Risk Factor Surveillance System, 2016 to 2018. Popul Health Manag. 2021 06; 24(3):414-415. PMID: 32941106.
      Citations:    Fields:    Translation:Humans
    194. Hussain A, Ballantyne CM, Nambi V. Zero Coronary Artery Calcium Score: Desirable, but Enough? Circulation. 2020 09 08; 142(10):917-919. PMID: 32897743.
      Citations: 5     Fields:    Translation:Humans
    195. Lian Z, Saeed A, Peng X, Perrard XD, Jia X, Hussain A, Ballantyne CM, Wu H. Monocyte phenotyping and management of lipoprotein X syndrome. J Clin Lipidol. 2020 Nov - Dec; 14(6):850-858. PMID: 33011137; PMCID: PMC7736232.
      Citations: 1     Fields:    Translation:HumansCells
    196. Kataruka A, Mahtta D, Akeroyd JM, Hira RS, Kazi DS, Spertus JA, Bhatt DL, Petersen LA, Ballantyne CM, Virani SS. Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System. Cardiovasc Drugs Ther. 2021 06; 35(3):533-538. PMID: 32880803.
      Citations:    Fields:    Translation:Humans
    197. Bays HE, Catapano AL, Duell PB, Gotto AM, Leiter LA, Mancini GBJ, Ray KK, Bloedon LT, Sasiela WJ, Ye Z, Ballantyne CM, Banach M, Laufs U. Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials. J Clin Lipidol. 2020 Sep - Oct; 14(5):649-659.e6. PMID: 32980290.
      Citations: 11     Fields:    Translation:Humans
    198. Mahtta D, Ahmed ST, Ramsey DJ, Akeroyd JM, Lee MT, Rodriguez F, Michos ED, Itchhaporia D, Nasir K, Alam M, Jneid H, Ballantyne CM, Petersen LA, Virani SS. Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD. Cardiovasc Drugs Ther. 2020 12; 34(6):745-754. PMID: 32840709.
      Citations: 2     Fields:    Translation:Humans
    199. Mehta A, Virani SS, Ayers CR, Sun W, Hoogeveen RC, Rohatgi A, Berry JD, Joshi PH, Ballantyne CM, Khera A. Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk. J Am Coll Cardiol. 2020 08 18; 76(7):781-793. PMID: 32792075.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    200. Krittanawong C, Kumar A, Wang Z, Narasimhan B, Mahtta D, Jneid H, Baber U, Mehran R, Tang W, Ballantyne CM, Virani SS. Coronary artery disease in the young in the US population-based cohort. Am J Cardiovasc Dis. 2020; 10(3):189-194. PMID: 32923100; PMCID: PMC7486526.
      Citations: 4     
    201. Tang O, Matsushita K, Coresh J, Ndumele C, McEvoy JW, Sharrett AR, Hoogeveen R, Ballantyne CM, Selvin E. High-Sensitivity Cardiac Troponin I and T for Cardiovascular Risk Stratification in Adults With Diabetes. Diabetes Care. 2020 10; 43(10):e144-e146. PMID: 32788284; PMCID: PMC7510022.
      Citations: 4     Fields:    Translation:Humans
    202. Mahtta D, Ramsey DJ, Al Rifai M, Nasir K, Samad Z, Aguilar D, Jneid H, Ballantyne CM, Petersen LA, Virani SS. Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease. JAMA Netw Open. 2020 08 03; 3(8):e2011051. PMID: 32816031; PMCID: PMC7441361.
      Citations: 10     Fields:    Translation:Humans
    203. Gore MO, Ayers CR, Khera A, deFilippi CR, Wang TJ, Seliger SL, Nambi V, Selvin E, Berry JD, Hundley WG, Budoff M, Greenland P, Drazner MH, Ballantyne CM, Levine BD, de Lemos JA. Combining Biomarkers and Imaging for Short-Term Assessment of Cardiovascular Disease Risk in Apparently Healthy Adults. J Am Heart Assoc. 2020 08 04; 9(15):e015410. PMID: 32698652; PMCID: PMC7792258.
      Citations: 4     Fields:    Translation:Humans
    204. Ding N, Yang C, Ballew SH, Kalbaugh CA, McEvoy JW, Salameh M, Aguilar D, Hoogeveen RC, Nambi V, Selvin E, Folsom AR, Heiss G, Coresh J, Ballantyne CM, Matsushita K. Fibrosis and Inflammatory Markers and Long-Term Risk of Peripheral Artery Disease: The ARIC Study. Arterioscler Thromb Vasc Biol. 2020 09; 40(9):2322-2331. PMID: 32698688; PMCID: PMC7678951.
      Citations: 11     Fields:    Translation:Humans
    205. Mahtta D, Gupta A, Ramsey DJ, Rifai MA, Mehta A, Krittanawong C, Lee MT, Nasir K, Samad Z, Blumenthal RS, Jneid H, Ballantyne CM, Petersen LA, Virani SS. Autoimmune Rheumatic Diseases and Premature Atherosclerotic Cardiovascular Disease: An Analysis From the VITAL Registry. Am J Med. 2020 12; 133(12):1424-1432.e1. PMID: 32598903.
      Citations: 8     Fields:    Translation:Humans
    206. Aguilar D, Sun C, Hoogeveen RC, Nambi V, Selvin E, Matsushita K, Saeed A, McEvoy JW, Shah AM, Solomon SD, Boerwinkle E, Ballantyne CM. Levels and Change in Galectin-3 and Association With Cardiovascular Events: The ARIC Study. J Am Heart Assoc. 2020 07 07; 9(13):e015405. PMID: 32573308; PMCID: PMC7670497.
      Citations: 5     Fields:    Translation:HumansCells
    207. Singh K, Chandra A, Sperry T, Joshi PH, Khera A, Virani SS, Ballantyne CM, Otvos JD, Dullaart RPF, Gruppen EG, Connelly MA, Ayers CR, Rohatgi A. Associations Between High-Density Lipoprotein Particles and Ischemic Events by Vascular Domain, Sex, and Ethnicity: A Pooled Cohort Analysis. Circulation. 2020 08 18; 142(7):657-669. PMID: 32804568; PMCID: PMC7425196.
      Citations: 16     Fields:    Translation:Humans
    208. Pickett JK, Shah M, Gillette M, Jones P, Virani S, Ballantyne C, Nambi V. Acute Tubular Injury in a Patient on a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor. JACC Case Rep. 2020 Jun 17; 2(7):1042-1045. PMID: 34317411; PMCID: PMC8302111.
      Citations: 1     
    209. Hussain A, Ballantyne CM, Saeed A, Virani SS. Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions. Curr Atheroscler Rep. 2020 06 03; 22(7):25. PMID: 32494924.
      Citations: 10     Fields:    Translation:Humans
    210. Wu H, Ballantyne CM. Metabolic Inflammation and Insulin Resistance in Obesity. Circ Res. 2020 05 22; 126(11):1549-1564. PMID: 32437299; PMCID: PMC7250139.
      Citations: 97     Fields:    Translation:HumansAnimalsCells
    211. Liu J, Elbadawi A, Elgendy IY, Megaly M, Ogunbayo GO, Krittanawong C, Tamis-Holland JE, Ballantyne CM, Khalid MU, Virani S, Gulati M, Albert M, Bozkurt B, Jneid H. Age-Stratified Sex Disparities in Care and Outcomes in Patients With ST-Elevation Myocardial Infarction. Am J Med. 2020 11; 133(11):1293-1301.e1. PMID: 32417118.
      Citations: 6     Fields:    Translation:Humans
    212. Florido R, Kwak L, Lazo M, Michos ED, Nambi V, Blumenthal RS, Gerstenblith G, Palta P, Russell SD, Ballantyne CM, Selvin E, Folsom AR, Coresh J, Ndumele CE. Physical Activity and Incident Heart Failure in High-Risk Subgroups: The ARIC Study. J Am Heart Assoc. 2020 05 18; 9(10):e014885. PMID: 32390492; PMCID: PMC7660876.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    213. Wu H, Xu L, Ballantyne CM. Dietary and Pharmacological Fatty Acids and Cardiovascular Health. J Clin Endocrinol Metab. 2020 04 01; 105(4). PMID: 31678992; PMCID: PMC7174038.
      Citations: 4     Fields:    Translation:Humans
    214. Al Rifai M, Merchant AT, Nambi V, Jia X, Gulati M, Valero-Elizondo J, Nasir K, Ballantyne CM, Virani SS. Temporal Trends in E-Cigarette Use Among U.S. Adults: Behavioral Risk Factor Surveillance System, 2016 to 2018. Am J Med. 2020 09; 133(9):e508-e511. PMID: 32222250.
      Citations: 7     Fields:    Translation:Humans
    215. Tang O, Daya N, Matsushita K, Coresh J, Sharrett AR, Hoogeveen R, Jia X, Windham BG, Ballantyne C, Selvin E. Performance of High-Sensitivity Cardiac Troponin Assays to Reflect Comorbidity Burden and Improve Mortality Risk Stratification in Older Adults With Diabetes. Diabetes Care. 2020 06; 43(6):1200-1208. PMID: 32161049; PMCID: PMC7245347.
      Citations: 8     Fields:    Translation:Humans
    216. Mahtta D, Ahmed ST, Shah NR, Ramsey DJ, Akeroyd JM, Nasir K, Hamzeh IR, Elgendy IY, Waldo SW, Al-Mallah MH, Jneid H, Ballantyne CM, Petersen LA, Virani SS. Facility-Level Variation in Cardiac Stress Test Use Among Patients With Diabetes: Findings From the Veterans Affairs National Database. Diabetes Care. 2020 05; 43(5):e58-e60. PMID: 32161052; PMCID: PMC7171940.
      Citations: 1     Fields:    
    217. Schwartz GG, Leiter LA, Ballantyne CM, Barter PJ, Black DM, Kallend D, Laghrissi-Thode F, Leitersdorf E, McMurray JJV, Nicholls SJ, Preiss D, Shah PK, Kittelson J, Olsson AG, Tardif JC. Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease. Diabetes Care. 2020 05; 43(5):1077-1084. PMID: 32144166; PMCID: PMC7171952.
      Citations: 5     Fields:    Translation:Humans
    218. Mathews L, Ishigami J, Ding N, Hoogeveen RC, Kucharska-Newton A, Ballantyne CM, Gottesman R, Selvin E, Matsushita K. Cardiac Biomarkers and Subsequent Risk of Hospitalization With Bleeding in the Community: Atherosclerosis Risk in Communities Study. J Am Heart Assoc. 2020 03 03; 9(5):e013560. PMID: 32114886; PMCID: PMC7335570.
      Citations: 3     Fields:    Translation:Humans
    219. Agarwala A, Michos ED, Samad Z, Ballantyne CM, Virani SS. The Use of Sex-Specific Factors in the Assessment of Women's Cardiovascular Risk. Circulation. 2020 02 18; 141(7):592-599. PMID: 32065772; PMCID: PMC7032610.
      Citations: 27     Fields:    Translation:Humans
    220. Wong ND, Amsterdam EA, Ballantyne C, Khera A, Nasir K, Toth PP, American Society for Preventive Cardiology. Spotlight from the American Society for Preventive Cardiology on Key Features of the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol. Am J Cardiovasc Drugs. 2020 Feb; 20(1):1-9. PMID: 31286451; PMCID: PMC6946888.
      Citations: 2     Fields:    Translation:Humans
    221. McEvoy JW, Daya N, Rahman F, Hoogeveen RC, Blumenthal RS, Shah AM, Ballantyne CM, Coresh J, Selvin E. Association of Isolated Diastolic Hypertension as Defined by the 2017 ACC/AHA Blood Pressure Guideline With Incident Cardiovascular Outcomes. JAMA. 2020 Jan 28; 323(4):329-338. PMID: 31990314; PMCID: PMC6990938.
      Citations: 37     Fields:    Translation:Humans
    222. Lewis AA, Ayers CR, Selvin E, Neeland I, Ballantyne CM, Nambi V, Pandey A, Powell-Wiley TM, Drazner MH, Carnethon MR, Berry JD, Seliger SL, DeFilippi CR, de Lemos JA. Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure: A Multicohort Study. Circulation. 2020 03 24; 141(12):957-967. PMID: 31931608; PMCID: PMC7093253.
      Citations: 10     Fields:    Translation:Humans
    223. Bittner VA, Jacobson TA, Ballantyne CM, Guyton JR. JCL roundtable: Omega-3 fatty acids and cardiovascular outcomes. J Clin Lipidol. 2020 Jan - Feb; 14(1):4-15. PMID: 32192643.
      Citations: 1     Fields:    Translation:Humans
    224. Ballantyne CM. PRECISION MEDICINE FOR CARDIOVASCULAR DISEASE PREVENTION: WHERE DO WE STAND IN 2019 WITH A FOCUS ON INFLAMMATION AND LIPIDS? Trans Am Clin Climatol Assoc. 2020; 131:42-47. PMID: 32675841; PMCID: PMC7358503.
      Citations:    Fields:    
    225. Florido R, Lee AK, McEvoy JW, Hoogeveen RC, Koton S, Vitolins MZ, Shenoy C, Russell SD, Blumenthal RS, Ndumele CE, Ballantyne CM, Joshu CE, Platz EA, Selvin E. Cancer Survivorship and Subclinical Myocardial Damage. Am J Epidemiol. 2019 12 31; 188(12):2188-2195. PMID: 30927355; PMCID: PMC7212406.
      Citations: 3     Fields:    Translation:Humans
    226. Ishigami J, Hoogeveen RC, Ballantyne CM, Folsom AR, Coresh J, Selvin E, Matsushita K. Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2019 12 31; 188(12):2146-2155. PMID: 31063194; PMCID: PMC7212398.
      Citations: 2     Fields:    Translation:Humans
    227. Yang EY, Khan MA, Graviss EA, Nguyen DT, Bhimaraj A, Nambi V, Hoogeveen RC, Ballantyne CM, Zoghbi WA, Shah DJ. Relationship of extracellular volume assessed on cardiac magnetic resonance and serum cardiac troponins and natriuretic peptides with heart failure outcomes. Sci Rep. 2019 12 27; 9(1):20168. PMID: 31882822; PMCID: PMC6934524.
      Citations: 2     Fields:    Translation:HumansCells
    228. Jia X, Ramsey DJ, Rifai MA, Ahmed ST, Akeroyd JM, Dixon DL, Gluckman TJ, Nambi V, Ballantyne CM, Petersen LA, Stone NJ, Virani SS. Impact of Lipid Monitoring on Treatment Intensification of Cholesterol Lowering Therapies (from the Veterans Affairs Healthcare System). Am J Cardiol. 2020 03 15; 125(6):874-879. PMID: 31952841.
      Citations: 1     Fields:    Translation:Humans
    229. Salahuddin T, Kittelson J, Shah PK, Nicholls SJ, Leitersdorf E, Leiter LA, Kallend D, Black DM, Barter PJ, Ballantyne CM, Schwartz GG, Tardif JC, Olsson AG. Association of high-density lipoprotein particle concentration with cardiovascular risk following acute coronary syndrome: A case-cohort analysis of the dal-Outcomes trial. Am Heart J. 2020 03; 221:60-66. PMID: 31927126.
      Citations: 1     Fields:    Translation:Humans
    230. Yang EY, Ghosn MG, Khan MA, Gramze NL, Brunner G, Nabi F, Nambi V, Nagueh SF, Nguyen DT, Graviss EA, Schelbert EB, Ballantyne CM, Zoghbi WA, Shah DJ. Myocardial Extracellular Volume Fraction Adds Prognostic Information Beyond Myocardial Replacement Fibrosis. Circ Cardiovasc Imaging. 2019 12; 12(12):e009535. PMID: 31838882; PMCID: PMC7529265.
      Citations: 13     Fields:    Translation:HumansCells
    231. Noordam R, Bos MM, Wang H, Winkler TW, Bentley AR, de Vries PS, Sung YJ, Schwander K, Cade BE, Manning A, Aschard H, Brown MR, Chen H, Franceschini N, Musani SK, Richard M, Vojinovic D, Aslibekyan S, Bartz TM, de Las Fuentes L, Feitosa M, Ilkov M, Kho M, Kraja A, Li C, Lim E, Liu Y, Mook-Kanamori DO, Rankinen T, Tajuddin SM, van der Spek A, Wang Z, Marten J, Alver M, Evangelou E, Graff ME, He M, Marques-Vidal P, Nolte IM, Palmer ND, Rauramaa R, Shu XO, Snieder H, Weiss S, Wen W, Yanek LR, Adolfo C, Ballantyne C, Bielak L, Biermasz NR, Boerwinkle E, Dimou N, Eiriksdottir G, Gao C, Gharib SA, Gottlieb DJ, Harris TB, Heikkinen S, Hixson JE, Homuth G, Ikram MA, Komulainen P, Lee J, Liu J, Lohman KK, Luik AI, Martin LW, Metspalu A, Milaneschi Y, Nalls MA, O'Connell J, Peyser P, Raitakari OT, Reiner AP, Rensen PCN, Rice TK, Rich SS, Roenneberg T, Rotter JI, Schreiner PJ, Shikany J, Sidney SS, Sims M, Sitlani CM, Sofer T, Swertz MA, Taylor KD, van Duijn CM, Wallance RB, van Dijk KW, Yu C, Zonderman AB, Becker DM, Elliott P, Grabe HJ, Lakka TA, North KE, Penninx BWJH, Vollenweider P, Wagenknecht LE, Wu T, Xiang YB, Zheng W, Arnett DK, Bouchard C, Evans MK, Gudnason V, Kardia S, Kelly TN, Kritchevsky SB, Loos RJF, Province M, Psaty BM, Rotimi C, Zhu X, Amin N, Cupples LA, Fornage M, Fox EF, Guo X, Gauderman WJ, Rice K, Kooperberg C, Munroe PB, Liu CT, Morrison AC, Rao DC, van Heemst D, Redline S, Kilpel?inen TO, Horimoto AR, Laville V, K?hnel B, Lyytik?inen LP, Haba-Rubio J, Heinzer R, Krieger JE, M?gi R, Meitinger T, Peters A, Strauch K, Uitterlinden AG, V?lzke H, Waldenberger M, Esko T, Gieger C, Lehtim?ki T, Pereira AC. Multi-ancestry sleep-by-SNP interaction analysis in 126,926 individuals reveals lipid loci stratified by sleep duration. Nat Commun. 2019 11 12; 10(1):5121. PMID: 31719535; PMCID: PMC6851116.
      Citations: 22     Fields:    Translation:Humans
    232. Pandey A, Patel KV, Vongpatanasin W, Ayers C, Berry JD, Mentz RJ, Blaha MJ, McEvoy JW, Muntner P, Vaduganathan M, Correa A, Butler J, Shimbo D, Nambi V, deFilippi C, Seliger SL, Ballantyne CM, Selvin E, de Lemos JA, Joshi PH. Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis. Circulation. 2019 12 17; 140(25):2076-2088. PMID: 31707797; PMCID: PMC8330617.
      Citations: 11     Fields:    Translation:Humans
    233. Bhatt DL, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT, Juliano RA, Jiao L, Granowitz C, Olshansky B, Chung MK, Gibson CM, Giugliano RP, Budoff MJ, Ballantyne CM, REDUCE-IT Investigators, Steg PG, Tardif JC. REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States. Circulation. 2020 02 04; 141(5):367-375. PMID: 31707829; PMCID: PMC7004453.
      Citations: 30     Fields:    Translation:Humans
    234. Jia X, Sun W, Hoogeveen RC, Nambi V, Matsushita K, Folsom AR, Heiss G, Couper DJ, Solomon SD, Boerwinkle E, Shah A, Selvin E, de Lemos JA, Ballantyne CM. Response by Jia et al to Letter Regarding Article, "High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study". Circulation. 2019 11 12; 140(20):e772-e773. PMID: 31710526; PMCID: PMC7202330.
      Citations: 1     Fields:    Translation:Humans
    235. Nambi V, Virani SS, Jones PH, Ballantyne CM. "Zero": The New Superhero or Superhero in Training? J Am Coll Cardiol. 2019 11 05; 74(18):2331. PMID: 31672196.
      Citations:    Fields:    Translation:Humans
    236. Cannon CP, de Lemos JA, Rosenson RS, Ballantyne CM, Liu Y, Yazdi D, Elliott-Davey M, Mues KE, Bhatt DL, Kosiborod MN, GOULD Investigators. Getting to an ImprOved Understanding of Low-Density Lipoprotein-Cholesterol and Dyslipidemia Management (GOULD): Methods and baseline data of a registry of high cardiovascular risk patients in the United States. Am Heart J. 2020 01; 219:70-77. PMID: 31726422.
      Citations: 5     Fields:    Translation:Humans
    237. Lian Z, Perrard XD, Peng X, Raya JL, Hernandez AA, Johnson CG, Lagor WR, Pownall HJ, Hoogeveen RC, Simon SI, Sacks FM, Ballantyne CM, Wu H. Replacing Saturated Fat With Unsaturated Fat in Western Diet Reduces Foamy Monocytes and Atherosclerosis in Male Ldlr-/- Mice. Arterioscler Thromb Vasc Biol. 2020 01; 40(1):72-85. PMID: 31619061; PMCID: PMC6991890.
      Citations: 8     Fields:    Translation:AnimalsCells
    238. Shapiro MD, Maron DJ, Morris PB, Kosiborod M, Sandesara PB, Virani SS, Khera A, Ballantyne CM, Baum SJ, Sperling LS, Bhatt DL, Fazio S. Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives. J Am Coll Cardiol. 2019 10 15; 74(15):1926-1942. PMID: 31601373.
      Citations: 15     Fields:    Translation:Humans
    239. Bhatt DL, Steg PG, Miller M, Juliano RA, Ballantyne CM. Reply: Ischemic Event Reduction and Triglycerides. J Am Coll Cardiol. 2019 10 08; 74(14):1849-1850. PMID: 31582151.
      Citations: 5     Fields:    Translation:Humans
    240. Myhre PL, Claggett B, Ballantyne CM, Selvin E, Solomon SD, Skali H, Shah AM, R?sj? H, Omland T. Association Between Circulating Troponin Concentrations, Left Ventricular Systolic and Diastolic Functions, and Incident Heart Failure in Older Adults. JAMA Cardiol. 2019 10 01; 4(10):997-1006. PMID: 31483438; PMCID: PMC6727783.
      Citations: 15     Fields:    Translation:Humans
    241. Georgakis MK, Malik R, Pana TA, Demissie S, Ayers C, Fornage M, Beiser AS, Benjamin EJ, Boekholdt SM, Hoogeveen RC, Koenig W, Wareham N, Ballantyne CM, Seshadri S, Myint PK, de Lemos JA, Dichgans M, Bj?rkbacka H, Elhadad MA, Engstr?m G, Herder C, Melander O, Orho-Melander M, Schiopu A, S?derholm M, Peters A, Nilsson J. Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: Meta-Analysis of Population-Based Studies Involving 17?180 Individuals. Circ Res. 2019 09 27; 125(8):773-782. PMID: 31476962; PMCID: PMC6763364.
      Citations: 31     Fields:    Translation:Humans
    242. Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Jiao L, Tardif JC, Gregson J, Pocock SJ, Ballantyne CM, REDUCE-IT Investigators. Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride Tertiles. J Am Coll Cardiol. 2019 08 27; 74(8):1159-1161. PMID: 31439224.
      Citations: 20     Fields:    Translation:Humans
    243. Virani SS, Akeroyd JM, Ahmed ST, Krittanawong C, Martin LA, Slagle J, Gobbel GT, Matheny ME, Ballantyne CM, Petersen LA. The use of structured data elements to identify ASCVD patients with statin-associated side effects: Insights from the Department of Veterans Affairs. J Clin Lipidol. 2019 Sep - Oct; 13(5):797-803.e1. PMID: 31501043; PMCID: PMC8393880.
      Citations: 6     Fields:    Translation:Humans
    244. Virani SS, Akeroyd JM, Smith SC, Al-Mallah M, Maddox TM, Morris PB, Petersen LA, Ballantyne CM, Grundy SM, Stone NJ. Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018?AHA/ACC Cholesterol Guidelines. J Am Coll Cardiol. 2019 08 06; 74(5):712-714. PMID: 31370962.
      Citations: 6     Fields:    Translation:Humans
    245. Pokharel Y, Mouhanna F, Schneider ALC, Rawlings AM, Knopman DS, Nambi V, Virani SS, Hoogeveen RC, Alonso A, Heiss G, Coresh J, Mosley T, Gottesman R, Selvin E, Ballantyne C, Power MC. High-Sensitive Troponin T, Natriuretic Peptide, and Cognitive Change. J Am Geriatr Soc. 2019 11; 67(11):2353-2361. PMID: 31359423; PMCID: PMC6861618.
      Citations: 2     Fields:    Translation:Humans
    246. Ballantyne CM, Ray KK, Leiter LA, Bays HE, Goldberg AC, Stroes ES, MacDougall D, Zhao X, Catapano AL, Laufs U. Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy. Eur J Prev Cardiol. 2020 04; 27(6):593-603. PMID: 31357887; PMCID: PMC7153222.
      Citations: 45     Fields:    Translation:HumansCellsCTClinical Trials
    247. Vijayaraghavan K, Szerlip HM, Ballantyne CM, Bays HE, Philip S, Doyle RT, Juliano RA, Granowitz C. Icosapent ethyl reduces atherogenic markers in high-risk statin-treated patients with stage 3 chronic kidney disease and high triglycerides. Postgrad Med. 2019 Aug; 131(6):390-396. PMID: 31306043.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    248. Mok Y, Sang Y, Ballew SH, Hoogeveen RC, Ballantyne CM, Rosamond W, Coresh J, Selvin E, Matsushita K. Premorbid levels of high-sensitivity cardiac troponin T and natriuretic peptide and prognosis after incident myocardial infarction. Am Heart J. 2019 10; 216:62-73. PMID: 31404723; PMCID: PMC6842707.
      Citations: 1     Fields:    Translation:Humans
    249. Ballantyne CM, Nambi V. Seven Metrics That Will Determine Your Cardiovascular Success or Failure. JACC Heart Fail. 2019 08; 7(8):648-650. PMID: 31302041.
      Citations:    Fields:    Translation:Humans
    250. Juraschek SP, Daya N, Appel LJ, Miller ER, Matsushita K, Michos ED, Windham BG, Ballantyne CM, Selvin E. Subclinical Cardiovascular Disease and Fall Risk in Older Adults: Results From the Atherosclerosis Risk in Communities Study. J Am Geriatr Soc. 2019 09; 67(9):1795-1802. PMID: 31493355; PMCID: PMC6733582.
      Citations: 3     Fields:    Translation:Humans
    251. Ballantyne CM. Lipoprotein(a) and Risk for Stroke and Myocardial Infarction: Why Aren't We Screening? J Am Coll Cardiol. 2019 07 09; 74(1):67-69. PMID: 31272553.
      Citations:    Fields:    Translation:Humans
    252. Arnold SV, de Lemos JA, Rosenson RS, Ballantyne CM, Liu Y, Mues KE, Alam S, Elliott-Davey M, Bhatt DL, Cannon CP, Kosiborod M, GOULD Investigators. Use of Guideline-Recommended Risk Reduction Strategies Among Patients With Diabetes and Atherosclerotic Cardiovascular Disease. Circulation. 2019 08 13; 140(7):618-620. PMID: 31174429.
      Citations: 22     Fields:    Translation:Humans
    253. Miller M, Ballantyne CM, Bays HE, Granowitz C, Doyle RT, Juliano RA, Philip S. Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Atherogenic Lipid/Lipoprotein, Apolipoprotein, and Inflammatory Parameters in Patients With Elevated High-Sensitivity C-Reactive Protein (from the ANCHOR Study). Am J Cardiol. 2019 09 01; 124(5):696-701. PMID: 31277790.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    254. de Vries PS, Brown MR, Bentley AR, Sung YJ, Winkler TW, Ntalla I, Schwander K, Kraja AT, Guo X, Franceschini N, Cheng CY, Sim X, Vojinovic D, Huffman JE, Musani SK, Li C, Feitosa MF, Richard MA, Noordam R, Aschard H, Bartz TM, Bielak LF, Deng X, Dorajoo R, Lohman KK, Manning AK, Rankinen T, Smith AV, Tajuddin SM, Evangelou E, Graff M, Alver M, Boissel M, Chai JF, Chen X, Divers J, Gandin I, Gao C, Goel A, Hagemeijer Y, Harris SE, Hartwig FP, He M, Horimoto ARVR, Hsu FC, Jackson AU, Kasturiratne A, Komulainen P, Laguzzi F, Lee JH, Luan J, Matoba N, Nolte IM, Pietzner M, Riaz M, Said MA, Scott RA, Sofer T, Takeuchi F, Tayo BO, van der Most PJ, Wang Y, Ware EB, Wen W, Yanek LR, Zhang W, Zhao JH, Afaq S, Amin N, Amini M, Arking DE, Aung T, Ballantyne C, Boerwinkle E, Broeckel U, Campbell A, Charumathi S, Chen YI, Connell JM, de Faire U, de Las Fuentes L, de Silva HJ, Ding J, Dominiczak AF, Duan Q, Eaton CB, Eppinga RN, Faul JD, Fisher V, Forrester T, Franco OH, Friedlander Y, Ghanbari M, Giulianini F, Grabe HJ, Grove ML, Gu CC, Harris TB, Heikkinen S, Heng CK, Hirata M, Hixson JE, Howard BV, Ikram MA, InterAct Consortium, Jacobs DR, Johnson C, Jonas JB, Kammerer CM, Katsuya T, Khor CC, Koh WP, Koistinen HA, Kolcic I, Kooperberg C, Krieger JE, Kritchevsky SB, Kubo M, Kuusisto J, Lakka TA, Langefeld CD, Langenberg C, Launer LJ, Lehne B, Lemaitre RN, Li Y, Liang J, Liu J, Liu K, Loh M, Louie T, Manichaikul AW, McKenzie CA, Metspalu A, Milaneschi Y, Milani L, Mohlke KL, Mosley TH, Mukamal KJ, Nalls MA, Nauck M, Nelson CP, Sotoodehnia N, O'Connell JR, Palmer ND, Pazoki R, Pedersen NL, Peyser PA, Polasek O, Poulter N, Raffel LJ, Raitakari OT, Reiner AP, Rice TK, Rich SS, Robino A, Robinson JG, Rose LM, Rudan I, Schmidt CO, Schreiner PJ, Scott WR, Sever P, Shi Y, Sidney S, Sims M, Smith BH, Smith JA, Snieder H, Starr JM, Tan N, Taylor KD, Teo YY, Tham YC, van Heemst D, Vuckovic D, Wang L, Wang Y, Wang Z, Wei WB, Williams C, Wilson G, Wojczynski MK, Yao J, Yu B, Yu C, Yuan JM, Zhao W, Zonderman AB, Becker DM, Boehnke M, Bowden DW, Chambers JC, Deary IJ, Farrall M, Freedman BI, Froguel P, Gasparini P, Horta BL, Kamatani Y, Kato N, Kooner JS, Laakso M, Leander K, Lifelines Cohort, Groningen, The Netherlands (Lifelines Cohort Study), Magnusson PKE, Penninx B, Pereira AC, Rauramaa R, Samani NJ, Scott J, Shu XO, van der Harst P, Wagenknecht LE, Wang YX, Wareham NJ, Watkins H, Weir DR, Wickremasinghe AR, Zheng W, Elliott P, North KE, Bouchard C, Evans MK, Gudnason V, Liu CT, Liu Y, Psaty BM, Ridker PM, van Dam RM, Kardia SLR, Zhu X, Rotimi CN, Mook-Kanamori DO, Fornage M, Kelly TN, Fox ER, Hayward C, van Duijn CM, Tai ES, Wong TY, Liu J, Rotter JI, Gauderman WJ, Province MA, Munroe PB, Rice K, Chasman DI, Cupples LA, Rao DC, Morrison AC, K?hnel B, Lyytik?inen LP, Stanc?kov? A, Varga TV, Canouil M, de Mutsert R, Kilpel?inen TO, M?gi R, Meitinger T, Peters A, Strauch K, Uitterlinden AG, Waldenberger M, Esko T, Franks PW, Gieger C, Lehtim?ki T. Multiancestry Genome-Wide Association Study of Lipid Levels Incorporating Gene-Alcohol Interactions. Am J Epidemiol. 2019 06 01; 188(6):1033-1054. PMID: 30698716; PMCID: PMC6545280.
      Citations: 32     Fields:    Translation:Humans
    255. Jia X, Al Rifai M, Ramsey DJ, Ahmed ST, Akeroyd JM, Nambi V, Ballantyne CM, Petersen LA, Stone NJ, Virani SS. Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health System. Am J Med. 2019 09; 132(9):e693-e700. PMID: 31103643.
      Citations: 3     Fields:    Translation:Humans
    256. Wang Z, Zhu C, Nambi V, Morrison AC, Folsom AR, Ballantyne CM, Boerwinkle E, Yu B. Metabolomic Pattern Predicts Incident Coronary Heart Disease. Arterioscler Thromb Vasc Biol. 2019 07; 39(7):1475-1482. PMID: 31092011; PMCID: PMC6839698.
      Citations: 17     Fields:    Translation:Humans
    257. Saeed A, Hadley TD, Jia X, Ballantyne CM. Statin use in carnitine palmitoyltransferase II deficiency. J Clin Lipidol. 2019 Jul - Aug; 13(4):550-553. PMID: 31235404.
      Citations: 1     Fields:    Translation:Humans
    258. Pokharel Y, Mouhanna F, Nambi V, Virani SS, Hoogeveen R, Alonso A, Heiss G, Coresh J, Mosley T, Gottesman RF, Ballantyne CM, Power MC. ApoB, small-dense LDL-C, Lp(a), LpPLA2 activity, and cognitive change. Neurology. 2019 05 28; 92(22):e2580-e2593. PMID: 31043469; PMCID: PMC6556082.
      Citations: 7     Fields:    Translation:Humans
    259. Jia X, Sun W, Hoogeveen RC, Nambi V, Matsushita K, Folsom AR, Heiss G, Couper DJ, Solomon SD, Boerwinkle E, Shah A, Selvin E, de Lemos JA, Ballantyne CM. High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study. Circulation. 2019 06 04; 139(23):2642-2653. PMID: 31030544; PMCID: PMC6546524.
      Citations: 48     Fields:    Translation:HumansCells
    260. Trang A, Kampangkaew J, Fernandes R, Tiwana J, Misra A, Hamzeh I, Blaustein A, Aguilar D, Shah T, Ballantyne C, Quinones M, Nagueh SF, Dokanish H, Virani SS, Deswal A, Kirkpatrick JN, Nambi V. Understanding by General Providers of the Echocardiogram Report. Am J Cardiol. 2019 07 15; 124(2):296-302. PMID: 31104774.
      Citations:    Fields:    Translation:Humans
    261. Madan N, Lee AK, Matsushita K, Hoogeveen RC, Ballantyne CM, Selvin E, McEvoy JW. Relation of Isolated Systolic Hypertension and Pulse Pressure to High-Sensitivity Cardiac Troponin-T and N-Terminal pro-B-Type Natriuretic Peptide in Older Adults (from the Atherosclerosis Risk in Communities Study). Am J Cardiol. 2019 07 15; 124(2):245-252. PMID: 31088661; PMCID: PMC6581585.
      Citations: 4     Fields:    Translation:Humans
    262. Wu H, Ballantyne CM. Letter by Wu and Ballantyne Regarding Article, "Protein Kinase C? via Activating Transcription Factor 2-Mediated CD36 Expression and Foam Cell Formation of Ly6Chi Cells Contributes to Atherosclerosis". Circulation. 2019 04 23; 139(17):2077-2078. PMID: 31013133; PMCID: PMC6481314.
      Citations:    Fields:    Translation:HumansCells
    263. Bentley AR, Sung YJ, Brown MR, Winkler TW, Kraja AT, Ntalla I, Schwander K, Chasman DI, Lim E, Deng X, Guo X, Liu J, Lu Y, Cheng CY, Sim X, Vojinovic D, Huffman JE, Musani SK, Li C, Feitosa MF, Richard MA, Noordam R, Baker J, Chen G, Bartz TM, Ding J, Dorajoo R, Manning AK, Rankinen T, Smith AV, Tajuddin SM, Zhao W, Graff M, Alver M, Boissel M, Chai JF, Chen X, Divers J, Evangelou E, Gao C, Goel A, Hagemeijer Y, Harris SE, Hartwig FP, He M, Hsu FC, Hung YJ, Jackson AU, Kasturiratne A, Komulainen P, Leander K, Lin KH, Luan J, Matoba N, Nolte IM, Pietzner M, Prins B, Riaz M, Robino A, Said MA, Schupf N, Scott RA, Sofer T, Takeuchi F, Tayo BO, van der Most PJ, Wang TD, Wang Y, Ware EB, Wen W, Xiang YB, Yanek LR, Zhang W, Zhao JH, Adeyemo A, Afaq S, Amin N, Amini M, Arking DE, Arzumanyan Z, Aung T, Ballantyne C, Barr RG, Bielak LF, Boerwinkle E, Bottinger EP, Broeckel U, Brown M, Cade BE, Campbell A, Charumathi S, Chen YI, Christensen K, COGENT-Kidney Consortium, Concas MP, Connell JM, de Las Fuentes L, de Silva HJ, de Vries PS, Doumatey A, Duan Q, Eaton CB, Eppinga RN, Faul JD, Floyd JS, Forouhi NG, Forrester T, Friedlander Y, Gandin I, Gao H, Ghanbari M, Gharib SA, Gigante B, Giulianini F, Grabe HJ, Gu CC, Harris TB, Heikkinen S, Heng CK, Hirata M, Hixson JE, Ikram MA, EPIC-InterAct Consortium, Jia Y, Joehanes R, Johnson C, Jonas JB, Justice AE, Katsuya T, Khor CC, Koh WP, Kolcic I, Kooperberg C, Kritchevsky SB, Kubo M, Kuusisto J, Lakka TA, Langefeld CD, Langenberg C, Launer LJ, Lehne B, Lewis CE, Li Y, Liang J, Lin S, Liu CT, Liu J, Liu K, Loh M, Lohman KK, Louie T, Luzzi A, Mahajan A, Manichaikul AW, McKenzie CA, Metspalu A, Milaneschi Y, Milani L, Mohlke KL, Momozawa Y, Morris AP, Murray AD, Nalls MA, Nauck M, Nelson CP, North KE, O'Connell JR, Palmer ND, Papanicolau GJ, Pedersen NL, Peyser PA, Polasek O, Poulter N, Raitakari OT, Reiner AP, Rice TK, Rich SS, Robinson JG, Rose LM, Rosendaal FR, Rudan I, Schmidt CO, Schreiner PJ, Scott WR, Sever P, Shi Y, Sidney S, Sims M, Smith JA, Snieder H, Starr JM, Strauch K, Stringham HM, Tan NYQ, Tang H, Taylor KD, Teo YY, Tham YC, Tiemeier H, Turner ST, Understanding Society Scientific Group, van Heemst D, Wang H, Wang L, Wang L, Wei WB, Williams CA, Wilson G, Wojczynski MK, Yao J, Young K, Yu C, Yuan JM, Zhou J, Zonderman AB, Becker DM, Boehnke M, Bowden DW, Chambers JC, Cooper RS, de Faire U, Deary IJ, Elliott P, Farrall M, Freedman BI, Froguel P, Gasparini P, Horta BL, Juang JJ, Kamatani Y, Kammerer CM, Kato N, Kooner JS, Laakso M, Laurie CC, Lee IT, Lifelines Cohort, Magnusson PKE, Oldehinkel AJ, Penninx BWJH, Rauramaa R, Redline S, Samani NJ, Scott J, Shu XO, van der Harst P, Wagenknecht LE, Wang JS, Wang YX, Wareham NJ, Watkins H, Weir DR, Wickremasinghe AR, Wu T, Zeggini E, Zheng W, Bouchard C, Evans MK, Gudnason V, Kardia SLR, Liu Y, Psaty BM, Ridker PM, van Dam RM, Mook-Kanamori DO, Fornage M, Province MA, Kelly TN, Fox ER, Hayward C, van Duijn CM, Tai ES, Wong TY, Loos RJF, Franceschini N, Rotter JI, Zhu X, Bierut LJ, Gauderman WJ, Rice K, Munroe PB, Morrison AC, Rao DC, Rotimi CN, Cupples LA, Aschard H, Horimoto ARVR, K?hnel B, Lyytik?inen LP, Stanc?kov? A, Varga TV, Canouil M, Kilpel?inen TO, Krieger JE, M?gi R, Meitinger T, Peters A, Renstr?m F, Uitterlinden AG, Waldenberger M, Esko T, Franks PW, Gieger C, Lehtim?ki T, Pereira AC. Multi-ancestry genome-wide gene-smoking interaction study of 387,272 individuals identifies new loci associated with serum lipids. Nat Genet. 2019 04; 51(4):636-648. PMID: 30926973; PMCID: PMC6467258.
      Citations: 43     Fields:    Translation:Humans
    264. Bhatt DL, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT, Juliano RA, Jiao L, Granowitz C, Gregson J, Pocock SJ, Ballantyne CM, REDUCE-IT Investigators, Steg PG, Tardif JC. Effects of Icosapent Ethyl on Total?Ischemic Events: From REDUCE-IT. J Am Coll Cardiol. 2019 06 11; 73(22):2791-2802. PMID: 30898607.
      Citations: 65     Fields:    Translation:Humans
    265. Ray KK, Bays HE, Catapano AL, Lalwani ND, Bloedon LT, Sterling LR, Robinson PL, Ballantyne CM, CLEAR Harmony Trial. Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol. N Engl J Med. 2019 03 14; 380(11):1022-1032. PMID: 30865796.
      Citations: 107     Fields:    Translation:Humans
    266. Jia X, Akeroyd JM, Nasir K, Nambi V, Ballantyne CM, Petersen LA, Virani SS. Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial. Circulation. 2019 03 05; 139(10):1341-1343. PMID: 30865483.
      Citations: 6     Fields:    Translation:Humans
    267. Ballantyne CM, Manku MS, Bays HE, Philip S, Granowitz C, Doyle RT, Juliano RA. Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study. Cardiol Ther. 2019 Jun; 8(1):79-90. PMID: 30788718; PMCID: PMC6525216.
      Citations: 6     
    268. Singh M, Hanis CL, Redline S, Ballantyne CM, Hamzeh I, Aguilar D. Sleep apnea and galectin-3: possible sex-specific relationship. Sleep Breath. 2019 Dec; 23(4):1107-1114. PMID: 30721387; PMCID: PMC6761033.
      Citations: 3     Fields:    Translation:Humans
    269. Virani SS, Akeroyd JM, Nambi V, Michos ED, Morris PB, Nasir K, Smith SC, Stone NJ, Petersen LA, Ballantyne CM. Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial. Circulation. 2019 01 15; 139(3):410-412. PMID: 30586689.
      Citations: 3     Fields:    Translation:Humans
    270. Pandey A, Keshvani N, Ayers C, Correa A, Drazner MH, Lewis A, Rodriguez CJ, Hall ME, Fox ER, Mentz RJ, deFilippi C, Seliger SL, Ballantyne CM, Neeland IJ, de Lemos JA, Berry JD. Association of Cardiac Injury and Malignant Left Ventricular Hypertrophy With Risk of Heart Failure in African Americans: The Jackson Heart Study. JAMA Cardiol. 2019 01 01; 4(1):51-58. PMID: 30566191; PMCID: PMC6439681.
      Citations: 12     Fields:    Translation:Humans
    271. Hira RS, Kataruka A, Akeroyd JM, Ramsey DJ, Pokharel Y, Gurm HS, Nasir K, Deswal A, Jneid H, Alam M, Ballantyne CM, Petersen LA, Virani SS. Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2019 01; 12(1):e004817. PMID: 30636483.
      Citations:    Fields:    Translation:HumansPHPublic Health
    272. Jia X, Lorenz P, Ballantyne CM. Poststatin Lipid Therapeutics: A Review. Methodist Debakey Cardiovasc J. 2019 Jan-Mar; 15(1):32-38. PMID: 31049147; PMCID: PMC6489602.
      Citations: 4     Fields:    Translation:HumansAnimals
    273. Saeed A, Sun W, Agarwala A, Virani SS, Nambi V, Coresh J, Selvin E, Boerwinkle E, Jones PH, Ballantyne CM, Hoogeveen RC. Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study. Atherosclerosis. 2019 03; 282:52-56. PMID: 30685442; PMCID: PMC6699162.
      Citations: 13     Fields:    Translation:Humans
    274. Ramsey D, Ahmed ST, Mishra SR, Petersen LA, Muntner P, Winkelmayer WC, Ramanathan V, Navaneethan SD, Akeroyd JM, Ballantyne C, Virani SS. Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1842-1850. PMID: 30498000; PMCID: PMC6302320.
      Citations: 7     Fields:    Translation:Humans
    275. Virani SS, Ballantyne CM. Low-Density Lipoprotein Cholesterol: Is 160 the New 190? Circulation. 2018 11 20; 138(21):2326-2329. PMID: 30571588; PMCID: PMC6363356.
      Citations: 4     Fields:    Translation:Humans
    276. Reeskamp LF, Kastelein JJP, Moriarty PM, Duell PB, Catapano AL, Santos RD, Ballantyne CM. Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia. Atherosclerosis. 2019 01; 280:109-117. PMID: 30500603.
      Citations: 17     Fields:    Translation:Humans
    277. REDUCE-IT Investigators, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 2019 01 03; 380(1):11-22. PMID: 30415628.
      Citations: 573     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    278. Ligthart S, Vaez A, de Vries PS, Prins BP, Van der Most PJ, Tanaka T, Naderi E, Rose LM, Wu Y, Karlsson R, Barbalic M, Lin H, Zhu G, Sidore C, Trompet S, Mangino M, Kemp JP, Abbasi A, Kacprowski T, Verweij N, Smith AV, Huang T, Feitosa MF, Lohman KK, Kleber ME, Milaneschi Y, Huq M, Vlachopoulou E, Oldmeadow C, Deelen J, Perola M, Zhao JH, Feenstra B, LifeLines Cohort Study, Amini M, CHARGE Inflammation Working Group, Schraut KE, Fornage M, Suktitipat B, Chen WM, Li X, Nutile T, Malerba G, Luan J, Bak T, Schork N, Mahajan A, Marioni RE, Mihailov E, Eriksson J, Ozel AB, Zhang W, Nethander M, Cheng YC, Aslibekyan S, Ang W, Gandin I, Portas L, Kooperberg C, Hofer E, Rajan KB, Schurmann C, den Hollander W, Ahluwalia TS, Zhao J, Draisma HHM, Ford I, Timpson N, Teumer A, Huang H, Liu Y, Huang J, Uh HW, Geller F, Joshi PK, Yanek LR, Trabetti E, Lehne B, Vozzi D, Verbanck M, Biino G, Saba Y, Meulenbelt I, O'Connell JR, Laakso M, Giulianini F, Magnusson PKE, Ballantyne CM, Hottenga JJ, Montgomery GW, Rivadineira F, Rueedi R, Steri M, Herzig KH, Stott DJ, Menni C, St Pourcain B, Felix SB, Pers TH, Bakker SJL, Kraft P, Vaidya D, Delgado G, Smit JH, Sinisalo J, Williams SR, Holliday EG, Moed M, Langenberg C, Ding J, Campbell H, Sale MM, Chen YI, James AL, Ruggiero D, Soranzo N, Hartman CA, Smith EN, Berenson GS, Hernandez D, Giedraitis V, Liewald D, Fischer K, Larsson A, Wang Y, Scott WR, Beilby J, Ryan KA, Pennell CE, Vuckovic D, Concas MP, Schmidt R, Mendes de Leon CF, Bottinger EP, Kloppenburg M, Paternoster L, Boehnke M, Musk AW, Willemsen G, Evans DM, Madden PAF, Zoledziewska M, Karhunen V, Kritchevsky SB, Sattar N, Lachance G, Clarke R, Harris TB, Raitakari OT, Attia JR, van Heemst D, Kajantie E, Sorice R, Scott RA, Ferrucci L, Lindgren CM, Starr JM, Karlsson M, Lind L, Li JZ, Chambers JC, Mori TA, de Geus EJCN, Heath AC, Martin NG, Auvinen J, Buckley BM, de Craen AJM, Scott RJ, McEvoy M, Beekman M, Bombieri C, Ridker PM, Mohlke KL, Pedersen NL, Morrison AC, Boomsma DI, Whitfield JB, Strachan DP, Hofman A, Vollenweider P, Cucca F, Jarvelin MR, Jukema JW, Spector TD, Hamsten A, Zeller T, Nauck M, Gudnason V, Qi L, Borecki IB, Rotter JI, Wild PS, Lokki ML, Boyle M, Salomaa V, Melbye M, Wilson JF, Penninx BWJH, Becker DM, Worrall BB, Gibson G, Krauss RM, Ciullo M, Zaza G, Wareham NJ, Oldehinkel AJ, Palmer LJ, Murray SS, Bandinelli S, Ingelsson E, Deary IJ, Vandenput L, van der Harst P, Desch KC, Kooner JS, Ohlsson C, Hayward C, Shuldiner AR, Arnett DK, Beilin LJ, Robino A, Froguel P, Pirastu M, Jess T, Loos RJF, Evans DA, Schmidt H, Smith GD, Slagboom PE, Eiriksdottir G, Morris AP, Psaty BM, Tracy RP, Nolte IM, Boerwinkle E, Reiner AP, Gross M, Bis JC, Franke L, Franco OH, Benjamin EJ, Chasman DI, Snieder H, Dehghan A, Alizadeh BZ, V?sa U, Stathopoulou MG, Pool R, Mac? A, Sabater-Lleal M, Marzi C, Mueller C, Lyytik?inen LP, Lahti J, Del Greco M F, Thiering E, Yengo L, Wahl S, Fr?nberg M, Peters A, Gro?mann V, Sepp?l? I, R?ikk?nen K, Fuchsberger C, Tiesler CMT, Mellstr?m D, Lorentzon M, Balkau B, K?h?nen M, Kutalik Z, Gambaro G, Hicks AA, Standl M, Waldenberger M, Strauch K, Meitinger T, Uitterlinden AG, Grallert H, M?rz W, Eriksson JG, Pramstaller PP, Heinrich J, M?gi R, Lehtim?ki T, Koenig W, Visvikis-Siest S, Dupuis J. Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders. Am J Hum Genet. 2018 11 01; 103(5):691-706. PMID: 30388399; PMCID: PMC6218410.
      Citations: 97     Fields:    Translation:Humans
    279. Nicholls SJ, Puri R, Anderson T, Ballantyne CM, Cho L, Kastelein JJP, Somaratne R, Kassahun H, Yang J, Wasserman SM, Honda S, Shishikura D, Scherer DJ, Borgman M, Brennan DM, Wolski K, Nissen SE, Koenig W. Effect of Evolocumab on Coronary?Plaque Composition. J Am Coll Cardiol. 2018 10 23; 72(17):2012-2021. PMID: 30336824.
      Citations: 28     Fields:    Translation:Humans
    280. Ridker PM, Libby P, MacFadyen JG, Thuren T, Ballantyne C, Fonseca F, Shimokawa H, Everett BM, Glynn RJ, Koenig W. Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS). Eur Heart J. 2018 10 07; 39(38):3499-3507. PMID: 30165610.
      Citations: 134     Fields:    Translation:HumansCellsPHPublic Health
    281. Nicholls SJ, Lincoff AM, Bash D, Ballantyne CM, Barter PJ, Davidson MH, Kastelein JJP, McGuire DK, Mozaffarian D, Pedersen TR, Ridker PM, Ray K, Wolski K, Nissen SE, Koenig W, Karlson BW, Lundstr?m T. Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial. Clin Cardiol. 2018 Oct; 41(10):1281-1288. PMID: 30125052; PMCID: PMC6489732.
      Citations: 55     Fields:    Translation:Humans
    282. Nicholls SJ, Puri R, Ballantyne CM, Jukema JW, Kastelein JJP, Wright RS, Kallend D, Wijngaard P, Borgman M, Wolski K, Nissen SE, Koenig W. Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial. JAMA Cardiol. 2018 09 01; 3(9):806-814. PMID: 30046837; PMCID: PMC6233637.
      Citations: 40     Fields:    Translation:Humans
    283. Ballantyne CM, Bhatt DL, Cannon CP, Fazio S, Sabatine MS. WITHDRAWN: Raising the Bar by Lowering the Target: Integrating PCSK9 Inhibitors Into Hypercholesterolemia Management. Am J Cardiol. 2018 Aug 16. PMID: 30301542.
      Citations:    Fields:    
    284. Saeed A, Virani SS, Ballantyne CM, Taylor AA, Nambi V. Are All Benefits and Harms Equal? J Am Coll Cardiol. 2018 08 14; 72(7):819-820. PMID: 30092962.
      Citations:    Fields:    Translation:Humans
    285. Folsom AR, Lutsey PL, Heckbert SR, Poudel K, Basu S, Hoogeveen RC, Cushman M, Ballantyne CM. Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism. J Thromb Haemost. 2018 10; 16(10):1964-1972. PMID: 30007116; PMCID: PMC6173641.
      Citations: 3     Fields:    Translation:HumansCells
    286. Sturm AC, Knowles JW, Gidding SS, Ahmad ZS, Ahmed CD, Ballantyne CM, Baum SJ, Cuchel M, de Ferranti SD, Defesche JC, Freiberger T, Hershberger RE, Hovingh GK, Karayan L, Kastelein JJP, Kindt I, Lane SR, Leigh SE, Linton MF, Neal WA, Harada-Shiba M, Sijbrands EJ, Stitziel NO, Yamashita S, Wilemon KA, Ledbetter DH, Rader DJ, Convened by the Familial Hypercholesterolemia Foundation, Bourbon M, Carri? A, Mata P, Nordestgaard BG, Santos RD. Clinical Genetic Testing for Familial?Hypercholesterolemia: JACC Scientific Expert Panel. J Am Coll Cardiol. 2018 08 07; 72(6):662-680. PMID: 30071997.
      Citations: 92     Fields:    Translation:Humans
    287. Saeed A, Feofanova EV, Yu B, Sun W, Virani SS, Nambi V, Coresh J, Guild CS, Boerwinkle E, Ballantyne CM, Hoogeveen RC. Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease. J Am Coll Cardiol. 2018 07 10; 72(2):156-169. PMID: 29976289; PMCID: PMC6051722.
      Citations: 35     Fields:    Translation:Humans
    288. Faza NN, Akeroyd JM, Ramsey DJ, Shah T, Nasir K, Deswal A, Ballantyne CM, Petersen LA, Virani SS. Effectiveness of NPs and PAs in managing diabetes and cardiovascular disease. JAAPA. 2018 Jul; 31(7):39-45. PMID: 29957606.
      Citations: 6     Fields:    Translation:Humans
    289. Saeed A, Dabhadkar K, Virani SS, Jones PH, Ballantyne CM, Nambi V. Correction to: Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future Directions. Curr Atheroscler Rep. 2018 06 19; 20(9):42. PMID: 29915890.
      Citations:    Fields:    
    290. Ballantyne CM, Banach M, Mancini GBJ, Lepor NE, Hanselman JC, Zhao X, Leiter LA. Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study. Atherosclerosis. 2018 10; 277:195-203. PMID: 29910030.
      Citations: 51     Fields:    Translation:HumansCellsCTClinical Trials
    291. Wu J, Wu H, An J, Ballantyne CM, Cyster JG. Critical role of integrin CD11c in splenic dendritic cell capture of missing-self CD47 cells to induce adaptive immunity. Proc Natl Acad Sci U S A. 2018 06 26; 115(26):6786-6791. PMID: 29891680; PMCID: PMC6042080.
      Citations: 20     Fields:    Translation:AnimalsCells
    292. Basra SS, Wang TY, Simon DN, Chiswell K, Peterson ED, Virani SS, Alam M, Nambi V, Denktas AE, Deswal A, Bozkurt B, Ballantyne CM, Jneid H. Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry. J Am Heart Assoc. 2018 06 09; 7(12). PMID: 29886424; PMCID: PMC6220549.
      Citations: 5     Fields:    Translation:Humans
    293. Saeed A, Virani SS, Jones PH, Ballantyne CM, Nambi V. Case reports of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition nonresponse. J Clin Lipidol. 2018 Sep - Oct; 12(5):1141-1145. PMID: 30318064.
      Citations: 2     Fields:    Translation:Humans
    294. Saeed A, Dabhadkar K, Virani SS, Jones PH, Ballantyne CM, Nambi V. Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future Directions. Curr Atheroscler Rep. 2018 05 21; 20(7):35. PMID: 29781057.
      Citations: 6     Fields:    Translation:Humans
    295. Virani SS, Kennedy KF, Akeroyd JM, Morris PB, Bittner VA, Masoudi FA, Stone NJ, Petersen LA, Ballantyne CM. Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol =190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry. Circ Cardiovasc Qual Outcomes. 2018 05; 11(5):e004652. PMID: 29748356; PMCID: PMC5951397.
      Citations: 11     Fields:    Translation:HumansCells
    296. Ding N, Kwak L, Ballew SH, Jaar B, Hoogeveen RC, Ballantyne CM, Sharrett AR, Folsom AR, Heiss G, Salameh M, Coresh J, Hirsch AT, Selvin E, Matsushita K. Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis. 2018 07; 274:86-93. PMID: 29753232; PMCID: PMC5999570.
      Citations: 8     Fields:    Translation:Humans
    297. McBride CL, Akeroyd JM, Ramsey DJ, Nambi V, Nasir K, Michos ED, Bush RL, Jneid H, Morris PB, Bittner VA, Ballantyne CM, Petersen LA, Virani SS. Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs. Vasc Med. 2018 06; 23(3):232-240. PMID: 29600737.
      Citations: 15     Fields:    Translation:Humans
    298. Brinton EA, Ballantyne CM, Guyton JR, Philip S, Doyle RT, Juliano RA, Mosca L. Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis. J Womens Health (Larchmt). 2018 09; 27(9):1170-1176. PMID: 29583081; PMCID: PMC6148718.
      Citations: 6     Fields:    Translation:Humans
    299. Saeed A, Nambi V, Sun W, Virani SS, Taffet GE, Deswal A, Selvin E, Matsushita K, Wagenknecht LE, Hoogeveen R, Coresh J, de Lemos JA, Ballantyne CM. Short-Term Global Cardiovascular Disease Risk?Prediction in Older Adults. J Am Coll Cardiol. 2018 06 05; 71(22):2527-2536. PMID: 29535064; PMCID: PMC5984171.
      Citations: 17     Fields:    Translation:Humans
    300. Saeed A, Ballantyne CM. Bempedoic Acid (ETC-1002): A Current Review. Cardiol Clin. 2018 May; 36(2):257-264. PMID: 29609755.
      Citations: 9     Fields:    Translation:Humans
    301. Kayani WT, Ballantyne CM. Improving Outcomes After Myocardial Infarction in the US Population. J Am Heart Assoc. 2018 02 17; 7(4). PMID: 29455157; PMCID: PMC5850209.
      Citations: 4     Fields:    Translation:Humans
    302. Tibuakuu M, Kianoush S, DeFilippis AP, McEvoy JW, Zhao D, Guallar E, Ballantyne CM, Hoogeveen RC, Blaha MJ, Michos ED. Usefulness of Lipoprotein-Associated Phospholipase A2 Activity and C-Reactive Protein in Identifying High-Risk Smokers for Atherosclerotic Cardiovascular Disease (from the Atherosclerosis Risk in Communities Study). Am J Cardiol. 2018 05 01; 121(9):1056-1064. PMID: 29525060; PMCID: PMC5927844.
      Citations: 4     Fields:    Translation:Humans
    303. McCullough PA, Ballantyne CM, Sanganalmath SK, Langslet G, Baum SJ, Shah PK, Koren A, Mandel J, Davidson MH. Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials). Am J Cardiol. 2018 04 15; 121(8):940-948. PMID: 29472008.
      Citations: 2     Fields:    Translation:Humans
    304. Schwartz GG, Ballantyne CM, Barter PJ, Kallend D, Leiter LA, Leitersdorf E, McMurray JJV, Nicholls SJ, Shah PK, Kittelson J, Olsson AG, Tardif JC. Association of Lipoprotein(a) With Risk of Recurrent Ischemic Events Following Acute Coronary Syndrome: Analysis of the dal-Outcomes Randomized Clinical Trial. JAMA Cardiol. 2018 02 01; 3(2):164-168. PMID: 29071331; PMCID: PMC5838593.
      Citations: 18     Fields:    Translation:Humans
    305. Florido R, Kwak L, Lazo M, Nambi V, Ahmed HM, Hegde SM, Gerstenblith G, Blumenthal RS, Ballantyne CM, Selvin E, Folsom AR, Coresh J, Ndumele CE. Six-Year Changes in Physical Activity and the Risk of Incident Heart Failure: ARIC Study. Circulation. 2018 05 15; 137(20):2142-2151. PMID: 29386202; PMCID: PMC6219377.
      Citations: 15     Fields:    Translation:Humans
    306. Nambi V, Deswal A, Ballantyne CM. Prevention of "Failure": Is It a Failure of Prevention? Circulation. 2018 01 09; 137(2):106-108. PMID: 29311345; PMCID: PMC5942594.
      Citations: 3     Fields:    Translation:Humans
    307. Aronis KN, Zhao D, Hoogeveen RC, Alonso A, Ballantyne CM, Guallar E, Jones SR, Martin SS, Nazarian S, Steffen BT, Michos ED, Virani SS. Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study. J Am Heart Assoc. 2017 Dec 15; 6(12). PMID: 29246963; PMCID: PMC5779047.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    308. Vart P, Matsushita K, Rawlings AM, Selvin E, Crews DC, Ndumele CE, Ballantyne CM, Heiss G, Kucharska-Newton A, Szklo M, Coresh J. SES, Heart Failure, and N-terminal Pro-b-type Natriuretic Peptide: The Atherosclerosis Risk in Communities Study. Am J Prev Med. 2018 02; 54(2):229-236. PMID: 29241718; PMCID: PMC5828682.
      Citations: 8     Fields:    Translation:Humans
    309. Garg PK, Bartz TM, Norby FL, Jorgensen NW, McClelland RL, Ballantyne CM, Chen LY, Gottdiener JS, Greenland P, Hoogeveen R, Jenny NS, Kizer JR, Rosenson RS, Soliman EZ, Cushman M, Alonso A, Heckbert SR. Association of lipoprotein-associated phospholipase A2 and risk of incident atrial fibrillation: Findings from 3 cohorts. Am Heart J. 2018 03; 197:62-69. PMID: 29447785; PMCID: PMC5860682.
      Citations: 1     Fields:    Translation:Humans
    310. Kubota Y, Folsom AR, Ballantyne CM, Tang W. Lipoprotein(a) and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study. Atherosclerosis. 2018 01; 268:63-67. PMID: 29182987; PMCID: PMC5788200.
      Citations: 7     Fields:    Translation:HumansCells
    311. Fretz A, McEvoy JW, Rebholz CM, Ndumele CE, Florido R, Hoogeveen RC, Ballantyne CM, Selvin E. Relation of Lifestyle Factors and Life's Simple 7 Score to Temporal Reduction in Troponin Levels Measured by a High-Sensitivity Assay (from the Atherosclerosis Risk in Communities Study). Am J Cardiol. 2018 02 15; 121(4):430-436. PMID: 29268937; PMCID: PMC5783761.
      Citations: 4     Fields:    Translation:Humans
    312. Ndumele CE, Cobb L, Lazo M, Bello NA, Shah A, Nambi V, Blumenthal RS, Gerstenblith G, Solomon SD, Ballantyne CM, Selvin E, Coresh J. Weight History and Subclinical Myocardial Damage. Clin Chem. 2018 01; 64(1):201-209. PMID: 29158254; PMCID: PMC6219376.
      Citations: 4     Fields:    Translation:Humans
    313. Garg PK, Norby FL, Polfus LM, Boerwinkle E, Gibbs RA, Grove ML, Folsom AR, Garimella PS, Matsushita K, Hoogeveen RC, Ballantyne CM. Lipoprotein-associated phospholipase A2 and risk of incident peripheral arterial disease: Findings from The Atherosclerosis Risk in Communities study (ARIC). Atherosclerosis. 2018 01; 268:12-18. PMID: 29169030; PMCID: PMC6392003.
      Citations: 5     Fields:    Translation:HumansCells
    314. Walker KA, Power MC, Hoogeveen RC, Folsom AR, Ballantyne CM, Knopman DS, Windham BG, Selvin E, Jack CR, Gottesman RF. Midlife Systemic Inflammation, Late-Life White Matter Integrity, and Cerebral Small Vessel Disease: The Atherosclerosis Risk in Communities Study. Stroke. 2017 12; 48(12):3196-3202. PMID: 29101255; PMCID: PMC5705320.
      Citations: 43     Fields:    Translation:Humans
    315. Walker KA, Hoogeveen RC, Folsom AR, Ballantyne CM, Knopman DS, Windham BG, Jack CR, Gottesman RF. Midlife systemic inflammatory markers are associated with late-life brain volume: The ARIC study. Neurology. 2017 Nov 28; 89(22):2262-2270. PMID: 29093073; PMCID: PMC5705246.
      Citations: 37     Fields:    Translation:Humans
    316. Harrington JL, Ayers C, Berry JD, Omland T, Pandey A, Seliger SL, Ballantyne CM, Kulinski J, deFilippi CR, de Lemos JA. Sedentary Behavior and Subclinical Cardiac Injury: Results From the Dallas Heart Study. Circulation. 2017 10 10; 136(15):1451-1453. PMID: 28993375; PMCID: PMC5679446.
      Citations: 3     Fields:    Translation:Humans
    317. Virani SS, Akeroyd JM, Ramsey DJ, Deswal A, Nasir K, Rajan SS, Ballantyne CM, Petersen LA. Health Care Resource Utilization for Outpatient Cardiovascular Disease and Diabetes Care Delivery Among Advanced Practice Providers and Physician Providers in Primary Care. Popul Health Manag. 2018 06; 21(3):209-216. PMID: 28994631.
      Citations: 8     Fields:    Translation:Humans
    318. Amrock SM, Duell PB, Knickelbine T, Martin SS, O'Brien EC, Watson KE, Mitri J, Kindt I, Shrader P, Baum SJ, Hemphill LC, Ahmed CD, Andersen RL, Kullo IJ, McCann D, Larry JA, Murray MF, Fishberg R, Guyton JR, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Underberg JA, Thompson P, Duffy D, Linton MF, Shapiro MD, Moriarty PM, Knowles JW, Ahmad ZS. Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH? patient registry. Atherosclerosis. 2017 Dec; 267:19-26. PMID: 29080546.
      Citations: 15     Fields:    Translation:Humans
    319. Lloyd-Jones DM, Morris PB, Ballantyne CM, Birtcher KK, Daly DD, DePalma SM, Minissian MB, Orringer CE, Smith SC. 2017 Focused Update of the 2016?ACC?Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in?the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol. 2017 Oct 03; 70(14):1785-1822. PMID: 28886926.
      Citations: 96     Fields:    Translation:Humans
    320. Rebholz CM, Selvin E, Liang M, Ballantyne CM, Hoogeveen RC, Aguilar D, McEvoy JW, Grams ME, Coresh J. Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease. Kidney Int. 2018 01; 93(1):252-259. PMID: 28865675; PMCID: PMC5750096.
      Citations: 19     Fields:    Translation:HumansCells
    321. CANTOS Trial Group, Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017 09 21; 377(12):1119-1131. PMID: 28845751.
      Citations: 2254     Fields:    Translation:HumansPHPublic Health
    322. van Capelleveen JC, Bochem AE, Boekholdt SM, Mora S, Hoogeveen RC, Ballantyne CM, Ridker PM, Sun W, Barter PJ, Tall AR, Zwinderman AH, Kastelein JJP, Wareham NJ, Khaw KT, Hovingh GK. Association of High-Density Lipoprotein-Cholesterol Versus Apolipoprotein A-I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer-Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and the Women's Health Study. J Am Heart Assoc. 2017 Aug 03; 6(8). PMID: 28775061; PMCID: PMC5586475.
      Citations: 7     Fields:    Translation:Humans
    323. Fashanu OE, Norby FL, Aguilar D, Ballantyne CM, Hoogeveen RC, Chen LY, Soliman EZ, Alonso A, Folsom AR. Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2017 Oct; 192:19-25. PMID: 28938960; PMCID: PMC5673118.
      Citations: 17     Fields:    Translation:Humans
    324. Puri R, Ballantyne CM, Hoogeveen RC, Shao M, Barter P, Libby P, Erbel R, Arsenault BJ, Raichlen JS, Nissen SE, Nicholls SJ, Chapman MJ. Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN. Atherosclerosis. 2017 Aug; 263:137-144. PMID: 28641153.
      Citations: 14     Fields:    Translation:Humans
    325. Lo GH, McAlindon TE, Katz JN, Driban JB, Price LL, Eaton CB, Petersen NJ, Ballantyne CM, Suarez-Almazor ME. Systolic and pulse pressure associate with incident knee osteoarthritis: data from the Osteoarthritis Initiative. Clin Rheumatol. 2017 Sep; 36(9):2121-2128. PMID: 28573369; PMCID: PMC5709188.
      Citations: 15     Fields:    Translation:Humans
    326. Zewinger S, Kleber ME, Tragante V, McCubrey RO, Schmidt AF, Direk K, Laufs U, Werner C, Rothenbacher D, Mons U, Breitling LP, Brenner H, Jennings RT, Petrakis I, Triem S, Klug M, Filips A, Lackner KJ, Vlachopoulou E, Pedersen ER, Tell GS, Sinisalo J, Nieminen MS, Laaksonen R, Trompet S, Smit RAJ, Sattar N, Jukema JW, Groesdonk HV, Delgado G, Stojakovic T, Pilbrow AP, Cameron VA, Richards AM, Doughty RN, Gong Y, Cooper-DeHoff R, Johnson J, Scholz M, Beutner F, Thiery J, Vilmundarson RO, McPherson R, Stewart AFR, Cresci S, Lenzini PA, Spertus JA, Olivieri O, Girelli D, Martinelli NI, Leiherer A, Saely CH, Drexel H, Braund PS, Nelson CP, Samani NJ, Kofink D, Hoefer IE, Pasterkamp G, Quyyumi AA, Ko YA, Hartiala JA, Allayee H, Tang WHW, Hazen SL, Eriksson N, Held C, Wallentin L, Siegbahn A, Karp I, Labos C, Pilote L, Engert JC, Brophy JM, Thanassoulis G, Virani SS, Ballantyne CM, Lee VV, Boerwinkle E, Holmes MV, Horne BD, Hingorani A, Asselbergs FW, Patel RS, GENIUS-CHD consortium, Scharnagl H, Fliser D, Speer T, Koenig W, Blankenberg S, Waldeyer C, Sinning C, Schnabel RB, Nyg?rd O, Svingen GFT, Smith JG, M?ndlein A, Hagstr?m E, ?kerblom A, Bogaty P, Szczeklik W, Kaczor M, Sanak M, Kr?mer BK, M?rz W. Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study. Lancet Diabetes Endocrinol. 2017 07; 5(7):534-543. PMID: 28566218; PMCID: PMC5651679.
      Citations: 25     Fields:    Translation:Humans
    327. Agarwala A, Pokharel Y, Saeed A, Sun W, Virani SS, Nambi V, Ndumele C, Shahar E, Heiss G, Boerwinkle E, Konety S, Hoogeveen RC, Ballantyne CM. The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study. Atherosclerosis. 2017 07; 262:131-137. PMID: 28554015; PMCID: PMC5523851.
      Citations: 10     Fields:    Translation:HumansCells
    328. Aziz MH, Cui K, Das M, Brown KE, Ardell CL, Febbraio M, Pluskota E, Han J, Wu H, Ballantyne CM, Smith JD, Cathcart MK, Yakubenko VP. The Upregulation of Integrin aD?2 (CD11d/CD18) on Inflammatory Macrophages Promotes Macrophage Retention in Vascular Lesions and Development of Atherosclerosis. J Immunol. 2017 06 15; 198(12):4855-4867. PMID: 28500072; PMCID: PMC5553324.
      Citations: 28     Fields:    Translation:HumansAnimalsCells
    329. Wu H, Ballantyne CM. Dyslipidaemia: PCSK9 inhibitors and foamy monocytes in familial hypercholesterolaemia. Nat Rev Cardiol. 2017 07; 14(7):385-386. PMID: 28492287; PMCID: PMC5808934.
      Citations: 8     Fields:    Translation:HumansCells
    330. Virani SS, Akeroyd JM, Nambi V, Heidenreich PA, Morris PB, Nasir K, Michos ED, Bittner VA, Petersen LA, Ballantyne CM. Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk): Insights From the Department of Veterans Affairs. Circulation. 2017 06 20; 135(25):2572-2574. PMID: 28465286.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    331. Florido R, Ndumele CE, Kwak L, Pang Y, Matsushita K, Schrack JA, Lazo M, Nambi V, Blumenthal RS, Folsom AR, Coresh J, Ballantyne CM, Selvin E. Physical Activity, Obesity, and Subclinical?Myocardial Damage. JACC Heart Fail. 2017 05; 5(5):377-384. PMID: 28449797; PMCID: PMC5412715.
      Citations: 8     Fields:    Translation:Humans
    332. Knowles JW, Howard WB, Karayan L, Baum SJ, Wilemon KA, Ballantyne CM, Myers KD. Access to Nonstatin Lipid-Lowering Therapies in Patients at High Risk of Atherosclerotic Cardiovascular Disease. Circulation. 2017 05 30; 135(22):2204-2206. PMID: 28446516.
      Citations: 13     Fields:    Translation:Humans
    333. Ballantyne CM, Shah S, Sapre A, Ashraf TB, Tobias SC, Sahin T, Ye P, Dong Y, Sheu WH, Kang DH, Ferreira Rossi PR, Moiseeva Y, Briones IR, Johnson-Levonas AO, Mitchel YB. A Multiregional, Randomized Evaluation of the Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol. Am J Cardiol. 2017 Aug 15; 120(4):569-576. PMID: 28624096.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    334. Mao H, Lockyer P, Li L, Ballantyne CM, Patterson C, Xie L, Pi X. Endothelial LRP1 regulates metabolic responses by acting as a co-activator of PPAR?. Nat Commun. 2017 04 10; 8:14960. PMID: 28393867; PMCID: PMC5394236.
      Citations: 24     Fields:    Translation:HumansAnimalsCells
    335. Nicholls SJ, Ray KK, Ballantyne CM, Beacham LA, Miller DL, Ruotolo G, Nissen SE, Riesmeyer JS, ACCENTUATE Investigators. Comparative effects of cholesteryl ester transfer protein inhibition, statin or ezetimibe on lipid factors: The ACCENTUATE trial. Atherosclerosis. 2017 06; 261:12-18. PMID: 28412650.
      Citations: 10     Fields:    Translation:Humans
    336. Pokharel Y, Tang F, Jones PG, Nambi V, Bittner VA, Hira RS, Nasir K, Chan PS, Maddox TM, Oetgen WJ, Heidenreich PA, Borden WB, Spertus JA, Petersen LA, Ballantyne CM, Virani SS. Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide. JAMA Cardiol. 2017 04 01; 2(4):361-369. PMID: 28249067; PMCID: PMC5470413.
      Citations: 30     Fields:    Translation:Humans
    337. de Lemos JA, Ayers CR, Levine BD, deFilippi CR, Wang TJ, Hundley WG, Berry JD, Seliger SL, McGuire DK, Ouyang P, Drazner MH, Budoff M, Greenland P, Ballantyne CM, Khera A. Multimodality Strategy for Cardiovascular Risk Assessment: Performance in 2 Population-Based Cohorts. Circulation. 2017 05 30; 135(22):2119-2132. PMID: 28360032; PMCID: PMC5486874.
      Citations: 31     Fields:    Translation:HumansPHPublic Health
    338. Bhatt DL, Brinton EA, Jacobson TA, Miller M, Ketchum SB, Doyle RT, Murphy SA, Soni PN, Braeckman RA, Juliano RA, Ballantyne CM, REDUCE-IT Investigators, Steg PG, Tardif JC. Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial. Clin Cardiol. 2017 Mar; 40(3):138-148. PMID: 28294373; PMCID: PMC5396348.
      Citations: 53     Fields:    Translation:HumansCTClinical Trials
    339. Saeed A, Virani SS, Jones PH, Nambi V, Ballantyne CM, Zoch D. A simplified pathway to proprotein convertase subtilisin/kexin type 9 inhibitor prior authorization approval: A lipid clinic experience. J Clin Lipidol. 2017 May - Jun; 11(3):596-599. PMID: 28506382.
      Citations: 2     Fields:    Translation:Humans
    340. Saeed A, Ballantyne CM. Assessing Cardiovascular Risk and Testing in Type 2 Diabetes. Curr Cardiol Rep. 2017 03; 19(3):19. PMID: 28220465.
      Citations: 7     Fields:    Translation:Humans
    341. Belalcazar LM, Ballantyne CM. Looking Back at Look AHEAD Through the Lens of Recent Diabetes Outcome Trials. Circulation. 2017 02 21; 135(8):720-723. PMID: 28223324; PMCID: PMC5324725.
      Citations: 2     Fields:    Translation:Humans
    342. Faridi KF, Zhao D, Martin SS, Lupton JR, Jones SR, Guallar E, Ballantyne CM, Lutsey PL, Michos ED. Serum vitamin D and change in lipid levels over 5?y: The Atherosclerosis Risk in Communities study. Nutrition. 2017 Jun; 38:85-93. PMID: 28526388; PMCID: PMC5443111.
      Citations: 13     Fields:    Translation:Humans
    343. Kats D, Sharrett AR, Ginsberg HN, Nambi V, Ballantyne CM, Hoogeveen RC, Heiss G. Postprandial lipemia and the risk of coronary heart disease and stroke: the Atherosclerosis Risk in Communities (ARIC) Study. BMJ Open Diabetes Res Care. 2017; 5(1):e000335. PMID: 28191321; PMCID: PMC5293824.
      Citations: 8     
    344. Khalid U, Wruck LM, Quibrera PM, Bozkurt B, Nambi V, Virani SS, Jneid H, Agarwal S, Chang PP, Loehr L, Basra SS, Rosamond W, Ballantyne CM, Deswal A. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study. Int J Cardiol. 2017 Apr 15; 233:61-66. PMID: 28185703; PMCID: PMC5368080.
      Citations: 12     Fields:    Translation:Humans
    345. Morrison AC, Huang Z, Yu B, Metcalf G, Liu X, Ballantyne C, Coresh J, Yu F, Muzny D, Feofanova E, Rustagi N, Gibbs R, Boerwinkle E. Practical Approaches for Whole-Genome Sequence Analysis of Heart- and Blood-Related Traits. Am J Hum Genet. 2017 02 02; 100(2):205-215. PMID: 28089252; PMCID: PMC5294677.
      Citations: 24     Fields:    Translation:HumansCells
    346. Pitts R, Gunzburger E, Ballantyne CM, Barter PJ, Kallend D, Leiter LA, Leitersdorf E, Nicholls SJ, Shah PK, McMurray JJ, Kittelson J, Schwartz GG, Tardif JC, Olsson AG. Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart Failure. J Am Heart Assoc. 2017 01 10; 6(1). PMID: 28073769; PMCID: PMC5523625.
      Citations: 1     Fields:    Translation:Humans
    347. Wu H, Ballantyne CM. Skeletal muscle inflammation and insulin resistance in obesity. J Clin Invest. 2017 01 03; 127(1):43-54. PMID: 28045398; PMCID: PMC5199705.
      Citations: 147     Fields:    Translation:HumansAnimalsCells
    348. Pokharel Y, Sun W, Virani SS, Nambi V, Hoogeveen RC, Chang PP, Ndumele CE, Solomon SD, Bozkurt B, Selvin E, Ballantyne CM, Deswal A. Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study. JACC Heart Fail. 2017 01; 5(1):56-63. PMID: 28017350; PMCID: PMC5425302.
      Citations: 12     Fields:    Translation:Humans
    349. Nicholls SJ, Puri R, Anderson T, Ballantyne CM, Cho L, Kastelein JJ, Somaratne R, Kassahun H, Yang J, Wasserman SM, Scott R, Ungi I, Podolec J, Ophuis AO, Cornel JH, Borgman M, Brennan DM, Nissen SE, Koenig W. Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial. JAMA. 2016 12 13; 316(22):2373-2384. PMID: 27846344.
      Citations: 214     Fields:    Translation:Humans
    350. Pitts R, Gunzburger E, Ballantyne CM, Barter PJ, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Nicholls SJ, Niesor EJ, Olsson AG, Shah PK, Tardif JC, Kittelson J, Schwartz GG. Treatment With Dalcetrapib Modifies the Relationship Between High-Density Lipoprotein Cholesterol and C-Reactive Protein. J Am Coll Cardiol. 2016 12 06; 68(22):2488-2490. PMID: 27908356.
      Citations:    Fields:    Translation:Humans
    351. Whelton SP, McEvoy JW, Lazo M, Coresh J, Ballantyne CM, Selvin E. High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study. Diabetes Care. 2017 Feb; 40(2):261-269. PMID: 28108537; PMCID: PMC5250695.
      Citations: 12     Fields:    Translation:Humans
    352. Michos ED, Selvin E, Misialek JR, McEvoy JW, Ndumele CE, Folsom AR, Lutsey PL, Ballantyne CM. 25-Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study. J Am Heart Assoc. 2016 11 07; 5(11). PMID: 27821403; PMCID: PMC5210331.
      Citations: 5     Fields:    Translation:Humans
    353. Mosca L, Ballantyne CM, Bays HE, Guyton JR, Philip S, Doyle RT, Juliano RA. Usefulness of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) in Women to Lower Triglyceride Levels (Results from the MARINE and ANCHOR Trials). Am J Cardiol. 2017 Feb 01; 119(3):397-403. PMID: 27939227.
      Citations: 6     Fields:    Translation:Humans
    354. Ballantyne CM, Shah S, Kher U, Hunter JA, Gill GG, Cressman MD, Ashraf TB, Johnson-Levonas AO, Mitchel YB. Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients with Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol. Am J Cardiol. 2017 Feb 01; 119(3):388-396. PMID: 27956003.
      Citations: 1     Fields:    Translation:Humans
    355. Blom DJ, Koren MJ, Roth E, Monsalvo ML, Djedjos CS, Nelson P, Elliott M, Wasserman SM, Ballantyne CM, Holman RR. Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome. Diabetes Obes Metab. 2017 01; 19(1):98-107. PMID: 27619750.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    356. Singh J, Brunner G, Morrisett JD, Ballantyne CM, Lumsden AB, Shah DJ, Decuzzi P. Patient-Specific Flow Descriptors and Normalized wall index in Peripheral Artery Disease: a Preliminary Study. Comput Methods Biomech Biomed Eng Imaging Vis. 2018; 6(2):119-127. PMID: 29503774; PMCID: PMC5830147.
      Citations: 4     
    357. Bilen O, Ballantyne CM. Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase. Curr Atheroscler Rep. 2016 10; 18(10):61. PMID: 27663902; PMCID: PMC5035316.
      Citations: 17     Fields:    Translation:Humans
    358. Blazing MA, Giugliano RP, de Lemos JA, Cannon CP, Tonkin A, Ballantyne CM, Lewis BS, Musliner TA, Tershakovec AM, Lokhnygina Y, White JA, Reist C, McCagg A, Braunwald E. On-treatment analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT). Am Heart J. 2016 Dec; 182:89-96. PMID: 27914504.
      Citations: 5     Fields:    Translation:Humans
    359. Pokharel Y, Gosch K, Nambi V, Chan PS, Kosiborod M, Oetgen WJ, Spertus JA, Ballantyne CM, Petersen LA, Virani SS. Practice-Level Variation in?Statin Use Among Patients With Diabetes: Insights From the PINNACLE Registry. J Am Coll Cardiol. 2016 09 20; 68(12):1368-9. PMID: 27634128; PMCID: PMC5250510.
      Citations: 14     Fields:    Translation:Humans
    360. Lee AK, McEvoy JW, Hoogeveen RC, Ballantyne CM, Selvin E. Severe Hypoglycemia and Elevated High-Sensitivity Cardiac Troponin T in Older Adults With Diabetes: The ARIC Study. J Am Coll Cardiol. 2016 09 20; 68(12):1370-1. PMID: 27634129; PMCID: PMC5084452.
      Citations: 7     Fields:    Translation:Humans
    361. Willeit P, Kaptoge S, Welsh P, Butterworth AS, Chowdhury R, Spackman SA, Pennells L, Gao P, Burgess S, Freitag DF, Sweeting M, Wood AM, Cook NR, Judd S, Trompet S, Nambi V, Olsen MH, Everett BM, Kee F, Salomaa V, Levy D, Kauhanen J, Laukkanen JA, Kavousi M, Ninomiya T, Casas JP, Daniels LB, Lind L, Kistorp CN, Rosenberg J, Mueller T, Rubattu S, Panagiotakos DB, Franco OH, de Lemos JA, Luchner A, Kizer JR, Kiechl S, Salonen JT, Goya Wannamethee S, de Boer RA, Andersson J, Melander O, Ballantyne ChM, DeFilippi Ch, Ridker PM, Cushman M, Rosamond WD, Thompson SG, Gudnason V, Sattar N, Danesh J, Di Angelantonio E, ?rnl?v J, Nordestgaard BG, J?rgensen T. Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis. Lancet Diabetes Endocrinol. 2016 10; 4(10):840-9. PMID: 27599814; PMCID: PMC5035346.
      Citations: 59     Fields:    Translation:Humans
    362. Postmus I, Warren HR, Trompet S, Avery CL, Bis JC, Chasman DI, de Keyser CE, Deshmukh HA, Evans DS, Feng Q, Li X, Smit RA, Smith AV, Sun F, Taylor KD, Arnold AM, Barnes MR, Barratt BJ, Betteridge J, Boekholdt SM, Boerwinkle E, Buckley BM, Chen YI, de Craen AJ, Cummings SR, Denny JC, Durrington PN, Eiriksdottir G, Ford I, Guo X, Harris TB, Heckbert SR, Hofman A, Hovingh GK, Kastelein JJ, Launer LJ, Liu CT, Liu Y, Lumley T, McKeigue PM, Munroe PB, Neil A, Nickerson DA, O'Brien E, O'Donnell CJ, Post W, Poulter N, Vasan RS, Rice K, Rich SS, Rivadeneira F, Sattar N, Sever P, Shaw-Hawkins S, Shields DC, Slagboom PE, Smith NL, Smith JD, Sotoodehnia N, Stanton A, Stott DJ, Stricker BH, Wei WQ, Westendorp RG, Whitsel EA, Wiggins KL, Wilke RA, Ballantyne CM, Colhoun HM, Cupples LA, Franco OH, Gudnason V, Hitman G, Palmer CN, Psaty BM, Ridker PM, Stafford JM, Stein CM, Caulfield MJ, Jukema JW, Rotter JI, Krauss RM, Arsenault BJ, Dub? MP, Nyberg F, St?rmer T, Uitterlinden AG, Tardif JC. Meta-analysis of genome-wide association studies of HDL cholesterol response to statins. J Med Genet. 2016 12; 53(12):835-845. PMID: 27587472; PMCID: PMC5309131.
      Citations: 14     Fields:    Translation:Humans
    363. McEvoy JW, Chen Y, Rawlings A, Hoogeveen RC, Ballantyne CM, Blumenthal RS, Coresh J, Selvin E. Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure Control. J Am Coll Cardiol. 2016 10 18; 68(16):1713-1722. PMID: 27590090; PMCID: PMC5089057.
      Citations: 96     Fields:    Translation:Humans
    364. Khan IM, Pokharel Y, Dadu RT, Lewis DE, Hoogeveen RC, Wu H, Ballantyne CM. Postprandial Monocyte Activation in Individuals With Metabolic Syndrome. J Clin Endocrinol Metab. 2016 11; 101(11):4195-4204. PMID: 27575945; PMCID: PMC5095236.
      Citations: 21     Fields:    Translation:HumansCells
    365. Virani SS, Akeroyd JM, Ramsey DJ, Chan WJ, Frazier L, Nasir K, S Rajan S, Ballantyne CM, Petersen LA. Comparative effectiveness of outpatient cardiovascular disease and diabetes care delivery between advanced practice providers and physician providers in primary care: Implications for care under the Affordable Care Act. Am Heart J. 2016 Nov; 181:74-82. PMID: 27823696.
      Citations: 12     Fields:    Translation:Humans
    366. Agarwala A, Virani S, Couper D, Chambless L, Boerwinkle E, Astor BC, Hoogeveen RC, Coresh J, Sharrett AR, Folsom AR, Mosley T, Ballantyne CM, Nambi V. Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study. Atherosclerosis. 2016 10; 253:156-163. PMID: 27665201; PMCID: PMC5081270.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    367. Ballantyne CM, Bays HE, Philip S, Doyle RT, Braeckman RA, Stirtan WG, Soni PN, Juliano RA. Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies. Atherosclerosis. 2016 10; 253:81-87. PMID: 27596132.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    368. Kamran H, Nambi V, Negi S, Yang EY, Chen C, Virani SS, Kougias P, Lumsden AB, Morrisett JD, Ballantyne CM, Brunner G. Magnetic Resonance Venous Volume Measurements in Peripheral Artery Disease (from ELIMIT). Am J Cardiol. 2016 Nov 01; 118(9):1399-1404. PMID: 27670795; PMCID: PMC5179037.
      Citations: 2     Fields:    Translation:Humans
    369. Ahmad ZS, Andersen RL, Andersen LH, O'Brien EC, Kindt I, Shrader P, Vasandani C, Newman CB, deGoma EM, Baum SJ, Hemphill LC, Hudgins LC, Ahmed CD, Kullo IJ, Gidding SS, Duffy D, Neal W, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Linton MF, Duell PB, Shapiro MD, Moriarty PM, Knowles JW. US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry. J Clin Lipidol. 2016 Sep-Oct; 10(5):1223-9. PMID: 27678440; PMCID: PMC5381273.
      Citations: 13     Fields:    Translation:Humans
    370. McEvoy JW, Chen Y, Ndumele CE, Solomon SD, Nambi V, Ballantyne CM, Blumenthal RS, Coresh J, Selvin E. Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death. JAMA Cardiol. 2016 08 01; 1(5):519-28. PMID: 27439107; PMCID: PMC5084093.
      Citations: 44     Fields:    Translation:Humans
    371. Hira RS, Cowart JB, Akeroyd JM, Ramsey DJ, Pokharel Y, Nambi V, Jneid H, Deswal A, Denktas A, Taylor A, Nasir K, Ballantyne CM, Petersen LA, Virani SS. Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease. Am J Cardiol. 2016 Oct 15; 118(8):1144-1149. PMID: 27553104.
      Citations: 11     Fields:    Translation:Humans
    372. Ndumele CE, Matsushita K, Lazo M, Bello N, Blumenthal RS, Gerstenblith G, Nambi V, Ballantyne CM, Solomon SD, Selvin E, Folsom AR, Coresh J. Obesity and Subtypes of Incident Cardiovascular Disease. J Am Heart Assoc. 2016 07 28; 5(8). PMID: 27468925; PMCID: PMC5015307.
      Citations: 57     Fields:    Translation:Humans
    373. Bays HE, Ballantyne CM, Doyle RT, Juliano RA, Philip S. Icosapent ethyl: Eicosapentaenoic acid concentration and triglyceride-lowering effects across clinical studies. Prostaglandins Other Lipid Mediat. 2016 09; 125:57-64. PMID: 27418543.
      Citations: 11     Fields:    Translation:HumansCells
    374. Zhou H, Ran Y, Da Q, Shaw TS, Shang D, Reddy AK, Ballantyne CM, Ware J, Wu H, Peng Y, L?pez JA. Defective Association of the Platelet Glycoprotein Ib-IX Complex with the Glycosphingolipid-Enriched Membrane Domain Inhibits Murine Thrombus and Atheroma Formation. J Immunol. 2016 07 01; 197(1):288-95. PMID: 27206768; PMCID: PMC4929148.
      Citations: 6     Fields:    Translation:AnimalsCells
    375. McEvoy JW, Chen Y, Halushka MK, Christenson E, Blumenthal RS, Christenson RH, Selvin E, Ballantyne CM. Galectin-3 and Risk of Heart Failure and Death in Blacks and Whites. J Am Heart Assoc. 2016 05 13; 5(5). PMID: 27178204; PMCID: PMC4889181.
      Citations: 16     Fields:    Translation:Humans
    376. Rana JS, Tabada GH, Solomon MD, Lo JC, Jaffe MG, Sung SH, Ballantyne CM, Go AS. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in?a?Large?Contemporary, Multiethnic?Population. J Am Coll Cardiol. 2016 05 10; 67(18):2118-2130. PMID: 27151343; PMCID: PMC5097466.
      Citations: 93     Fields:    Translation:HumansPHPublic Health
    377. Nissen SE, Stroes E, Dent-Acosta RE, Rosenson RS, Lehman SJ, Sattar N, Preiss D, Bruckert E, Lepor N, Ballantyne CM, Gouni-Berthold I, Elliott M, Brennan DM, Wasserman SM, Somaratne R, Scott R, Stein EA, GAUSS-3 Investigators, Ce?ka R. Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial. JAMA. 2016 Apr 19; 315(15):1580-90. PMID: 27039291.
      Citations: 103     Fields:    Translation:Humans
    378. Ballantyne CM, McKenney JM, MacDougall DE, Margulies JR, Robinson PL, Hanselman JC, Lalwani ND. Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy. Am J Cardiol. 2016 Jun 15; 117(12):1928-33. PMID: 27138185.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    379. Pokharel Y, Akeroyd JM, Ramsey DJ, Hira RS, Nambi V, Shah T, Woodard LD, Winchester DE, Ballantyne CM, Petersen LA, Virani SS. Statin Use and Its Facility-Level Variation in Patients With Diabetes: Insight From the Veterans Affairs National Database. Clin Cardiol. 2016 Apr; 39(4):185-91. PMID: 27059708; PMCID: PMC4840034.
      Citations: 15     Fields:    Translation:Humans
    380. Writing Committee, Lloyd-Jones DM, Morris PB, Ballantyne CM, Birtcher KK, Daly DD, DePalma SM, Minissian MB, Orringer CE, Smith SC. 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2016 07 05; 68(1):92-125. PMID: 27046161.
      Citations: 115     Fields:    Translation:Humans
    381. Nadruz W, Claggett B, Querejeta Roca G, Shah AM, Cheng S, Heiss G, Ballantyne CM, Solomon SD, Gon?alves A. Influence of cigarette smoking on cardiac biomarkers: the Atherosclerosis Risk in Communities (ARIC) Study. Eur J Heart Fail. 2016 06; 18(6):629-37. PMID: 27030444; PMCID: PMC4915996.
      Citations: 13     Fields:    Translation:Humans
    382. deGoma EM, Ahmad ZS, O'Brien EC, Kindt I, Shrader P, Newman CB, Pokharel Y, Baum SJ, Hemphill LC, Hudgins LC, Ahmed CD, Gidding SS, Duffy D, Neal W, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Linton MF, Duell PB, Shapiro MD, Moriarty PM, Knowles JW. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry. Circ Cardiovasc Genet. 2016 Jun; 9(3):240-9. PMID: 27013694; PMCID: PMC5315030.
      Citations: 46     Fields:    Translation:HumansCells
    383. Rubin J, Matsushita K, Lazo M, Ballantyne CM, Nambi V, Hoogeveen R, Sharrett AR, Blumenthal RS, Coresh J, Selvin E. Determinants of minimal elevation in high-sensitivity cardiac troponin T in the general population. Clin Biochem. 2016 Jun; 49(9):657-662. PMID: 26975902; PMCID: PMC4889514.
      Citations: 10     Fields:    Translation:Humans
    384. Pokharel Y, Steinberg L, Chan W, Akeroyd JM, Jones PH, Nambi V, Nasir K, Petersen L, Ballantyne CM, Virani SS. A dataset to assess providers? knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline. Data Brief. 2016 Jun; 7:595-8. PMID: 27054163; PMCID: PMC4802420.
      Citations: 1     
    385. Nissen SE, Dent-Acosta RE, Rosenson RS, Stroes E, Sattar N, Preiss D, Mancini GB, Ballantyne CM, Catapano A, Gouni-Berthold I, Stein EA, Xue A, Wasserman SM, Scott R, Thompson PD, GAUSS-3 Investigators. Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial. Clin Cardiol. 2016 Mar; 39(3):137-44. PMID: 26946077; PMCID: PMC6490723.
      Citations: 13     Fields:    Translation:CTClinical Trials
    386. Bilen O, Pokharel Y, Ballantyne CM. Genetic Testing in Hyperlipidemia. Endocrinol Metab Clin North Am. 2016 Mar; 45(1):129-40. PMID: 26893002.
      Citations:    Fields:    
    387. Ballantyne CM, Bays HE, Braeckman RA, Philip S, Stirtan WG, Doyle RT, Soni PN, Juliano RA. Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C-III levels in patients from the MARINE and ANCHOR studies. J Clin Lipidol. 2016 May-Jun; 10(3):635-645.e1. PMID: 27206952.
      Citations: 12     Fields:    Translation:Humans
    388. Brunner G, Bismuth J, Nambi V, Ballantyne CM, Taylor AA, Lumsden AB, Morrisett JD, Shah DJ. Calf muscle perfusion as measured with magnetic resonance imaging to assess peripheral arterial disease. Med Biol Eng Comput. 2016 Nov; 54(11):1667-1681. PMID: 26906279; PMCID: PMC5152942.
      Citations: 8     Fields:    Translation:Humans
    389. Nissen SE, Somaratne R, Cho L, Kastelein JJ, Ballantyne CM, Anderson TJ, Yang J, Kassahun H, Wasserman SM, Scott R, Borgman M, Nicholls SJ, Puri R, Koenig W. Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV). Am Heart J. 2016 Jun; 176:83-92. PMID: 27264224.
      Citations: 16     Fields:    Translation:Humans
    390. Ogunwale AN, Morrison AC, Sun W, Dodge RC, Virani SS, Taylor A, Gottesman RF, Yang E, Wei P, McEvoy JW, Heiss G, Boerwinkle E, Ballantyne CM, Nambi V. The impact of multiple single day blood pressure readings on cardiovascular risk estimation: The Atherosclerosis Risk in Communities study. Eur J Prev Cardiol. 2016 09; 23(14):1529-36. PMID: 26869459; PMCID: PMC4981557.
      Citations: 1     Fields:    Translation:Humans
    391. Fretz A, Schneider AL, McEvoy JW, Hoogeveen R, Ballantyne CM, Coresh J, Selvin E. The Association of Socioeconomic Status With Subclinical Myocardial Damage, Incident Cardiovascular Events, and Mortality in the ARIC Study. Am J Epidemiol. 2016 Mar 01; 183(5):452-61. PMID: 26861239; PMCID: PMC4772435.
      Citations: 14     Fields:    Translation:Humans
    392. Vu KN, Ballantyne CM, Hoogeveen RC, Nambi V, Volcik KA, Boerwinkle E, Morrison AC. Causal Role of Alcohol Consumption in an Improved Lipid Profile: The Atherosclerosis Risk in Communities (ARIC) Study. PLoS One. 2016; 11(2):e0148765. PMID: 26849558; PMCID: PMC4744040.
      Citations: 25     Fields:    Translation:HumansCTClinical Trials
    393. Nicholls SJ, Puri R, Wolski K, Ballantyne CM, Barter PJ, Brewer HB, Kastelein JJ, Hu B, Uno K, Kataoka Y, Herrman JP, Merkely B, Borgman M, Nissen SE. Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial. Am J Cardiovasc Drugs. 2016 Feb; 16(1):55-65. PMID: 26385396.
      Citations: 39     Fields:    Translation:HumansCTClinical Trials
    394. McRae MP, Bozkurt B, Ballantyne CM, Sanchez X, Christodoulides N, Simmons G, Nambi V, Misra A, Miller CS, Ebersole JL, Campbell C, McDevitt JT. Cardiac ScoreCard: A Diagnostic Multivariate Index Assay System for Predicting a Spectrum of Cardiovascular Disease. Expert Syst Appl. 2016 Jul 15; 54:136-147. PMID: 31467464; PMCID: PMC6715313.
      Citations: 3     
    395. Ndumele CE, Matsushita K, Sang Y, Lazo M, Agarwal SK, Nambi V, Deswal A, Blumenthal RS, Ballantyne CM, Coresh J, Selvin E. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2016 Feb 16; 133(7):631-8. PMID: 26746175; PMCID: PMC4758863.
      Citations: 36     Fields:    Translation:Humans
    396. Pokharel Y, Steinberg L, Chan W, Akeroyd JM, Jones PH, Nambi V, Nasir K, Petersen L, Ballantyne CM, Virani SS. Case-based educational intervention to assess change in providers' knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline. Atherosclerosis. 2016 Mar; 246:115-20. PMID: 26773472; PMCID: PMC5723424.
      Citations: 9     Fields:    Translation:Humans
    397. Gori M, Gupta DK, Claggett B, Selvin E, Folsom AR, Matsushita K, Bello NA, Cheng S, Shah A, Skali H, Vardeny O, Ni H, Ballantyne CM, Astor BC, Klein BE, Aguilar D, Solomon SD. Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 2016 May; 39(5):677-85. PMID: 26740635; PMCID: PMC4839173.
      Citations: 18     Fields:    Translation:Humans
    398. Thompson PD, MacDougall DE, Newton RS, Margulies JR, Hanselman JC, Orloff DG, McKenney JM, Ballantyne CM. Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance. J Clin Lipidol. 2016 May-Jun; 10(3):556-67. PMID: 27206943.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    399. Ballantyne CM. Lipoprotein(a) and Heart Failure: Another Reason to Study Interventions in Patients With Very High Levels of Lipoprotein(a)? JACC Heart Fail. 2016 Jan; 4(1):88-9. PMID: 26738954.
      Citations:    Fields:    Translation:Humans
    400. Kumar A, Yang EY, Brunner G, Murray TO, Virani SS, Garami Z, Ballantyne CM, Morrisett JD, Nambi V. Plaque Volume of Carotid Endarterectomy Specimens Measured by 3D Ultrasound Technology. JACC Cardiovasc Imaging. 2016 09; 9(9):1118-1119. PMID: 26684968.
      Citations:    Fields:    Translation:Humans
    401. Virani SS, Pokharel Y, Steinberg L, Chan W, Akeroyd JM, Gowani SA, Kalra A, Polsani V, Miedema MD, Jones PH, Nambi V, Petersen LA, Ballantyne CM. Provider understanding of the 2013 ACC/AHA cholesterol guideline. J Clin Lipidol. 2016 May-Jun; 10(3):497-504.e4. PMID: 27206936.
      Citations: 30     Fields:    Translation:Humans
    402. Parikh RH, Seliger SL, de Lemos J, Nambi V, Christenson R, Ayers C, Sun W, Gottdiener JS, Kuller LH, Ballantyne C, deFilippi CR. Prognostic Significance of High-Sensitivity Cardiac Troponin T Concentrations between the Limit of Blank and Limit of Detection in Community-Dwelling Adults: A Metaanalysis. Clin Chem. 2015 Dec; 61(12):1524-31. PMID: 26506994.
      Citations: 15     Fields:    Translation:Humans
    403. Virani SS, Maddox TM, Chan PS, Tang F, Akeroyd JM, Risch SA, Oetgen WJ, Deswal A, Bozkurt B, Ballantyne CM, Petersen LA. Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights From the NCDR PINNACLE Registry. J Am Coll Cardiol. 2015 Oct 20; 66(16):1803-1812. PMID: 26483105; PMCID: PMC4872507.
      Citations: 14     Fields:    Translation:Humans
    404. Sharafkhaneh A, Katigbak J, Hirshkowitz M, Sharafkhaneh H, Sharafkhaneh SP, Ballantyne CM, Bozkurt B, Nambi V. Severity of hypoxia modulates effect of CPAP on myocardial stress as measured by highly sensitive troponin T. Respir Res. 2015 Oct 16; 16:126. PMID: 26475736; PMCID: PMC4609126.
      Citations: 2     Fields:    Translation:HumansCells
    405. Doody RS, Demirovic J, Ballantyne CM, Chan W, Barber R, Powell S, Pavlik V, Texas Alzheimer's Disease Research and Care Consortium. Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease. Alzheimers Dement (Amst). 2015 Dec; 1(4):464-71. PMID: 27239525; PMCID: PMC4879494.
      Citations: 12     
    406. Shah AM, Claggett B, Folsom AR, Lutsey PL, Ballantyne CM, Heiss G, Solomon SD. Ideal Cardiovascular Health During Adult Life and Cardiovascular Structure and Function Among the Elderly. Circulation. 2015 Nov 24; 132(21):1979-89. PMID: 26350059; PMCID: PMC4835821.
      Citations: 27     Fields:    Translation:Humans
    407. Rosen JB, Ballantyne CM, Hsueh WA, Lin J, Shah AK, Lowe RS, Tershakovec AM. Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease risk. Lipids Health Dis. 2015 Sep 04; 14:103. PMID: 26336957; PMCID: PMC4559874.
      Citations: 3     Fields:    Translation:Humans
    408. Roca GQ, Redline S, Claggett B, Bello N, Ballantyne CM, Solomon SD, Shah AM. Sex-Specific Association of Sleep Apnea Severity With Subclinical Myocardial Injury, Ventricular Hypertrophy, and Heart Failure Risk in a Community-Dwelling Cohort: The Atherosclerosis Risk in Communities-Sleep Heart Health Study. Circulation. 2015 Oct 06; 132(14):1329-37. PMID: 26316620; PMCID: PMC4596785.
      Citations: 58     Fields:    Translation:Humans
    409. Bhaskara S, Whitsel EA, Ballantyne CM, Folsom AR. Validity of self-report of lipid medication use: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 2015 Oct; 242(2):625-9. PMID: 26342332; PMCID: PMC4575898.
      Citations: 2     Fields:    Translation:Humans
    410. Lazo M, Halushka MK, Shen L, Maruthur N, Rebholz CM, Rawlings AM, Hoogeveen RC, Brinkley TE, Ballantyne CM, Astor BC, Selvin E. Soluble receptor for advanced glycation end products and the risk for incident heart failure: The Atherosclerosis Risk in Communities Study. Am Heart J. 2015 Nov; 170(5):961-7. PMID: 26542505; PMCID: PMC4638130.
      Citations: 21     Fields:    Translation:Humans
    411. McEvoy JW, Chen Y, Nambi V, Ballantyne CM, Sharrett AR, Appel LJ, Post WS, Blumenthal RS, Matsushita K, Selvin E. High-Sensitivity Cardiac Troponin T and Risk of Hypertension. Circulation. 2015 Sep 01; 132(9):825-33. PMID: 26152706; PMCID: PMC4558242.
      Citations: 36     Fields:    Translation:Humans
    412. Miedema MD, Lopez FL, Blaha MJ, Virani SS, Coresh J, Ballantyne CM, Folsom AR. Implications of the Eighth Joint National Committee Guidelines for the Management of High Blood Pressure for Aging Adults: Atherosclerosis Risk in Communities Study. Hypertension. 2015 Sep; 66(3):474-80. PMID: 26150438; PMCID: PMC4537363.
      Citations: 8     Fields:    Translation:Humans
    413. Xu L, Dai Perrard X, Perrard JL, Yang D, Xiao X, Teng BB, Simon SI, Ballantyne CM, Wu H. Foamy monocytes form early and contribute to nascent atherosclerosis in mice with hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2015 Aug; 35(8):1787-97. PMID: 26112011; PMCID: PMC4514542.
      Citations: 39     Fields:    Translation:HumansAnimalsCells
    414. Pokharel Y, Sun W, Polfus LM, Folsom AR, Heiss G, Sharrett AR, Boerwinkle E, Ballantyne CM, Hoogeveen RC. Lipoprotein associated phospholipase A2 activity, apolipoprotein C3 loss-of-function variants and cardiovascular disease: The Atherosclerosis Risk In Communities Study. Atherosclerosis. 2015 Aug; 241(2):641-8. PMID: 26117401; PMCID: PMC4731876.
      Citations: 6     Fields:    Translation:Humans
    415. Folsom AR, Yao L, Alonso A, Lutsey PL, Missov E, Lederle FA, Ballantyne CM, Tang W. Circulating Biomarkers and Abdominal Aortic Aneurysm Incidence: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2015 Aug 18; 132(7):578-85. PMID: 26085454; PMCID: PMC4543558.
      Citations: 29     Fields:    Translation:Humans
    416. Virani SS, Akeroyd JM, Nambi V, Maddox TM, Gillette MA, Michael Ho P, Rumsfeld J, Petersen LA, Ballantyne CM. Implications for Ezetimibe Therapy Use Based on IMPROVE-IT Criteria. Am J Med. 2015 Nov; 128(11):1253-6. PMID: 26071828.
      Citations: 2     Fields:    Translation:Humans
    417. Murray T, Yang EY, Brunner G, Kumar A, Lakkis N, Misra A, Virani SS, Hartley CJ, Morrisett JD, Ballantyne CM, Nambi V. Postprandial effects on arterial stiffness parameters in healthy young adults. Vasc Med. 2015 Dec; 20(6):501-8. PMID: 26060082.
      Citations: 3     Fields:    Translation:Humans
    418. Khan IM, Perrard XY, Brunner G, Lui H, Sparks LM, Smith SR, Wang X, Shi ZZ, Lewis DE, Wu H, Ballantyne CM. Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration and insulin resistance. Int J Obes (Lond). 2015 Nov; 39(11):1607-18. PMID: 26041698; PMCID: PMC5007876.
      Citations: 65     Fields:    Translation:AnimalsCells
    419. Knowles JW, Stone NJ, Ballantyne CM. Familial Hypercholesterolemia and the 2013 American College of Cardiology/American Heart Association Guidelines: Myths, Oversimplification, and Misinterpretation Versus Facts. Am J Cardiol. 2015 Aug 01; 116(3):481-4. PMID: 26043952.
      Citations: 7     Fields:    Translation:Humans
    420. Parrinello CM, Grams ME, Couper D, Ballantyne CM, Hoogeveen RC, Eckfeldt JH, Selvin E, Coresh J. Recalibration of blood analytes over 25 years in the atherosclerosis risk in communities study: impact of recalibration on chronic kidney disease prevalence and incidence. Clin Chem. 2015 Jul; 61(7):938-47. PMID: 25952043; PMCID: PMC4782184.
      Citations: 50     Fields:    Translation:Humans
    421. Bilen O, Pokharel Y, Ballantyne CM. Genetic testing in hyperlipidemia. Cardiol Clin. 2015 May; 33(2):267-75. PMID: 25939299.
      Citations: 3     Fields:    Translation:Humans
    422. Wyne KL, Ballantyne CM, Gill EA. The world and lipidology as it relates to cardiology. Cardiol Clin. 2015 May; 33(2):xiii-xiv. PMID: 25939304.
      Citations:    Fields:    Translation:Humans
    423. Pokharel Y, Virani SS, Ballantyne CM. The promise of proprotein convertase subtilisin/kexin 9 inhibitors for the treatment of familial hypercholesterolemia. Curr Atheroscler Rep. 2015 May; 17(5):508. PMID: 25782778.
      Citations:    Fields:    Translation:Humans
    424. Bays HE, Ballantyne CM, Braeckman RA, Stirtan WG, Doyle RT, Philip S, Soni PN, Juliano RA. Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester): Effects Upon High-Sensitivity C-Reactive Protein and Lipid Parameters in Patients With Metabolic Syndrome. Metab Syndr Relat Disord. 2015 Aug; 13(6):239-47. PMID: 25893544.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    425. Parrinello CM, Lutsey PL, Ballantyne CM, Folsom AR, Pankow JS, Selvin E. Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality. Am Heart J. 2015 Aug; 170(2):380-9. PMID: 26299237; PMCID: PMC4548857.
      Citations: 48     Fields:    Translation:Humans
    426. McEvoy JW, Lazo M, Chen Y, Shen L, Nambi V, Hoogeveen RC, Ballantyne CM, Blumenthal RS, Coresh J, Selvin E. Patterns and determinants of temporal change in high-sensitivity cardiac troponin-T: The Atherosclerosis Risk in Communities Cohort Study. Int J Cardiol. 2015; 187:651-7. PMID: 25880403; PMCID: PMC4442046.
      Citations: 17     Fields:    Translation:Humans
    427. Emami H, Vucic E, Subramanian S, Abdelbaky A, Fayad ZA, Du S, Roth E, Ballantyne CM, Mohler ER, Farkouh ME, Kim J, Farmer M, Li L, Ehlgen A, Langenickel TH, Velasquez L, Hayes W, Tawakol A. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial. Atherosclerosis. 2015 Jun; 240(2):490-6. PMID: 25913664.
      Citations: 30     Fields:    Translation:Humans
    428. Sabatine MS, Giugliano RP, Wiviott SD, Raal FJ, Blom DJ, Robinson J, Ballantyne CM, Somaratne R, Legg J, Wasserman SM, Scott R, Koren MJ, Stein EA, Open-Label Study of Long-Term Evaluation against LDL Cholesterol (OSLER) Investigators. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N Engl J Med. 2015 Apr 16; 372(16):1500-9. PMID: 25773607.
      Citations: 421     Fields:    Translation:Humans
    429. Ballantyne CM, Neutel J, Cropp A, Duggan W, Wang EQ, Plowchalk D, Sweeney K, Kaila N, Vincent J, Bays H. Results of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, from a randomized, placebo-controlled, dose-ranging study in statin-treated subjects with hypercholesterolemia. Am J Cardiol. 2015 May 01; 115(9):1212-21. PMID: 25784512.
      Citations: 56     Fields:    Translation:HumansCTClinical Trials
    430. Hira RS, Kennedy K, Nambi V, Jneid H, Alam M, Basra SS, Ho PM, Deswal A, Ballantyne CM, Petersen LA, Virani SS. Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry. J Am Coll Cardiol. 2015 Jan 20; 65(2):111-21. PMID: 25593051.
      Citations: 26     Fields:    Translation:HumansPHPublic Health
    431. Huang X, Alonso A, Guo X, Umbach DM, Lichtenstein ML, Ballantyne CM, Mailman RB, Mosley TH, Chen H. Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study. Mov Disord. 2015 Apr; 30(4):552-9. PMID: 25639598; PMCID: PMC4390443.
      Citations: 42     Fields:    Translation:Humans
    432. Miedema MD, Lopez FL, Blaha MJ, Virani SS, Coresh J, Ballantyne CM, Folsom AR. Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US Cohort: the Atherosclerosis Risk in Communities Study Cohort. JAMA Intern Med. 2015 Jan; 175(1):138-40. PMID: 25401375; PMCID: PMC4652650.
      Citations: 8     Fields:    Translation:Humans
    433. Khalid U, Ather S, Bavishi C, Chan W, Loehr LR, Wruck LM, Rosamond WD, Chang PP, Coresh J, Virani SS, Nambi V, Bozkurt B, Ballantyne CM, Deswal A. Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study. J Am Coll Cardiol. 2014 Dec 30; 64(25):2743-9. PMID: 25541126; PMCID: PMC4280076.
      Citations: 23     Fields:    Translation:Humans
    434. Hira RS, Kennedy K, Alam M, Petersen LA, Ballantyne CM, Virani SS. Reply: Frequency of inappropriate and nonrecommended prasugrel prescription: great variations. J Am Coll Cardiol. 2014 Dec 09; 64(22):2434-5. PMID: 25465429.
      Citations:    Fields:    Translation:Humans
    435. Ballantyne CM, Braeckman RA, Bays HE, Kastelein JJ, Otvos JD, Stirtan WG, Doyle RT, Soni PN, Juliano RA. Effects of icosapent ethyl on lipoprotein particle concentration and size in statin-treated patients with persistent high triglycerides (the ANCHOR Study). J Clin Lipidol. 2015 May-Jun; 9(3):377-83. PMID: 26073397.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    436. Lazo M, Rubin J, Clark JM, Coresh J, Schneider AL, Ndumele C, Hoogeveen RC, Ballantyne CM, Selvin E. The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease. J Hepatol. 2015 Apr; 62(4):841-7. PMID: 25433159; PMCID: PMC4373587.
      Citations: 15     Fields:    Translation:Humans
    437. Al Rifai M, Schneider AL, Alonso A, Maruthur N, Parrinello CM, Astor BC, Hoogeveen RC, Soliman EZ, Chen LY, Ballantyne CM, Halushka MK, Selvin E. sRAGE, inflammation, and risk of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) Study. J Diabetes Complications. 2015 Mar; 29(2):180-5. PMID: 25499973; PMCID: PMC4333077.
      Citations: 13     Fields:    Translation:Humans
    438. Lehrer-Graiwer J, Singh P, Abdelbaky A, Vucic E, Korsgren M, Baruch A, Fredrickson J, van Bruggen N, Tang MT, Frendeus B, Rudd JHF, Hsieh F, Ballantyne CM, Ghoshhajra B, Rosenson RS, Koren M, Roth EM, Duprez DA, Fayad ZA, Tawakol AA. FDG-PET imaging for oxidized LDL in stable atherosclerotic disease: a phase II study of safety, tolerability, and anti-inflammatory activity. JACC Cardiovasc Imaging. 2015 Apr; 8(4):493-494. PMID: 25457756.
      Citations: 27     Fields:    Translation:HumansCTClinical Trials
    439. Myocardial Infarction Genetics Consortium Investigators, Stitziel NO, Won HH, Morrison AC, Peloso GM, Do R, Lange LA, Fontanillas P, Gupta N, Duga S, Goel A, Farrall M, Saleheen D, Ferrario P, Asselta R, Merlini PA, Marziliano N, Notarangelo MF, Schick U, Auer P, Assimes TL, Reilly M, Wilensky R, Rader DJ, Hovingh GK, Meitinger T, Kessler T, Kastrati A, Laugwitz KL, Siscovick D, Rotter JI, Hazen SL, Tracy R, Cresci S, Spertus J, Jackson R, Schwartz SM, Natarajan P, Crosby J, Muzny D, Ballantyne C, Rich SS, O'Donnell CJ, Abecasis G, Sunaev S, Nickerson DA, Buring JE, Ridker PM, Chasman DI, Austin E, Kullo IJ, Weeke PE, Shaffer CM, Bastarache LA, Denny JC, Roden DM, Palmer C, Deloukas P, Lin DY, Tang ZZ, Erdmann J, Schunkert H, Danesh J, Marrugat J, Elosua R, Ardissino D, McPherson R, Watkins H, Reiner AP, Wilson JG, Altshuler D, Gibbs RA, Lander ES, Boerwinkle E, Gabriel S, Kathiresan S, K?nig I. Inactivating mutations in NPC1L1 and protection from coronary heart disease. N Engl J Med. 2014 Nov 27; 371(22):2072-82. PMID: 25390462; PMCID: PMC4335708.
      Citations: 145     Fields:    Translation:HumansCells
    440. Wu H, Ballantyne CM. Inflammation versus host defense in obesity. Cell Metab. 2014 Nov 04; 20(5):708-709. PMID: 25440053; PMCID: PMC4755485.
      Citations: 6     Fields:    Translation:Animals
    441. Postmus I, Trompet S, Deshmukh HA, Barnes MR, Li X, Warren HR, Chasman DI, Zhou K, Arsenault BJ, Donnelly LA, Wiggins KL, Avery CL, Griffin P, Feng Q, Taylor KD, Li G, Evans DS, Smith AV, de Keyser CE, Johnson AD, de Craen AJ, Stott DJ, Buckley BM, Ford I, Westendorp RG, Slagboom PE, Sattar N, Munroe PB, Sever P, Poulter N, Stanton A, Shields DC, O'Brien E, Shaw-Hawkins S, Chen YD, Nickerson DA, Smith JD, Boekholdt SM, Hovingh GK, Kastelein JJ, McKeigue PM, Betteridge J, Neil A, Durrington PN, Doney A, Carr F, Morris A, McCarthy MI, Groop L, Ahlqvist E, Welcome Trust Case Control Consortium, Bis JC, Rice K, Smith NL, Lumley T, Whitsel EA, Boerwinkle E, Ngwa JS, O'Donnell CJ, Vasan RS, Wei WQ, Wilke RA, Liu CT, Sun F, Guo X, Heckbert SR, Post W, Sotoodehnia N, Arnold AM, Stafford JM, Ding J, Herrington DM, Kritchevsky SB, Eiriksdottir G, Launer LJ, Harris TB, Chu AY, Giulianini F, MacFadyen JG, Barratt BJ, Stricker BH, Hofman A, Rivadeneira F, Emilsson V, Franco OH, Ridker PM, Gudnason V, Liu Y, Denny JC, Ballantyne CM, Rotter JI, Adrienne Cupples L, Psaty BM, Palmer CN, Tardif JC, Colhoun HM, Hitman G, Krauss RM, Wouter Jukema J, Caulfield MJ, Dub? MP, St?rmer T, Nyberg F, Uitterlinden AG. Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins. Nat Commun. 2014 Oct 28; 5:5068. PMID: 25350695; PMCID: PMC4220464.
      Citations: 96     Fields:    Translation:Humans
    442. Pokharel Y, Sun W, de Lemos JA, Taffet GE, Virani SS, Ndumele CE, Mosley TH, Hoogeveen RC, Coresh J, Wright JD, Heiss G, Boerwinkle EA, Bozkurt B, Solomon SD, Ballantyne CM, Nambi V. High-sensitivity troponin T and cardiovascular events in systolic blood pressure categories: atherosclerosis risk in communities study. Hypertension. 2015 Jan; 65(1):78-84. PMID: 25350984; PMCID: PMC4268376.
      Citations: 15     Fields:    Translation:Humans
    443. Kim Y, Matsushita K, Sang Y, Grams ME, Skali H, Shah AM, Hoogeveen RC, Solomon SD, Ballantyne CM, Coresh J. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis. 2015 Apr; 65(4):550-8. PMID: 25446023; PMCID: PMC4369179.
      Citations: 9     Fields:    Translation:Humans
    444. Filion KB, Agarwal SK, Ballantyne CM, Eberg M, Hoogeveen RC, Huxley RR, Loehr LR, Nambi V, Soliman EZ, Alonso A. High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2015 Jan; 169(1):31-8.e3. PMID: 25497245; PMCID: PMC4429290.
      Citations: 20     Fields:    Translation:Humans
    445. Ndumele CE, Coresh J, Lazo M, Hoogeveen RC, Blumenthal RS, Folsom AR, Selvin E, Ballantyne CM, Nambi V. Obesity, subclinical myocardial injury, and incident heart failure. JACC Heart Fail. 2014 Dec; 2(6):600-7. PMID: 25443112; PMCID: PMC4345168.
      Citations: 33     Fields:    Translation:Humans
    446. Virani SS, Woodard LD, Akeroyd JM, Ramsey DJ, Ballantyne CM, Petersen LA. Is high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-intensity statin therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines. Clin Cardiol. 2014 Nov; 37(11):653-9. PMID: 25324147; PMCID: PMC6649436.
      Citations: 22     Fields:    Translation:Humans
    447. Garcia MN, Murray KO, Hotez PJ, Rossmann SN, Gorchakov R, Ontiveros A, Woc-Colburn L, Bottazzi ME, Rhodes CE, Ballantyne CM, Aguilar D. Development of chagas cardiac manifestations among Texas blood donors. Am J Cardiol. 2015 Jan 01; 115(1):113-7. PMID: 25456877.
      Citations: 13     Fields:    Translation:Humans
    448. Virani SS, Woodard LD, Ramsey DJ, Urech TH, Akeroyd JM, Shah T, Deswal A, Bozkurt B, Ballantyne CM, Petersen LA. Gender disparities in evidence-based statin therapy in patients with cardiovascular disease. Am J Cardiol. 2015 Jan 01; 115(1):21-6. PMID: 25456865.
      Citations: 49     Fields:    Translation:Humans
    449. Pokharel Y, Basra S, Lincoln AE, Tucker AM, Nambi V, Nasir K, Vogel RA, Wong ND, Boone JL, Roberts AJ, Ballantyne CM, Virani SS. Association of body mass index and waist circumference with subclinical atherosclerosis in retired NFL players. South Med J. 2014 Oct; 107(10):633-9. PMID: 25279867.
      Citations: 10     Fields:    Translation:Humans
    450. Basra SS, Pokharel Y, Hira RS, Bandeali SJ, Nambi V, Deswal A, Nasir K, Martin SS, Vogel RA, Roberts AJ, Ballantyne CM, Virani SS. Relation between playing position and coronary artery calcium scores in retired National Football League players. Am J Cardiol. 2014 Dec 15; 114(12):1836-40. PMID: 25432152.
      Citations: 7     Fields:    Translation:Humans
    451. Soloviev DA, Hazen SL, Szpak D, Bledzka KM, Ballantyne CM, Plow EF, Pluskota E. Dual role of the leukocyte integrin aM?2 in angiogenesis. J Immunol. 2014 Nov 01; 193(9):4712-21. PMID: 25261488; PMCID: PMC4201972.
      Citations: 16     Fields:    Translation:AnimalsCells
    452. Puri R, Nissen SE, Shao M, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Libby P, Raichlen JS, Uno K, Kataoka Y, Nicholls SJ. Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin. Arterioscler Thromb Vasc Biol. 2014 Nov; 34(11):2465-72. PMID: 25212234.
      Citations: 13     Fields:    Translation:Humans
    453. Hsu JF, Chou TC, Lu J, Chen SH, Chen FY, Chen CC, Chen JL, Elayda M, Ballantyne CM, Shayani S, Chen CH. Low-density lipoprotein electronegativity is a novel cardiometabolic risk factor. PLoS One. 2014; 9(9):e107340. PMID: 25203525; PMCID: PMC4159324.
      Citations: 11     Fields:    Translation:Humans
    454. Ababneh B, Rejjal L, Pokharel Y, Nambi V, Wang X, Tung CH, Han RI, Taylor AA, Kougias P, Lumsden AB, Lawrie G, Reardon M, Ballantyne CM, Morrisett JD, Brunner G. Distribution of calcification in carotid endarterectomy tissues: comparison of micro-computed tomography imaging with histology. Vasc Med. 2014 Oct; 19(5):343-50. PMID: 25193489.
      Citations: 3     Fields:    Translation:Humans
    455. Stegman B, Puri R, Cho L, Shao M, Ballantyne CM, Barter PJ, Erbel R, Libby P, Raichlen JS, Uno K, Kataoka Y, Nissen SE, Nicholls SJ, Chapman MJ. High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN. Diabetes Care. 2014 Nov; 37(11):3114-20. PMID: 25190674.
      Citations: 21     Fields:    Translation:Humans
    456. Selvin E, Lazo M, Chen Y, Shen L, Rubin J, McEvoy JW, Hoogeveen RC, Sharrett AR, Ballantyne CM, Coresh J. Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage. Circulation. 2014 Oct 14; 130(16):1374-82. PMID: 25149362; PMCID: PMC4198442.
      Citations: 61     Fields:    Translation:Humans
    457. Rebholz CM, Astor BC, Grams ME, Halushka MK, Lazo M, Hoogeveen RC, Ballantyne CM, Coresh J, Selvin E. Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities study. Nephrol Dial Transplant. 2015 Jan; 30(1):77-83. PMID: 25147225; PMCID: PMC4351358.
      Citations: 16     Fields:    Translation:Humans
    458. Pokharel Y, Nambi V, Martin SS, Hoogeveen RC, Nasir K, Khera A, Wong ND, Jones PH, Boone J, Roberts AJ, Ballantyne CM, Virani SS. Association between lipoprotein associated phospholipase A2 mass and subclinical coronary and carotid atherosclerosis in Retired National Football League players. Atherosclerosis. 2014 Oct; 236(2):251-6. PMID: 25105582.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    459. Sinner MF, Stepas KA, Moser CB, Krijthe BP, Aspelund T, Sotoodehnia N, Janssens AC, Kronmal RA, Magnani JW, Witteman JC, Chamberlain AM, Lubitz SA, Schnabel RB, Vasan RS, Wang TJ, Agarwal SK, McManus DD, Franco OH, Yin X, Larson MG, Burke GL, Launer LJ, Hofman A, Levy D, Gottdiener JS, Couper D, Harris TB, Astor BC, Ballantyne CM, Hoogeveen RC, Arai AE, Soliman EZ, Ellinor PT, Stricker BH, Gudnason V, Heckbert SR, Pencina MJ, Benjamin EJ, Alonso A, Fontes JD, K??b S. B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies. Europace. 2014 Oct; 16(10):1426-33. PMID: 25037055; PMCID: PMC4197895.
      Citations: 71     Fields:    Translation:Humans
    460. Morris PB, Ballantyne CM, Birtcher KK, Dunn SP, Urbina EM. Review of clinical practice guidelines for the management of LDL-related risk. J Am Coll Cardiol. 2014 Jul 15; 64(2):196-206. PMID: 25011724.
      Citations: 19     Fields:    Translation:Humans
    461. Dadu RT, Ballantyne CM. Lipid lowering with PCSK9 inhibitors. Nat Rev Cardiol. 2014 Oct; 11(10):563-75. PMID: 24958078.
      Citations: 74     Fields:    Translation:Humans
    462. Matsushita K, Sang Y, Ballew SH, Astor BC, Hoogeveen RC, Solomon SD, Ballantyne CM, Woodward M, Coresh J. Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study. Arterioscler Thromb Vasc Biol. 2014 Aug; 34(8):1770-7. PMID: 24876355; PMCID: PMC4172337.
      Citations: 25     Fields:    Translation:Humans
    463. Hira RS, Kennedy K, Jneid H, Alam M, Basra SS, Petersen LA, Ballantyne CM, Nambi V, Chan PS, Virani SS. Frequency and practice-level variation in inappropriate and nonrecommended prasugrel prescribing: insights from the NCDR PINNACLE registry. J Am Coll Cardiol. 2014 Jul 01; 63(25 Pt A):2876-7. PMID: 24814485.
      Citations: 18     Fields:    Translation:Humans
    464. Tardif JC, Ballantyne CM, Barter P, Dasseux JL, Fayad ZA, Guertin MC, Kastelein JJ, Keyserling C, Klepp H, Koenig W, L'Allier PL, Paolini JF, Tawakol A, Waters DD, Can HDL Infusions Significantly QUicken Atherosclerosis REgression (CHI-SQUARE) Investigators, Lesp?rance J, L?scher TF. Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial. Eur Heart J. 2014 Dec 07; 35(46):3277-86. PMID: 24780501; PMCID: PMC4258222.
      Citations: 85     Fields:    Translation:Humans
    465. Davidson MH, Rosenson RS, Maki KC, Nicholls SJ, Ballantyne CM, Mazzone T, Carlson DM, Williams LA, Kelly MT, Camp HS, Lele A, Stolzenbach JC. Effects of fenofibric acid on carotid intima-media thickness in patients with mixed dyslipidemia on atorvastatin therapy: randomized, placebo-controlled study (FIRST). Arterioscler Thromb Vasc Biol. 2014 Jun; 34(6):1298-306. PMID: 24743431.
      Citations: 26     Fields:    Translation:Humans
    466. Poon AK, Juraschek SP, Ballantyne CM, Steffes MW, Selvin E. Comparative associations of diabetes risk factors with five measures of hyperglycemia. BMJ Open Diabetes Res Care. 2014; 2(1):e000002. PMID: 25452853; PMCID: PMC4212576.
      Citations: 10     
    467. Blom DJ, Hala T, Bolognese M, Lillestol MJ, Toth PD, Burgess L, Ceska R, Roth E, Koren MJ, Ballantyne CM, Monsalvo ML, Tsirtsonis K, Kim JB, Scott R, Wasserman SM, Stein EA, DESCARTES Investigators. A 52-week placebo-controlled trial of evolocumab in hyperlipidemia. N Engl J Med. 2014 May 08; 370(19):1809-19. PMID: 24678979.
      Citations: 190     Fields:    Translation:HumansCTClinical Trials
    468. Gao F, Ballantyne C, Ma L, Virani SS, Keinan A, Brautbar A. Rare LPL gene variants attenuate triglyceride reduction and HDL cholesterol increase in response to fenofibric acid therapy in individuals with mixed dyslipidemia. Atherosclerosis. 2014 Jun; 234(2):249-53. PMID: 24704626; PMCID: PMC4078400.
      Citations: 8     Fields:    Translation:Humans
    469. Pokharel Y, Macedo FY, Nambi V, Martin SS, Nasir K, Wong ND, Boone J, Roberts AJ, Ballantyne CM, Virani SS. Neck circumference is not associated with subclinical atherosclerosis in retired National Football League players. Clin Cardiol. 2014 Jul; 37(7):402-7. PMID: 24648005; PMCID: PMC6649371.
      Citations: 5     Fields:    Translation:Humans
    470. Ray KK, Kastelein JJ, Boekholdt SM, Nicholls SJ, Khaw KT, Ballantyne CM, Catapano AL, Reiner ?, L?scher TF. The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011. Eur Heart J. 2014 Apr; 35(15):960-8. PMID: 24639424.
      Citations: 94     Fields:    Translation:HumansPHPublic Health
    471. Virani SS, Ballantyne CM, Petersen LA. Decrease the incentives to order lipid panels--reply. JAMA Intern Med. 2014 Mar; 174(3):473-4. PMID: 24590083.
      Citations:    Fields:    Translation:Humans
    472. Hoogeveen RC, Gaubatz JW, Sun W, Dodge RC, Crosby JR, Jiang J, Couper D, Virani SS, Kathiresan S, Boerwinkle E, Ballantyne CM. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol. 2014 May; 34(5):1069-77. PMID: 24558110; PMCID: PMC3999643.
      Citations: 159     Fields:    Translation:Humans
    473. Gore MO, Seliger SL, Defilippi CR, Nambi V, Christenson RH, Hashim IA, Hoogeveen RC, Ayers CR, Sun W, McGuire DK, Ballantyne CM, de Lemos JA. Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. J Am Coll Cardiol. 2014 Apr 15; 63(14):1441-8. PMID: 24530665; PMCID: PMC3984900.
      Citations: 85     Fields:    Translation:Humans
    474. Lange LA, Hu Y, Zhang H, Xue C, Schmidt EM, Tang ZZ, Bizon C, Lange EM, Smith JD, Turner EH, Jun G, Kang HM, Peloso G, Auer P, Li KP, Flannick J, Zhang J, Fuchsberger C, Gaulton K, Lindgren C, Locke A, Manning A, Sim X, Rivas MA, Holmen OL, Gottesman O, Lu Y, Ruderfer D, Stahl EA, Duan Q, Li Y, Durda P, Jiao S, Isaacs A, Hofman A, Bis JC, Correa A, Griswold ME, Jakobsdottir J, Smith AV, Schreiner PJ, Feitosa MF, Zhang Q, Huffman JE, Crosby J, Wassel CL, Do R, Franceschini N, Martin LW, Robinson JG, Assimes TL, Crosslin DR, Rosenthal EA, Tsai M, Rieder MJ, Farlow DN, Folsom AR, Lumley T, Fox ER, Carlson CS, Peters U, Jackson RD, van Duijn CM, Levy D, Rotter JI, Taylor HA, Gudnason V, Siscovick DS, Fornage M, Borecki IB, Hayward C, Rudan I, Chen YE, Bottinger EP, Loos RJ, Hveem K, Boehnke M, McCarthy M, Meitinger T, Ballantyne CM, Gabriel SB, O'Donnell CJ, Post WS, North KE, Reiner AP, Boerwinkle E, Psaty BM, Altshuler D, Kathiresan S, Lin DY, Jarvik GP, Cupples LA, Kooperberg C, Wilson JG, Nickerson DA, Abecasis GR, Rich SS, Tracy RP, Willer CJ, NHLBI Grand Opportunity Exome Sequencing Project, Uitterlinden AG, S?trom P, Groop L. Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol. Am J Hum Genet. 2014 Feb 06; 94(2):233-45. PMID: 24507775; PMCID: PMC3928660.
      Citations: 111     Fields:    Translation:Humans
    475. Folsom AR, Lutsey PL, Nambi V, deFilippi CR, Heckbert SR, Cushman M, Ballantyne CM. Troponin T, NT-proBNP, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). Vasc Med. 2014 Feb; 19(1):33-41. PMID: 24558027; PMCID: PMC4006375.
      Citations: 10     Fields:    Translation:Humans
    476. Khan IM, Dai Perrard XY, Perrard JL, Mansoori A, Wayne Smith C, Wu H, Ballantyne CM. Attenuated adipose tissue and skeletal muscle inflammation in obese mice with combined CD4+ and CD8+ T cell deficiency. Atherosclerosis. 2014 Apr; 233(2):419-428. PMID: 24530773; PMCID: PMC4094239.
      Citations: 41     Fields:    Translation:AnimalsCells
    477. Puri R, Libby P, Nissen SE, Wolski K, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Raichlen JS, Uno K, Kataoka Y, Tuzcu EM, Nicholls SJ. Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN. Eur Heart J Cardiovasc Imaging. 2014 Apr; 15(4):380-8. PMID: 24448227.
      Citations: 47     Fields:    Translation:Humans
    478. Rogers PA, Daye J, Huang H, Blaustein A, Virani S, Alam M, Kumar A, Paniagua D, Kar B, Bozkurt B, Ballantyne CM, Deswal A, Jneid H. Revascularization improves mortality in elderly patients with acute myocardial infarction complicated by cardiogenic shock. Int J Cardiol. 2014 Mar 01; 172(1):239-41. PMID: 24462137.
      Citations: 7     Fields:    Translation:Humans
    479. Tumova E, Sun W, Jones PH, Vrablik M, Ballantyne CM, Hoogeveen RC. The impact of rapid weight loss on oxidative stress markers and the expression of the metabolic syndrome in obese individuals. J Obes. 2013; 2013:729515. PMID: 24455214; PMCID: PMC3880717.
      Citations: 18     Fields:    Translation:Humans
    480. Querejeta Roca G, Redline S, Punjabi N, Claggett B, Ballantyne CM, Solomon SD, Shah AM. Sleep apnea is associated with subclinical myocardial injury in the community. The ARIC-SHHS study. Am J Respir Crit Care Med. 2013 Dec 15; 188(12):1460-5. PMID: 24156237; PMCID: PMC3917380.
      Citations: 28     Fields:    Translation:Humans
    481. Xu L, Ping F, Yin J, Xiao X, Xiang H, Ballantyne CM, Wu H, Li M. Elevated plasma SPARC levels are associated with insulin resistance, dyslipidemia, and inflammation in gestational diabetes mellitus. PLoS One. 2013; 8(12):e81615. PMID: 24349098; PMCID: PMC3857203.
      Citations: 21     Fields:    Translation:Humans
    482. Ballantyne CM, Hoogeveen RC, Raya JL, Cain VA, Palmer MK, GRAVITY Study Investigators, Karlson BW. Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high-risk patients: Results of the GRAVITY randomized study. Atherosclerosis. 2014 Jan; 232(1):86-93. PMID: 24401221.
      Citations: 10     Fields:    Translation:HumansCellsCTClinical Trials
    483. Jiang E, Perrard XD, Yang D, Khan IM, Perrard JL, Smith CW, Ballantyne CM, Wu H. Essential role of CD11a in CD8+ T-cell accumulation and activation in adipose tissue. Arterioscler Thromb Vasc Biol. 2014 Jan; 34(1):34-43. PMID: 24158516; PMCID: PMC4060534.
      Citations: 30     Fields:    Translation:AnimalsCells
    484. Brunner G, Yang EY, Kumar A, Sun W, Virani SS, Negi SI, Murray T, Lin PH, Hoogeveen RC, Chen C, Dong JF, Kougias P, Taylor A, Lumsden AB, Nambi V, Ballantyne CM, Morrisett JD. The Effect of Lipid Modification on Peripheral Artery Disease after Endovascular Intervention Trial (ELIMIT). Atherosclerosis. 2013 Dec; 231(2):371-7. PMID: 24267254; PMCID: PMC4545656.
      Citations: 10     Fields:    Translation:Humans
    485. Friedewald VE, Ballantyne CM, Bays HE, Jones PH. The editor's roundtable: hypertriglyceridemia. Am J Cardiol. 2013 Oct 15; 112(8):1133-41. PMID: 24079443.
      Citations: 1     Fields:    Translation:Humans
    486. Maxwell TJ, Ballantyne CM, Cheverud JM, Guild CS, Ndumele CE, Boerwinkle E. APOE modulates the correlation between triglycerides, cholesterol, and CHD through pleiotropy, and gene-by-gene interactions. Genetics. 2013 Dec; 195(4):1397-405. PMID: 24097412; PMCID: PMC3832281.
      Citations: 14     Fields:    Translation:Humans
    487. Bandeali SJ, Kayani WT, Lee VV, Elayda M, Alam M, Huang HD, Wilson JM, Jneid H, Birnbaum Y, Deswal A, Farmer J, Ballantyne CM, Virani SS. Association between preoperative diuretic use and in-hospital outcomes after cardiac surgery. Cardiovasc Ther. 2013 Oct; 31(5):291-7. PMID: 23517524.
      Citations: 4     Fields:    Translation:Humans
    488. Nissen SE, Libby P, Shao M, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Raichlen JS, Uno K, Kataoka Y, Nicholls SJ, Puri R. C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy. Circulation. 2013 Nov 26; 128(22):2395-403. PMID: 24043299.
      Citations: 34     Fields:    Translation:Humans
    489. Nambi V, Liu X, Chambless LE, de Lemos JA, Virani SS, Agarwal S, Boerwinkle E, Hoogeveen RC, Aguilar D, Astor BC, Srinivas PR, Deswal A, Mosley TH, Coresh J, Folsom AR, Heiss G, Ballantyne CM. Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study. Clin Chem. 2013 Dec; 59(12):1802-10. PMID: 24036936; PMCID: PMC4208068.
      Citations: 46     Fields:    Translation:Humans
    490. Whelton SP, Roy P, Astor BC, Zhang L, Hoogeveen RC, Ballantyne CM, Coresh J. Elevated high-sensitivity C-reactive protein as a risk marker of the attenuated relationship between serum cholesterol and cardiovascular events at older age. The ARIC Study. Am J Epidemiol. 2013 Oct 01; 178(7):1076-84. PMID: 24026395; PMCID: PMC3783092.
      Citations: 17     Fields:    Translation:Humans
    491. Virani SS, Woodard LD, Wang D, Chitwood SS, Landrum CR, Urech TH, Pietz K, Chen GJ, Hertz B, Murawsky J, Ballantyne CM, Petersen LA. Correlates of repeat lipid testing in patients with coronary heart disease. JAMA Intern Med. 2013 Aug 12; 173(15):1439-44. PMID: 23817669.
      Citations: 3     Fields:    Translation:Humans
    492. Virani SS, Lee VV, Brautbar A, Grove ML, Nambi V, Alam M, Elayda M, Wilson JM, Willerson JT, Boerwinkle E, Ballantyne CM. Single nucleotide polymorphisms in cholesteryl ester transfer protein gene and recurrent coronary heart disease or mortality in patients with established atherosclerosis. Am J Cardiol. 2013 Nov 01; 112(9):1287-92. PMID: 23891427; PMCID: PMC3800478.
      Citations:    Fields:    Translation:Humans
    493. Puri R, Nissen SE, Shao M, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Libby P, Raichlen JS, Uno K, Kataoka Y, Nicholls SJ. Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy. Eur Heart J. 2013 Nov; 34(41):3182-90. PMID: 23886915.
      Citations: 20     Fields:    Translation:Humans
    494. Huggins GS, Papandonatos GD, Erar B, Belalcazar LM, Brautbar A, Ballantyne C, Kitabchi AE, Wagenknecht LE, Knowler WC, Pownall HJ, Wing RR, Peter I, McCaffery JM, Genetics Subgroup of the Action for Health in Diabetes (Look AHEAD) Study. Do genetic modifiers of high-density lipoprotein cholesterol and triglyceride levels also modify their response to a lifestyle intervention in the setting of obesity and type-2 diabetes mellitus?: The Action for Health in Diabetes (Look AHEAD) study. Circ Cardiovasc Genet. 2013 Aug; 6(4):391-9. PMID: 23861364; PMCID: PMC4077278.
      Citations: 11     Fields:    Translation:Humans
    495. Dadu RT, Dodge R, Nambi V, Virani SS, Hoogeveen RC, Smith NL, Chen F, Pankow JS, Guild C, Tang WH, Boerwinkle E, Hazen SL, Ballantyne CM. Ceruloplasmin and heart failure in the Atherosclerosis Risk in Communities study. Circ Heart Fail. 2013 Sep 01; 6(5):936-43. PMID: 23861484; PMCID: PMC3908901.
      Citations: 22     Fields:    Translation:HumansCells
    496. Brinton EA, Ballantyne CM, Bays HE, Kastelein JJ, Braeckman RA, Soni PN. Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200-500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study. Cardiovasc Diabetol. 2013 Jul 09; 12:100. PMID: 23835245; PMCID: PMC3718763.
      Citations: 29     Fields:    Translation:HumansCTClinical Trials
    497. Huang HD, Alam M, Hamzeh I, Virani S, Deswal A, Aguilar D, Rogers P, Kougias P, Birnbaum Y, Paniagua D, Kar B, Ballantyne C, Bozkurt B, Jneid H. Patients with severe chronic kidney disease benefit from early revascularization after acute coronary syndrome. Int J Cardiol. 2013 Oct 09; 168(4):3741-6. PMID: 23845772.
      Citations: 14     Fields:    Translation:Humans
    498. Matsushita K, Williams EK, Mongraw-Chaffin ML, Coresh J, Schmidt MI, Brancati FL, Hoogeveen RC, Ballantyne CM, Young JH. The association of plasma lactate with incident cardiovascular outcomes: the ARIC Study. Am J Epidemiol. 2013 Aug 01; 178(3):401-9. PMID: 23817916; PMCID: PMC3727342.
      Citations: 12     Fields:    Translation:Humans
    499. Ballantyne CM, Davidson MH, Macdougall DE, Bays HE, Dicarlo LA, Rosenberg NL, Margulies J, Newton RS. Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase in patients with hypercholesterolemia: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial. J Am Coll Cardiol. 2013 Sep 24; 62(13):1154-62. PMID: 23770179.
      Citations: 36     Fields:    Translation:HumansCTClinical Trials
    500. Folsom AR, Lutsey PL, Roetker NS, Ballantyne CM, Hoogeveen RC, Rosamond WD, Cushman M, Atherosclerosis Risk in Communities (ARIC) Study. Lipoprotein-associated phospholipase A2 and venous thromboembolism: a prospective study. Thromb Res. 2013 Jul; 132(1):44-6. PMID: 23746626; PMCID: PMC3742644.
      Citations:    Fields:    Translation:Humans
    501. Yang EY, Brunner G, Dokainish H, Hartley CJ, Taffet G, Lakkis N, Taylor AA, Misra A, McCulloch ML, Morrisett JD, Virani SS, Ballantyne CM, Nagueh SF, Nambi V. Application of speckle-tracking in the evaluation of carotid artery function in subjects with hypertension and diabetes. J Am Soc Echocardiogr. 2013 Aug; 26(8):901-909.e1. PMID: 23759168; PMCID: PMC3725197.
      Citations: 6     Fields:    Translation:Humans
    502. Wooten JS, Nambi P, Gillard BK, Pownall HJ, Coraza I, Scott LW, Nambi V, Ballantyne CM, Balasubramanyam A. Intensive lifestyle modification reduces Lp-PLA2 in dyslipidemic HIV/HAART patients. Med Sci Sports Exerc. 2013 Jun; 45(6):1043-50. PMID: 23299761; PMCID: PMC3655089.
      Citations: 8     Fields:    Translation:HumansCells
    503. Vasudevan M, Tchoua U, Gillard BK, Jones PH, Ballantyne CM, Pownall HJ. Modest diet-induced weight loss reduces macrophage cholesterol efflux to plasma of patients with metabolic syndrome. J Clin Lipidol. 2013 Nov-Dec; 7(6):661-70. PMID: 24314365; PMCID: PMC4108339.
      Citations: 11     Fields:    Translation:HumansCells
    504. Ballantyne CM, Braeckman RA, Soni PN. Icosapent ethyl for the treatment of hypertriglyceridemia. Expert Opin Pharmacother. 2013 Jul; 14(10):1409-16. PMID: 23701295.
      Citations: 4     Fields:    Translation:Humans
    505. Dadu RT, Fornage M, Virani SS, Nambi V, Hoogeveen RC, Boerwinkle E, Alonso A, Gottesman RF, Mosley TH, Ballantyne CM. Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study. Stroke. 2013 Jul; 44(7):1803-8. PMID: 23660848; PMCID: PMC4334904.
      Citations: 26     Fields:    Translation:Humans
    506. Puri R, Nissen SE, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Libby P, Raichlen JS, St John J, Wolski K, Uno K, Kataoka Y, Nicholls SJ. Factors underlying regression of coronary atheroma with potent statin therapy. Eur Heart J. 2013 Jun; 34(24):1818-25. PMID: 23644179.
      Citations: 12     Fields:    Translation:Humans
    507. Alam M, Bandeali SJ, Kayani WT, Ahmad W, Shahzad SA, Jneid H, Birnbaum Y, Kleiman NS, Coselli JS, Ballantyne CM, Lakkis N, Virani SS. Comparison by meta-analysis of mortality after isolated coronary artery bypass grafting in women versus men. Am J Cardiol. 2013 Aug 01; 112(3):309-17. PMID: 23642381.
      Citations: 25     Fields:    Translation:Humans
    508. Belalcazar LM, Haffner SM, Lang W, Hoogeveen RC, Rushing J, Schwenke DC, Tracy RP, Pi-Sunyer FX, Kriska AM, Ballantyne CM, Look AHEAD (Action for Health in Diabetes) Research Group. Lifestyle intervention and/or statins for the reduction of C-reactive protein in type 2 diabetes: from the look AHEAD study. Obesity (Silver Spring). 2013 May; 21(5):944-50. PMID: 23512860; PMCID: PMC3689862.
      Citations: 18     Fields:    Translation:Humans
    509. Brautbar A, Barbalic M, Chen F, Belmont J, Virani SS, Scherer S, Hegele RA, Ballantyne CM. Rare APOA5 promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy. J Lipid Res. 2013 Jul; 54(7):1980-7. PMID: 23633496; PMCID: PMC3679399.
      Citations: 4     Fields:    Translation:HumansCells
    510. Nambi V, Brunner G, Ballantyne CM. Ultrasound in cardiovascular risk prediction: don't forget the plaque! J Am Heart Assoc. 2013 Apr 18; 2(2):e000180. PMID: 23598274; PMCID: PMC3647285.
      Citations: 8     Fields:    Translation:Humans
    511. Robinson JG, Ballantyne CM, Hsueh WA, Rosen JB, Lin J, Shah AK, Tomassini JE, Lowe RS, Tershakovec AM. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome. J Clin Lipidol. 2013 Jul-Aug; 7(4):292-303. PMID: 23890516.
      Citations: 6     Fields:    Translation:Humans
    512. Wu Y, Waite LL, Jackson AU, Sheu WH, Buyske S, Absher D, Arnett DK, Boerwinkle E, Bonnycastle LL, Carty CL, Cheng I, Cochran B, Croteau-Chonka DC, Dumitrescu L, Eaton CB, Franceschini N, Guo X, Henderson BE, Hindorff LA, Kim E, Kinnunen L, Komulainen P, Lee WJ, Le Marchand L, Lin Y, Lingaas-Holmen O, Mitchell SL, Narisu N, Robinson JG, Schumacher F, Sundvall J, Sung YJ, Swift AJ, Wang WC, Wilkens L, Wilsgaard T, Young AM, Adair LS, Ballantyne CM, Chakravarti A, Collins FS, Duggan D, Feranil AB, Ho LT, Hung YJ, Hunt SC, Hveem K, Juang JM, Kuusisto J, Laakso M, Lakka TA, Lee IT, Leppert MF, Matise TC, Moilanen L, Peters U, Quertermous T, Rauramaa R, Rotter JI, Saramies J, Tuomilehto J, Uusitupa M, Wang TD, Boehnke M, Haiman CA, Chen YD, Kooperberg C, Assimes TL, Crawford DC, Hsiung CA, North KE, Mohlke KL, Lindstr?m J, Stanc?kov? A, Bu?kov? P, Kes?niemi AY, Nj?lstad I. Trans-ethnic fine-mapping of lipid loci identifies population-specific signals and allelic heterogeneity that increases the trait variance explained. PLoS Genet. 2013 Mar; 9(3):e1003379. PMID: 23555291; PMCID: PMC3605054.
      Citations: 75     Fields:    Translation:Humans
    513. Ballantyne CM, Catapano AL, Norata GD. New therapeutic principles in dyslipidaemia: focus on LDL and Lp(a) lowering drugs. Eur Heart J. 2013 Jun; 34(24):1783-9. PMID: 23509227; PMCID: PMC3857929.
      Citations: 34     Fields:    Translation:Humans
    514. Folsom AR, Nambi V, Bell EJ, Oluleye OW, Gottesman RF, Lutsey PL, Huxley RR, Ballantyne CM. Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study. Stroke. 2013 Apr; 44(4):961-7. PMID: 23471272; PMCID: PMC3614093.
      Citations: 72     Fields:    Translation:Humans
    515. Selvin E, Halushka MK, Rawlings AM, Hoogeveen RC, Ballantyne CM, Coresh J, Astor BC. sRAGE and risk of diabetes, cardiovascular disease, and death. Diabetes. 2013 Jun; 62(6):2116-21. PMID: 23396398; PMCID: PMC3661610.
      Citations: 74     Fields:    Translation:Humans
    516. Ballantyne CM, Bays HE, Braeckman RA, Soni PN. Authors' reply. Am J Cardiol. 2013 Feb 01; 111(3):455-6. PMID: 23317532.
      Citations:    Fields:    Translation:Humans
    517. Bays HE, Ballantyne CM, Braeckman RA, Stirtan WG, Soni PN. Icosapent ethyl, a pure ethyl ester of eicosapentaenoic acid: effects on circulating markers of inflammation from the MARINE and ANCHOR studies. Am J Cardiovasc Drugs. 2013 Feb; 13(1):37-46. PMID: 23325450; PMCID: PMC3572383.
      Citations: 42     Fields:    Translation:HumansCTClinical Trials
    518. Waheed S, Matsushita K, Astor BC, Hoogeveen RC, Ballantyne C, Coresh J. Combined association of creatinine, albuminuria, and cystatin C with all-cause mortality and cardiovascular and kidney outcomes. Clin J Am Soc Nephrol. 2013 Mar; 8(3):434-42. PMID: 23258794; PMCID: PMC3586966.
      Citations: 17     Fields:    Translation:Humans
    519. Yu B, Barbalic M, Brautbar A, Nambi V, Hoogeveen RC, Tang W, Mosley TH, Rotter JI, deFilippi CR, O'Donnell CJ, Kathiresan S, Rice K, Heckbert SR, Ballantyne CM, Psaty BM, Boerwinkle E, CARDIoGRAM Consortium. Association of genome-wide variation with highly sensitive cardiac troponin-T levels in European Americans and Blacks: a meta-analysis from atherosclerosis risk in communities and cardiovascular health studies. Circ Cardiovasc Genet. 2013 Feb; 6(1):82-8. PMID: 23247143; PMCID: PMC3693561.
      Citations: 15     Fields:    Translation:Humans
    520. Ballantyne CM, Pitt B, Loscalzo J, Cain VA, Raichlen JS. Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial). Am J Cardiol. 2013 Feb 15; 111(4):506-9. PMID: 23237107.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    521. Oluleye OW, Folsom AR, Nambi V, Lutsey PL, Ballantyne CM, ARIC Study Investigators. Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality. Ann Epidemiol. 2013 Feb; 23(2):66-73. PMID: 23228375; PMCID: PMC3543509.
      Citations: 34     Fields:    Translation:HumansPHPublic Health
    522. Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS, dal-OUTCOMES Investigators. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med. 2012 Nov 29; 367(22):2089-99. PMID: 23126252.
      Citations: 638     Fields:    Translation:HumansPHPublic Health
    523. Ndumele CE, Matsushita K, Astor B, Virani SS, Mora S, Williams EK, Hoogeveen RC, Blumenthal RS, Sharrett AR, Ballantyne CM, Coresh J. Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study. Eur J Prev Cardiol. 2014 Jul; 21(7):866-75. PMID: 23109406.
      Citations: 8     Fields:    Translation:Humans
    524. Asselbergs FW, Guo Y, van Iperen EP, Sivapalaratnam S, Tragante V, Lanktree MB, Lange LA, Almoguera B, Appelman YE, Barnard J, Baumert J, Beitelshees AL, Bhangale TR, Chen YD, Gaunt TR, Gong Y, Hopewell JC, Johnson T, Kleber ME, Langaee TY, Li M, Li YR, Liu K, McDonough CW, Meijs MF, Middelberg RP, Musunuru K, Nelson CP, O'Connell JR, Padmanabhan S, Pankow JS, Pankratz N, Rafelt S, Rajagopalan R, Romaine SP, Schork NJ, Shaffer J, Shen H, Smith EN, Tischfield SE, van der Most PJ, van Vliet-Ostaptchouk JV, Verweij N, Volcik KA, Zhang L, Bailey KR, Bailey KM, Bauer F, Boer JM, Braund PS, Burt A, Burton PR, Buxbaum SG, Chen W, Cooper-Dehoff RM, Cupples LA, deJong JS, Delles C, Duggan D, Fornage M, Furlong CE, Glazer N, Gums JG, Hastie C, Holmes MV, Illig T, Kirkland SA, Kivimaki M, Klein R, Klein BE, Kooperberg C, Kottke-Marchant K, Kumari M, LaCroix AZ, Mallela L, Murugesan G, Ordovas J, Ouwehand WH, Post WS, Saxena R, Scharnagl H, Schreiner PJ, Shah T, Shields DC, Shimbo D, Srinivasan SR, Stolk RP, Swerdlow DI, Taylor HA, Topol EJ, Toskala E, van Pelt JL, van Setten J, Yusuf S, Whittaker JC, Zwinderman AH, LifeLines Cohort Study, Anand SS, Balmforth AJ, Berenson GS, Bezzina CR, Boehm BO, Boerwinkle E, Casas JP, Caulfield MJ, Clarke R, Connell JM, Cruickshanks KJ, Davidson KW, Day IN, de Bakker PI, Doevendans PA, Dominiczak AF, Hall AS, Hartman CA, Hengstenberg C, Hillege HL, Hofker MH, Humphries SE, Jarvik GP, Johnson JA, Kaess BM, Kathiresan S, Koenig W, Lawlor DA, Melander O, Mitchell BD, Montgomery GW, Munroe PB, Murray SS, Newhouse SJ, Onland-Moret NC, Poulter N, Psaty B, Redline S, Rich SS, Rotter JI, Schunkert H, Sever P, Shuldiner AR, Silverstein RL, Stanton A, Thorand B, Trip MD, Tsai MY, van der Harst P, van der Schoot E, van der Schouw YT, Verschuren WM, Watkins H, Wilde AA, Wolffenbuttel BH, Whitfield JB, Hovingh GK, Ballantyne CM, Wijmenga C, Reilly MP, Martin NG, Wilson JG, Rader DJ, Samani NJ, Reiner AP, Hegele RA, Kastelein JJ, Hingorani AD, Talmud PJ, Hakonarson H, Elbers CC, Keating BJ, Drenos F, M?rz W. Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet. 2012 Nov 02; 91(5):823-38. PMID: 23063622; PMCID: PMC3487124.
      Citations: 126     Fields:    Translation:Humans
    525. Kayani WT, Bandeali SJ, Lee VV, Elayda M, Khan A, Nambi V, Jneid H, Alam M, Wilson JM, Huang HD, Birnbaum Y, Ballantyne CM, Virani SS. Association between statins and infections after coronary artery bypass grafting. Int J Cardiol. 2013 Sep 20; 168(1):117-20. PMID: 23046597.
      Citations: 7     Fields:    Translation:Humans
    526. Negi SI, Brautbar A, Virani SS, Anand A, Polisecki E, Asztalos BF, Ballantyne CM, Schaefer EJ, Jones PH. A novel mutation in the ABCA1 gene causing an atypical phenotype of Tangier disease. J Clin Lipidol. 2013 Jan-Feb; 7(1):82-7. PMID: 23351586.
      Citations: 5     Fields:    Translation:Humans
    527. Davidson M, Rosenson RS, Maki KC, Nicholls SJ, Ballantyne CM, Setze C, Carlson DM, Stolzenbach J. Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial. Cardiovasc Drugs Ther. 2012 Aug; 26(4):349-58. PMID: 22622962; PMCID: PMC3407355.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    528. Bays HE, Braeckman RA, Ballantyne CM, Kastelein JJ, Otvos JD, Stirtan WG, Soni PN. Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study). J Clin Lipidol. 2012 Nov-Dec; 6(6):565-72. PMID: 23312052.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    529. Virani SS, Wang D, Woodard LD, Chitwood SS, Landrum CR, Zieve FJ, Ballantyne CM, Petersen LA. Non-high-density lipoprotein cholesterol reporting and goal attainment in primary care. J Clin Lipidol. 2012 Nov-Dec; 6(6):545-52. PMID: 23312050.
      Citations: 4     Fields:    Translation:Humans
    530. Virani SS, Pompeii L, Lincoln AE, Dunn RE, Tucker AM, Nambi V, Nasir K, Vogel RA, Boone JL, Roberts AJ, Ballantyne CM. Association between traditional cholesterol parameters, lipoprotein particle concentration, novel biomarkers and carotid plaques in retired National Football League players. Atherosclerosis. 2012 Jun; 222(2):551-6. PMID: 22525822.
      Citations: 9     Fields:    Translation:Humans
    531. Nicholls SJ, Gordon A, Johannson J, Ballantyne CM, Barter PJ, Brewer HB, Kastelein JJ, Wong NC, Borgman MR, Nissen SE. ApoA-I induction as a potential cardioprotective strategy: rationale for the SUSTAIN and ASSURE studies. Cardiovasc Drugs Ther. 2012 Apr; 26(2):181-7. PMID: 22349989.
      Citations: 28     Fields:    Translation:Humans
    532. Dastani Z, Hivert MF, Timpson N, Perry JR, Yuan X, Scott RA, Henneman P, Heid IM, Kizer JR, Fuchsberger C, Tanaka T, Morris AP, Small K, Isaacs A, Beekman M, Coassin S, Lohman K, Qi L, Kanoni S, Pankow JS, Uh HW, Wu Y, Bidulescu A, Rasmussen-Torvik LJ, Greenwood CM, Ladouceur M, Grimsby J, Manning AK, Liu CT, Kooner J, Mooser VE, Vollenweider P, Kapur KA, Chambers J, Wareham NJ, Langenberg C, Frants R, Willems-Vandijk K, Oostra BA, Willems SM, Lamina C, Winkler TW, Psaty BM, Tracy RP, Brody J, Chen I, Viikari J, Pramstaller PP, Evans DM, St Pourcain B, Sattar N, Wood AR, Bandinelli S, Carlson OD, Egan JM, van Heemst D, Kedenko L, Kristiansson K, Nuotio ML, Loo BM, Harris T, Garcia M, Kanaya A, Haun M, Klopp N, Wichmann HE, Deloukas P, Katsareli E, Couper DJ, Duncan BB, Kloppenburg M, Adair LS, Borja JB, DIAGRAM+ Consortium, MAGIC Consortium, GLGC Investigators, MuTHER Consortium, Wilson JG, Musani S, Guo X, Johnson T, Semple R, Teslovich TM, Allison MA, Redline S, Buxbaum SG, Mohlke KL, Meulenbelt I, Ballantyne CM, Dedoussis GV, Hu FB, Liu Y, Paulweber B, Spector TD, Slagboom PE, Ferrucci L, Jula A, Perola M, Raitakari O, Florez JC, Salomaa V, Eriksson JG, Frayling TM, Hicks AA, Smith GD, Siscovick DS, Kronenberg F, van Duijn C, Loos RJ, Waterworth DM, Meigs JB, Dupuis J, Richards JB, Voight BF, Scott LJ, Steinthorsdottir V, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS, Thorleifsson G, McCulloch LJ, Ferreira T, Grallert H, Amin N, Wu G, Willer CJ, Raychaudhuri S, McCarroll SA, Hofmann OM, van Hoek M, Navarro P, Ardlie K, Balkau B, Benediktsson R, Bennett AJ, Blagieva R, Boerwinkle E, Bonnycastle LL, Bravenboer B, Bumpstead S, Charpentier G, Chines PS, Cornelis M, Crawford G, Doney AS, Elliott KS, Elliott AL, Erdos MR, Fox CS, Franklin CS, Ganser M, Gieger C, Grarup N, Green T, Griffin S, Groves CJ, Guiducci C, Hadjadj S, Hassanali N, Herder C, Isomaa B, Jackson AU, Johnson PR, Kao WH, Kong A, Kraft P, Kuusisto J, Lauritzen T, Li M, Lieverse A, Lindgren CM, Lyssenko V, Marre M, Meitinger T, Midthjell K, Morken MA, Narisu N, Nilsson P, Owen KR, Payne F, Petersen AK, Platou C, Prokopenko I, Rathmann W, Rayner NW, Robertson NR, Rocheleau G, Roden M, Sampson MJ, Saxena R, Shields BM, Shrader P, Sigurdsson G, Strassburger K, Stringham HM, Sun Q, Swift AJ, Thorand B, Tichet J, Tuomi T, van Dam RM, van Haeften TW, van Herpt T, van Vliet-Ostaptchouk JV, Walters GB, Weedon MN, Wijmenga C, Witteman J, Bergman RN, Cauchi S, Collins FS, Gloyn AL, Gyllensten U, Hansen T, Hide WA, Hitman GA, Hofman A, Hunter DJ, Hveem K, Laakso M, Morris AD, Palmer CN, Rudan I, Sijbrands E, Stein LD, Tuomilehto J, Uitterlinden A, Walker M, Watanabe RM, Abecasis GR, Boehm BO, Campbell H, Daly MJ, Hattersley AT, Pedersen O, Groop L, Sladek R, Thorsteinsdottir U, Wilson JF, Illig T, Froguel P, van Duijn CM, Stefansson K, Altshuler D, Boehnke M, McCarthy MI, Soranzo N, Wheeler E, Glazer NL, Bouatia-Naji N, Randall J, Elliott P, Rybin D, Dehghan A, Hottenga JJ, Song K, Goel A, Lajunen T, Doney A, Kumari M, Timpson NJ, Zabena C, Ingelsson E, An P, O'Connell J, Luan J, Elliott A, McCarroll SA, Roccasecca RM, Sethupathy P, Ariyurek Y, Barter P, Beilby JP, Ben-Shlomo Y, Bergmann S, Bochud M, Borch-Johnsen K, Brunner E, Bumpstead SJ, Chen YD, Chines P, Clarke R, Coin LJ, Cooper MN, Crisponi L, Day IN, de Geus EJ, Delplanque J, Fedson AC, Fischer-Rosinsky A, Forouhi NG, Franzosi MG, Galan P, Goodarzi MO, Grundy S, Gwilliam R, Hammond N, Han X, Hartikainen AL, Hayward C, Heath SC, Hercberg S, Hillman DR, Hingorani AD, Hui J, Hung J, Kaakinen M, Kaprio J, Kesaniemi YA, Kivimaki M, Knight B, Koskinen S, Kovacs P, Kyvik KO, Lathrop GM, Lawlor DA, Le Bacquer O, Li Y, Mahley R, Mangino M, McAteer JB, McPherson R, Meisinger C, Melzer D, Meyre D, Mitchell BD, Mukherjee S, Naitza S, Neville MJ, Pakyz R, Paolisso G, Pattaro C, Pearson D, Peden JF, Pedersen NL, Pfeiffer AF, Pichler I, Polasek O, et al. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet. 2012; 8(3):e1002607. PMID: 22479202; PMCID: PMC3315470.
      Citations: 242     Fields:    Translation:Humans
    533. Ballantyne CM, Miller M, Niesor EJ, Burgess T, Kallend D, Stein EA. Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging study. Am Heart J. 2012 Mar; 163(3):515-21, 521.e1-3. PMID: 22424025.
      Citations: 25     Fields:    Translation:HumansCTClinical Trials
    534. Pritchett AM, Deswal A, Aguilar D, Foreyt JP, Chan W, Mann DL, Ballantyne C, Bozkurt B. Lifestyle Modification with Diet and Exercise in Obese Patients with Heart Failure - A Pilot Study. J Obes Weight Loss Ther. 2012 Mar 01; 2(2):1-8. PMID: 23125955; PMCID: PMC3484982.
      Citations: 5     
    535. Brown WV, Breslow J, Ballantyne C. Clinical use of genetic typing in human lipid disorders. J Clin Lipidol. 2012 May-Jun; 6(3):199-207. PMID: 22658144.
      Citations: 1     Fields:    Translation:Humans
    536. Virani SS, Brautbar A, Lee VV, MacArthur E, Morrison AC, Grove ML, Nambi V, Frazier L, Wilson JM, Willerson JT, Boerwinkle E, Ballantyne CM. Chromosome 9p21 single nucleotide polymorphisms are not associated with recurrent myocardial infarction in patients with established coronary artery disease. Circ J. 2012; 76(4):950-6. PMID: 22322877; PMCID: PMC3837386.
      Citations: 19     Fields:    Translation:HumansCells
    537. Astor BC, Shafi T, Hoogeveen RC, Matsushita K, Ballantyne CM, Inker LA, Coresh J. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population. Am J Kidney Dis. 2012 May; 59(5):653-62. PMID: 22305758; PMCID: PMC3880682.
      Citations: 82     Fields:    Translation:Humans
    538. Nambi V, Boerwinkle E, Lawson K, Brautbar A, Chambless L, Franeschini N, North KE, Virani SS, Folsom AR, Ballantyne CM. The 9p21 genetic variant is additive to carotid intima media thickness and plaque in improving coronary heart disease risk prediction in white participants of the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 2012 May; 222(1):135-7. PMID: 22349088; PMCID: PMC3334435.
      Citations: 6     Fields:    Translation:HumansCells
    539. Rubin J, Matsushita K, Ballantyne CM, Hoogeveen R, Coresh J, Selvin E. Chronic hyperglycemia and subclinical myocardial injury. J Am Coll Cardiol. 2012 Jan 31; 59(5):484-9. PMID: 22281251; PMCID: PMC3267958.
      Citations: 55     Fields:    Translation:Humans
    540. Goek ON, Hoogeveen RC, Ballantyne CM, Coresh J, Astor BC, K?ttgen A. Association of apolipoprotein A1 and B with kidney function and chronic kidney disease in two multiethnic population samples. Nephrol Dial Transplant. 2012 Jul; 27(7):2839-47. PMID: 22287661; PMCID: PMC3471548.
      Citations: 20     Fields:    Translation:Humans
    541. Dadu RT, Nambi V, Ballantyne CM. Developing and assessing cardiovascular biomarkers. Transl Res. 2012 Apr; 159(4):265-76. PMID: 22424430.
      Citations: 10     Fields:    Translation:Humans
    542. Brautbar A, Virani SS, Belmont J, Nambi V, Jones PH, Ballantyne CM. LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia. J Lipid Res. 2012 Mar; 53(3):556-560. PMID: 22236405; PMCID: PMC3276479.
      Citations: 8     Fields:    Translation:Humans
    543. Alam M, Lee VV, Elayda MA, Shahzad SA, Yang EY, Nambi V, Jneid H, Pan W, Coulter S, Wilson JM, Ramanathan KB, Ballantyne CM, Virani SS. Association of gender with morbidity and mortality after isolated coronary artery bypass grafting. A propensity score matched analysis. Int J Cardiol. 2013 Jul 15; 167(1):180-4. PMID: 22240765.
      Citations: 13     Fields:    Translation:Humans
    544. Lopez FL, Agarwal SK, Maclehose RF, Soliman EZ, Sharrett AR, Huxley RR, Konety S, Ballantyne CM, Alonso A. Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities study. Circ Arrhythm Electrophysiol. 2012 Feb; 5(1):155-62. PMID: 22227953; PMCID: PMC3290134.
      Citations: 53     Fields:    Translation:Humans
    545. Toth PP, Ballantyne CM, Davidson MH, Tomassini JE, Ramey DR, Neff D, Tershakovec AM, Hu XH, Tunceli K. Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects?on low-density lipoprotein-cholesterol reduction. J Clin Lipidol. 2012 Mar-Apr; 6(2):180-91. PMID: 22385552.
      Citations: 3     Fields:    Translation:Humans
    546. Ballantyne C, Gleim G, Liu N, Sisk CM, Johnson-Levonas AO, Mitchel Y. Effects of coadministered extended-release niacin/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia. J Clin Lipidol. 2012 May-Jun; 6(3):235-43. PMID: 22658147.
      Citations: 5     Fields:    Translation:Humans
    547. Virani SS, Ballantyne CM. Update on therapies targeting HDL: the mystery continues. Curr Opin Lipidol. 2011 Dec; 22(6):514-6. PMID: 22101565.
      Citations: 1     Fields:    Translation:HumansAnimals
    548. Virani SS, Brautbar A, Davis BC, Nambi V, Hoogeveen RC, Sharrett AR, Coresh J, Mosley TH, Morrisett JD, Catellier DJ, Folsom AR, Boerwinkle E, Ballantyne CM. Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2012 Jan 17; 125(2):241-9. PMID: 22128224; PMCID: PMC3760720.
      Citations: 83     Fields:    Translation:Humans
    549. Nicholls SJ, Ballantyne CM, Barter PJ, Chapman MJ, Erbel RM, Libby P, Raichlen JS, Uno K, Borgman M, Wolski K, Nissen SE. Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med. 2011 Dec 01; 365(22):2078-87. PMID: 22085316.
      Citations: 193     Fields:    Translation:Humans
    550. Negi SI, Steinberg L, Polsani VR, Gowani SA, Nambi V, Kumar V, Marinescu V, Jones PH, Petersen LA, Ballantyne CM, Virani SS. Non-high-density lipoprotein cholesterol calculation and goal awareness among physicians-in-training. J Clin Lipidol. 2012 Jan-Feb; 6(1):50-7. PMID: 22264574.
      Citations: 5     Fields:    Translation:Humans
    551. Lutsey PL, Rasmussen-Torvik LJ, Pankow JS, Alonso A, Smolenski DJ, Tang W, Coresh J, Volcik KA, Ballantyne CM, Boerwinkle E, Folsom AR. Relation of lipid gene scores to longitudinal trends in lipid levels and incidence of abnormal lipid levels among individuals of European ancestry: the Atherosclerosis Risk in Communities (ARIC) study. Circ Cardiovasc Genet. 2012 Feb 01; 5(1):73-80. PMID: 22057756; PMCID: PMC3288431.
      Citations: 18     Fields:    Translation:Humans
    552. Yang EY, Chambless L, Sharrett AR, Virani SS, Liu X, Tang Z, Boerwinkle E, Ballantyne CM, Nambi V. Carotid arterial wall characteristics are associated with incident ischemic stroke but not coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2012 Jan; 43(1):103-8. PMID: 22033999; PMCID: PMC3246524.
      Citations: 50     Fields:    Translation:Humans
    553. Bis JC, Dehghan A, Barbalic M, Baumert J, Lu C, Smith NL, Roberts R, Khuseyinova N, Schnabel RB, Rice KM, Rivadeneira F, Hoogeveen RC, Meisinger C, Keaney JF, Lemaitre R, Aulchenko YS, Vasan RS, Ellis S, Hazen SL, van Duijn CM, Nelson JJ, Schunkert H, McPherson RM, Stirnadel-Farrant HA, Psaty BM, Gieger C, Siscovick D, Hofman A, Illig T, Cushman M, Yamamoto JF, Rotter JI, Larson MG, Stewart AF, Boerwinkle E, Witteman JC, Tracy RP, Koenig W, Benjamin EJ, Ballantyne CM, Grallert H, Dupuis J, Uitterlinden AG, Fontes JD, M?rz W. Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies. Eur Heart J. 2012 Jan; 33(2):238-51. PMID: 22003152; PMCID: PMC3258449.
      Citations: 45     Fields:    Translation:Humans
    554. Bis JC, Kavousi M, Franceschini N, Isaacs A, Schminke U, Post WS, Smith AV, Cupples LA, Markus HS, Schmidt R, Huffman JE, Baumert J, Heckbert SR, Dehghan A, North K, Oostra B, Bevan S, Stoegerer EM, Hayward C, Raitakari O, Meisinger C, Schillert A, Sanna S, Cheng YC, Thorsson B, Fox CS, Rice K, Rivadeneira F, Nambi V, Halperin E, Petrovic KE, Peltonen L, Wichmann HE, Schnabel RB, Parsa A, Aspelund T, Demissie S, Kathiresan S, Reilly MP, Taylor K, Uitterlinden A, Couper DJ, Sitzer M, Illig T, Wild PS, Orru M, Shuldiner AR, Eiriksdottir G, White CC, Rotter JI, Hofman A, Seissler J, Zeller T, Usala G, Ernst F, Launer LJ, D'Agostino RB, O'Leary DH, Ballantyne C, Thiery J, Ziegler A, Lakatta EG, Chilukoti RK, Harris TB, Wolf PA, Psaty BM, Polak JF, Li X, Rathmann W, Uda M, Boerwinkle E, Klopp N, Schmidt H, Wilson JF, Viikari J, Koenig W, Blankenberg S, Newman AB, Witteman J, Heiss G, Duijn Cv, Scuteri A, Homuth G, Mitchell BD, Gudnason V, O'Donnell CJ, CARDIoGRAM Consortium, Abecasis GR, Lehtim?ki T, M?nzel T, V?lzke H, D?rr M, K?h?nen M, L?demann J. Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque. Nat Genet. 2011 Sep 11; 43(10):940-7. PMID: 21909108; PMCID: PMC3257519.
      Citations: 113     Fields:    Translation:Humans
    555. Yang EY, Dokainish H, Virani SS, Misra A, Pritchett AM, Lakkis N, Brunner G, Bobek J, McCulloch ML, Hartley CJ, Ballantyne CM, Nagueh SF, Nambi V. Segmental analysis of carotid arterial strain using speckle-tracking. J Am Soc Echocardiogr. 2011 Nov; 24(11):1276-1284.e5. PMID: 21907541; PMCID: PMC3200442.
      Citations: 11     Fields:    Translation:Humans
    556. Fayad ZA, Mani V, Woodward M, Kallend D, Abt M, Burgess T, Fuster V, Ballantyne CM, Stein EA, Tardif JC, Rudd JH, Farkouh ME, Tawakol A, dal-PLAQUE Investigators. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet. 2011 Oct 29; 378(9802):1547-59. PMID: 21908036; PMCID: PMC4151875.
      Citations: 203     Fields:    Translation:HumansCTClinical Trials
    557. Davidson MH, Ballantyne CM, Jacobson TA, Bittner VA, Braun LT, Brown AS, Brown WV, Cromwell WC, Goldberg RB, McKenney JM, Remaley AT, Sniderman AD, Toth PP, Tsimikas S, Ziajka PE, Maki KC, Dicklin MR. Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists. J Clin Lipidol. 2011 Sep-Oct; 5(5):338-67. PMID: 21981835.
      Citations: 68     Fields:    Translation:Humans
    558. Virani SS, Steinberg L, Murray T, Negi S, Nambi V, Woodard LD, Bozkurt B, Petersen LA, Ballantyne CM. Barriers to non-HDL cholesterol goal attainment by providers. Am J Med. 2011 Sep; 124(9):876-80.e2. PMID: 21854896; PMCID: PMC4180871.
      Citations: 10     Fields:    Translation:Humans
    559. Virani SS, Woodard LD, Chitwood SS, Landrum CR, Urech TH, Wang D, Murawsky J, Ballantyne CM, Petersen LA. Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular disease. Am Heart J. 2011 Oct; 162(4):725-732.e1. PMID: 21982666.
      Citations: 21     Fields:    Translation:Humans
    560. Brautbar A, Covarrubias D, Belmont J, Lara-Garduno F, Virani SS, Jones PH, Leal SM, Ballantyne CM. Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia. Atherosclerosis. 2011 Dec; 219(2):737-42. PMID: 21889769; PMCID: PMC6174528.
      Citations: 25     Fields:    Translation:HumansCTClinical Trials
    561. Brunner G, Nambi V, Yang E, Kumar A, Virani SS, Kougias P, Shah D, Lumsden A, Ballantyne CM, Morrisett JD. Automatic quantification of muscle volumes in magnetic resonance imaging scans of the lower extremities. Magn Reson Imaging. 2011 Oct; 29(8):1065-75. PMID: 21855242.
      Citations: 14     Fields:    Translation:Humans
    562. Virani SS, Catellier DJ, Pompeii LA, Nambi V, Hoogeveen RC, Wasserman BA, Coresh J, Mosley TH, Otvos JD, Sharrett AR, Boerwinkle E, Ballantyne CM. Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study. Atherosclerosis. 2011 Dec; 219(2):596-602. PMID: 21868017; PMCID: PMC3226845.
      Citations: 15     Fields:    Translation:Humans
    563. Wang Q, Perrard XD, Perrard JL, Mansoori A, Raya JL, Hoogeveen R, Smith CW, Ballantyne CM, Wu H. Differential effect of weight loss with low-fat diet or high-fat diet restriction on inflammation in the liver and adipose tissue of mice with diet-induced obesity. Atherosclerosis. 2011 Nov; 219(1):100-8. PMID: 21824616; PMCID: PMC3206136.
      Citations: 17     Fields:    Translation:AnimalsCells
    564. Ballantyne CM, Davidson MH, Setze CM, Kelly MT. Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (= 2 mg/L). cmb@bcm.tmc.edu. J Clin Lipidol. 2011 Sep-Oct; 5(5):401-7. PMID: 21981842.
      Citations: 2     Fields:    Translation:Humans
    565. Bays HE, Ballantyne CM, Kastelein JJ, Isaacsohn JL, Braeckman RA, Soni PN. Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] trial). Am J Cardiol. 2011 Sep 01; 108(5):682-90. PMID: 21683321.
      Citations: 79     Fields:    Translation:HumansCTClinical Trials
    566. Robinson JG, Ballantyne CM, Hsueh W, Rosen J, Lin J, Shah A, Lowe RS, Hanson ME, Tershakovec AM. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study). J Clin Lipidol. 2011 Nov-Dec; 5(6):474-82. PMID: 22108151.
      Citations: 5     Fields:    Translation:Humans
    567. Nambi V, Chambless L, He M, Folsom AR, Mosley T, Boerwinkle E, Ballantyne CM. Common carotid artery intima-media thickness is as good as carotid intima-media thickness of all carotid artery segments in improving prediction of coronary heart disease risk in the Atherosclerosis Risk in Communities (ARIC) study. Eur Heart J. 2012 Jan; 33(2):183-90. PMID: 21666250; PMCID: PMC3258447.
      Citations: 58     Fields:    Translation:Humans
    568. Friedewald VE, Ballantyne CM, Davidson MH, Gotto AM, Ridker PM, Roberts WC. The editor's roundtable: JUPITER follow-up. Am J Cardiol. 2011 May 15; 107(10):1549-57. PMID: 21539951.
      Citations:    Fields:    Translation:Humans
    569. Balasubramanyam A, Coraza I, Smith EO, Scott LW, Patel P, Iyer D, Taylor AA, Giordano TP, Sekhar RV, Clark P, Cuevas-Sanchez E, Kamble S, Ballantyne CM, Pownall HJ. Combination of niacin and fenofibrate with lifestyle changes improves dyslipidemia and hypoadiponectinemia in HIV patients on antiretroviral therapy: results of "heart positive," a randomized, controlled trial. J Clin Endocrinol Metab. 2011 Jul; 96(7):2236-47. PMID: 21565796; PMCID: PMC3135191.
      Citations: 26     Fields:    Translation:Humans
    570. Virani SS, Woodard LD, Landrum CR, Pietz K, Wang D, Ballantyne CM, Petersen LA. Institutional, provider, and patient correlates of low-density lipoprotein and non-high-density lipoprotein cholesterol goal attainment according to the Adult Treatment Panel III guidelines. Am Heart J. 2011 Jun; 161(6):1140-6. PMID: 21641361.
      Citations: 7     Fields:    Translation:Humans
    571. Berger JS, Ballantyne CM, Davidson MH, Johnson JL, Tarka EA, Lawrence D, Trivedi T, Zalewski A, Mohler ER. Peripheral artery disease, biomarkers, and darapladib. Am Heart J. 2011 May; 161(5):972-8. PMID: 21570531; PMCID: PMC3750980.
      Citations: 8     Fields:    Translation:Humans
    572. Agarwal SK, Avery CL, Ballantyne CM, Catellier D, Nambi V, Saunders J, Sharrett AR, Coresh J, Heiss G, Hoogeveen RC. Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study. Clin Chem. 2011 Jun; 57(6):891-7. PMID: 21519038; PMCID: PMC4928588.
      Citations: 42     Fields:    Translation:Humans
    573. Belalcazar LM, Ballantyne CM, Lang W, Haffner SM, Rushing J, Schwenke DC, Pi-Sunyer FX, Tracy RP, Look Action for Health in Diabetes Research Group. Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study. Arterioscler Thromb Vasc Biol. 2011 Jul; 31(7):1689-95. PMID: 21512162; PMCID: PMC3130500.
      Citations: 18     Fields:    Translation:Humans
    574. Alam M, Siddiqui S, Lee VV, Elayda MA, Nambi V, Yang EY, Jneid HM, Wilson JM, Ballantyne CM, Virani SS. Isolated coronary artery bypass grafting in obese individuals: a propensity matched analysis of outcomes. Circ J. 2011; 75(6):1378-85. PMID: 21498907.
      Citations: 5     Fields:    Translation:Humans
    575. Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, Goldberg AC, Howard WJ, Jacobson MS, Kris-Etherton PM, Lennie TA, Levi M, Mazzone T, Pennathur S, American Heart Association Clinical Lipidology, Thrombosis, and Prevention Committee of the Council , Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular Nursing, Council on the Kidney in Cardiovascular Disease. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011 May 24; 123(20):2292-333. PMID: 21502576.
      Citations: 578     Fields:    Translation:Humans
    576. Goldberg AC, Hopkins PN, Toth PP, Ballantyne CM, Rader DJ, Robinson JG, Daniels SR, Gidding SS, de Ferranti SD, Ito MK, McGowan MP, Moriarty PM, Cromwell WC, Ross JL, Ziajka PE, National Lipid Association Expert Panel on Familial Hypercholesterolemia. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011 Jun; 5(3 Suppl):S1-8. PMID: 21600525.
      Citations: 134     Fields:    Translation:Humans
    577. Hopkins PN, Toth PP, Ballantyne CM, Rader DJ, National Lipid Association Expert Panel on Familial Hypercholesterolemia. Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011 Jun; 5(3 Suppl):S9-17. PMID: 21600530.
      Citations: 75     Fields:    Translation:Humans
    578. Nicholls SJ, Borgman M, Nissen SE, Raichlen JS, Ballantyne C, Barter P, Chapman MJ, Erbel R, Libby P. Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: effect of Rosuvastatin versus AtorvastatiN). Curr Med Res Opin. 2011 Jun; 27(6):1119-29. PMID: 21446892.
      Citations: 7     Fields:    Translation:Humans
    579. Yang EY, Polsani VR, Washburn MJ, Zang W, Hall AL, Virani SS, Hodge MD, Parker D, Kerwin WS, Lawrie GM, Garami Z, Ballantyne CM, Morrisett JD, Nambi V. Real-time co-registration using novel ultrasound technology: ex vivo validation and in vivo applications. J Am Soc Echocardiogr. 2011 Jul; 24(7):720-8. PMID: 21439782; PMCID: PMC3123396.
      Citations: 3     Fields:    Translation:Humans
    580. Saunders JT, Nambi V, de Lemos JA, Chambless LE, Virani SS, Boerwinkle E, Hoogeveen RC, Liu X, Astor BC, Mosley TH, Folsom AR, Heiss G, Coresh J, Ballantyne CM. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation. 2011 Apr 05; 123(13):1367-76. PMID: 21422391; PMCID: PMC3072024.
      Citations: 273     Fields:    Translation:Humans
    581. Virani SS, Brautbar A, Lee VV, Elayda M, Sami S, Nambi V, Frazier L, Wilson JM, Willerson JT, Boerwinkle E, Ballantyne CM. Usefulness of single nucleotide polymorphism in chromosome 4q25 to predict in-hospital and long-term development of atrial fibrillation and survival in patients undergoing coronary artery bypass grafting. Am J Cardiol. 2011 May 15; 107(10):1504-9. PMID: 21414601; PMCID: PMC3087849.
      Citations: 18     Fields:    Translation:HumansCells
    582. Goldberg AC, Hopkins PN, Toth PP, Ballantyne CM, Rader DJ, Robinson JG, Daniels SR, Gidding SS, de Ferranti SD, Ito MK, McGowan MP, Moriarty PM, Cromwell WC, Ross JL, Ziajka PE. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011 May-Jun; 5(3):133-140. PMID: 21600517.
      Citations: 66     Fields:    Translation:Humans
    583. Campos M, Sun W, Yu F, Barbalic M, Tang W, Chambless LE, Wu KK, Ballantyne C, Folsom AR, Boerwinkle E, Dong JF. Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort. Blood. 2011 May 12; 117(19):5224-30. PMID: 21343614; PMCID: PMC3109544.
      Citations: 28     Fields:    Translation:HumansCells
    584. Brautbar A, Ballantyne CM. Pharmacological strategies for lowering LDL cholesterol: statins and beyond. Nat Rev Cardiol. 2011 May; 8(5):253-65. PMID: 21321561.
      Citations: 37     Fields:    Translation:HumansAnimals
    585. Dehghan A, Barbalic M, Bis JC, Eiriksdottir G, Lu C, Pellikka N, Wallaschofski H, Kettunen J, Henneman P, Baumert J, Strachan DP, Fuchsberger C, Vitart V, Wilson JF, Naitza S, Rudock ME, Surakka I, de Geus EJ, Alizadeh BZ, Guralnik J, Shuldiner A, Tanaka T, Zee RY, Schnabel RB, Nambi V, Kavousi M, Ripatti S, Nauck M, Smith NL, Smith AV, Sundvall J, Scheet P, Liu Y, Ruokonen A, Rose LM, Larson MG, Hoogeveen RC, Freimer NB, Teumer A, Tracy RP, Launer LJ, Buring JE, Yamamoto JF, Folsom AR, Sijbrands EJ, Pankow J, Elliott P, Keaney JF, Sun W, Sarin AP, Badola S, Astor BC, Hofman A, Pouta A, Werdan K, Greiser KH, Kuss O, Meyer zu Schwabedissen HE, Thiery J, Jamshidi Y, Nolte IM, Soranzo N, Spector TD, Parker AN, Aspelund T, Bates D, Young L, Tsui K, Siscovick DS, Guo X, Rotter JI, Uda M, Schlessinger D, Rudan I, Hicks AA, Penninx BW, Thorand B, Gieger C, Coresh J, Willemsen G, Harris TB, Uitterlinden AG, Rice K, Salomaa V, Willems van Dijk K, Boerwinkle E, Vasan RS, Ferrucci L, Gibson QD, Bandinelli S, Snieder H, Boomsma DI, Xiao X, Campbell H, Hayward C, Pramstaller PP, van Duijn CM, Peltonen L, Psaty BM, Gudnason V, Ridker PM, Homuth G, Koenig W, Ballantyne CM, Witteman JC, Benjamin EJ, Perola M, Chasman DI, Dupuis J, Par? G, Fontes JD, V?lzke H, J?rvelin MR, Radke D. Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation. 2011 Feb 22; 123(7):731-8. PMID: 21300955; PMCID: PMC3147232.
      Citations: 255     Fields:    Translation:Humans
    586. Ballantyne CM, Jones PH, Kelly MT, Setze CM, Lele A, Thakker KM, Stolzenbach JC. Long-term efficacy of adding fenofibric acid to moderate-dose statin therapy in patients with persistent elevated triglycerides. Cardiovasc Drugs Ther. 2011 Feb; 25(1):59-67. PMID: 21416219; PMCID: PMC3070075.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    587. Nicholls SJ, Gordon A, Johansson J, Wolski K, Ballantyne CM, Kastelein JJ, Taylor A, Borgman M, Nissen SE. Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial. J Am Coll Cardiol. 2011 Mar 01; 57(9):1111-9. PMID: 21255957.
      Citations: 59     Fields:    Translation:Humans
    588. Saunders J, Nambi V, Kimball KT, Virani SS, Morrisett JD, Lumsden AB, Ballantyne CM, Dong JF, ELIMIT Investigators. Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients. J Vasc Surg. 2011 Mar; 53(3):668-75. PMID: 21227624; PMCID: PMC3197816.
      Citations: 5     Fields:    Translation:Humans
    589. Gower RM, Wu H, Foster GA, Devaraj S, Jialal I, Ballantyne CM, Knowlton AA, Simon SI. CD11c/CD18 expression is upregulated on blood monocytes during hypertriglyceridemia and enhances adhesion to vascular cell adhesion molecule-1. Arterioscler Thromb Vasc Biol. 2011 Jan; 31(1):160-6. PMID: 21030716; PMCID: PMC3038249.
      Citations: 72     Fields:    Translation:HumansCells
    590. Virani SS, Nambi V, Hoogeveen R, Wasserman BA, Coresh J, Gonzalez F, Chambless LE, Mosley TH, Boerwinkle E, Ballantyne CM. Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study. Eur Heart J. 2011 Feb; 32(4):459-68. PMID: 20943669; PMCID: PMC3106284.
      Citations: 25     Fields:    Translation:Humans
    591. Wang Q, Perrard XD, Perrard JL, Mansoori A, Smith CW, Ballantyne CM, Wu H. Effect of the cannabinoid receptor-1 antagonist rimonabant on inflammation in mice with diet-induced obesity. Obesity (Silver Spring). 2011 Mar; 19(3):505-13. PMID: 20885384; PMCID: PMC3272877.
      Citations: 11     Fields:    Translation:Animals
    592. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Ripatti S, Chasman DI, Willer CJ, Johansen CT, Fouchier SW, Isaacs A, Peloso GM, Barbalic M, Ricketts SL, Bis JC, Aulchenko YS, Thorleifsson G, Feitosa MF, Chambers J, Orho-Melander M, Melander O, Johnson T, Li X, Guo X, Li M, Shin Cho Y, Jin Go M, Jin Kim Y, Lee JY, Park T, Kim K, Sim X, Twee-Hee Ong R, Croteau-Chonka DC, Lange LA, Smith JD, Song K, Hua Zhao J, Yuan X, Luan J, Lamina C, Ziegler A, Zhang W, Zee RY, Wright AF, Witteman JC, Wilson JF, Willemsen G, Wichmann HE, Whitfield JB, Waterworth DM, Wareham NJ, Vollenweider P, Voight BF, Vitart V, Uitterlinden AG, Uda M, Tuomilehto J, Thompson JR, Tanaka T, Surakka I, Stringham HM, Spector TD, Soranzo N, Smit JH, Sinisalo J, Silander K, Sijbrands EJ, Scuteri A, Scott J, Schlessinger D, Sanna S, Salomaa V, Saharinen J, Sabatti C, Ruokonen A, Rudan I, Rose LM, Roberts R, Rieder M, Psaty BM, Pramstaller PP, Pichler I, Perola M, Penninx BW, Pedersen NL, Pattaro C, Parker AN, Pare G, Oostra BA, O'Donnell CJ, Nieminen MS, Nickerson DA, Montgomery GW, Meitinger T, McPherson R, McCarthy MI, McArdle W, Masson D, Martin NG, Marroni F, Mangino M, Magnusson PK, Lucas G, Luben R, Loos RJ, Lokki ML, Lettre G, Langenberg C, Launer LJ, Lakatta EG, Laaksonen R, Kyvik KO, Kronenberg F, Khaw KT, Kaprio J, Kaplan LM, Johansson A, Jarvelin MR, Janssens AC, Ingelsson E, Igl W, Kees Hovingh G, Hottenga JJ, Hofman A, Hicks AA, Hengstenberg C, Heid IM, Hayward C, Havulinna AS, Hastie ND, Harris TB, Haritunians T, Hall AS, Gyllensten U, Guiducci C, Groop LC, Gonzalez E, Gieger C, Freimer NB, Ferrucci L, Erdmann J, Elliott P, Ejebe KG, Dominiczak AF, Demissie S, Deloukas P, de Geus EJ, de Faire U, Crawford G, Collins FS, Chen YD, Caulfield MJ, Campbell H, Burtt NP, Bonnycastle LL, Boomsma DI, Boekholdt SM, Bergman RN, Bandinelli S, Ballantyne CM, Assimes TL, Quertermous T, Altshuler D, Seielstad M, Wong TY, Tai ES, Feranil AB, Kuzawa CW, Adair LS, Taylor HA, Borecki IB, Gabriel SB, Wilson JG, Holm H, Thorsteinsdottir U, Gudnason V, Krauss RM, Mohlke KL, Ordovas JM, Munroe PB, Kooner JS, Tall AR, Hegele RA, Kastelein JJ, Schadt EE, Rotter JI, Boerwinkle E, Strachan DP, Mooser V, Stefansson K, Reilly MP, Samani NJ, Schunkert H, Cupples LA, Sandhu MS, Ridker PM, Rader DJ, van Duijn CM, Peltonen L, Boehnke M, Kathiresan S, Waeber G, K?nig IR, D?ring A, Barroso I, Abecasis GR. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010 Aug 05; 466(7307):707-13. PMID: 20686565; PMCID: PMC3039276.
      Citations: 1812     Fields:    Translation:HumansAnimals
    593. Belalcazar LM, Reboussin DM, Haffner SM, Hoogeveen RC, Kriska AM, Schwenke DC, Tracy RP, Pi-Sunyer FX, Ballantyne CM, Look AHEAD Research Group. A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care. 2010 Nov; 33(11):2297-303. PMID: 20682679; PMCID: PMC2963483.
      Citations: 45     Fields:    Translation:Humans
    594. Brown WV, Ballantyne CM, Jones PH, Marcovina S. Management of Lp(a). J Clin Lipidol. 2010 Jul-Aug; 4(4):240-7. PMID: 21122656.
      Citations: 14     Fields:    Translation:Humans
    595. Vergeer M, Zhou R, Bots ML, Koglin J, Akdim F, Mitchel YB, Huijgen R, Sapre A, de Groot E, Sijbrands EJ, Pasternak RC, Marais AD, Ballantyne CM, Isaacsohn JL, Stalenhoef AF, Kastelein JJ, Duivenvoorden R, Gagn? C. Carotid atherosclerosis progression in familial hypercholesterolemia patients: a pooled analysis of the ASAP, ENHANCE, RADIANCE 1, and CAPTIVATE studies. Circ Cardiovasc Imaging. 2010 Jul; 3(4):398-404. PMID: 20494942.
      Citations: 5     Fields:    Translation:Humans
    596. Lp-PLA(2) Studies Collaboration, Thompson A, Gao P, Orfei L, Watson S, Di Angelantonio E, Kaptoge S, Ballantyne C, Cannon CP, Criqui M, Cushman M, Hofman A, Packard C, Thompson SG, Collins R, Danesh J. Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet. 2010 May 01; 375(9725):1536-44. PMID: 20435228; PMCID: PMC2864403.
      Citations: 218     Fields:    Translation:Humans
    597. Nambi V, Chambless L, Folsom AR, He M, Hu Y, Mosley T, Volcik K, Boerwinkle E, Ballantyne CM. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol. 2010 Apr 13; 55(15):1600-7. PMID: 20378078; PMCID: PMC2862308.
      Citations: 269     Fields:    Translation:Humans
    598. Virani SS, Nambi V, Polsani VR, Lee VV, Elayda M, Kohsaka S, Pan W, Reul RM, Wilson JM, Petersen LA, Willerson JT, Ballantyne CM. Preoperative statin therapy decreases risk of postoperative renal insufficiency. Cardiovasc Ther. 2010 Apr; 28(2):80-6. PMID: 20398096.
      Citations: 14     Fields:    Translation:Humans
    599. Volcik KA, Ballantyne CM, Hoogeveen R, Folsom AR, Boerwinkle E. Intercellular adhesion molecule-1 G241R polymorphism predicts risk of incident ischemic stroke: Atherosclerosis Risk in Communities study. Stroke. 2010 May; 41(5):1038-40. PMID: 20360547; PMCID: PMC3036988.
      Citations: 5     Fields:    Translation:Humans
    600. Maki KC, Dicklin MR, Davidson MH, Doyle RT, Ballantyne CM, COMBination of prescription Omega-3 with Simvastatin (COMBOS) Investigators. Baseline lipoprotein lipids and low-density lipoprotein cholesterol response to prescription omega-3 acid ethyl ester added to Simvastatin therapy. Am J Cardiol. 2010 May 15; 105(10):1409-12. PMID: 20451686.
      Citations: 3     Fields:    Translation:Humans
    601. Hiatt WR, Hirsch AT, Creager MA, Rajagopalan S, Mohler ER, Ballantyne CM, Regensteiner JG, Treat-Jacobson D, Dale RA, Rooke T. Effect of niacin ER/lovastatin on claudication symptoms in patients with peripheral artery disease. Vasc Med. 2010 Jun; 15(3):171-9. PMID: 20212073.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    602. Gaubatz JW, Ballantyne CM, Wasserman BA, He M, Chambless LE, Boerwinkle E, Hoogeveen RC. Association of circulating matrix metalloproteinases with carotid artery characteristics: the Atherosclerosis Risk in Communities Carotid MRI Study. Arterioscler Thromb Vasc Biol. 2010 May; 30(5):1034-42. PMID: 20167662; PMCID: PMC2860383.
      Citations: 17     Fields:    Translation:Humans
    603. Barbalic M, Dehghan A, Bis JC, Hoogeveen RC, Schnabel RB, Nambi V, Bretler M, Smith NL, Peters A, Lu C, Tracy RP, Aleksic N, Heeriga J, Keaney JF, Rice K, Lip GY, Vasan RS, Glazer NL, Larson MG, Uitterlinden AG, Yamamoto J, Durda P, Haritunians T, Psaty BM, Boerwinkle E, Hofman A, Koenig W, Jenny NS, Witteman JC, Ballantyne C, Benjamin EJ, Dupuis J. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet. 2010 May 01; 19(9):1863-72. PMID: 20167578; PMCID: PMC2850624.
      Citations: 111     Fields:    Translation:HumansCells
    604. McKenney J, Bays H, Koren M, Ballantyne CM, Paolini JF, Mitchel Y, Betteridge A, Kuznetsova O, Sapre A, Sisk CM, Maccubbin D. Safety of extended-release niacin/laropiprant in patients with dyslipidemia. J Clin Lipidol. 2010 Mar-Apr; 4(2):105-112.e1. PMID: 21122637.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    605. Yang EY, Nambi V, Tang Z, Virani SS, Boerwinkle E, Hoogeveen RC, Astor BC, Mosley TH, Coresh J, Chambless L, Ballantyne CM. Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study. J Am Coll Cardiol. 2009 Dec 15; 54(25):2388-95. PMID: 20082929; PMCID: PMC2829945.
      Citations: 11     Fields:    Translation:Humans
    606. Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mathieson J, dal-OUTCOMES Committees and Investigators. Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. Am Heart J. 2009 Dec; 158(6):896-901.e3. PMID: 19958854.
      Citations: 60     Fields:    Translation:Humans
    607. Polis AB, Abate N, Catapano AL, Ballantyne CM, Davidson MH, Smugar SS, Tershakovec AM. Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category. Metab Syndr Relat Disord. 2009 Dec; 7(6):601-10. PMID: 19929597.
      Citations: 3     Fields:    Translation:Humans
    608. Wu H, Perrard XD, Wang Q, Perrard JL, Polsani VR, Jones PH, Smith CW, Ballantyne CM. CD11c expression in adipose tissue and blood and its role in diet-induced obesity. Arterioscler Thromb Vasc Biol. 2010 Feb; 30(2):186-92. PMID: 19910635; PMCID: PMC2830649.
      Citations: 75     Fields:    Translation:HumansAnimalsCells
    609. Chen SN, Cilingiroglu M, Todd J, Lombardi R, Willerson JT, Gotto AM, Ballantyne CM, Marian AJ. Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis. BMC Med Genet. 2009 Oct 30; 10:111. PMID: 19878569; PMCID: PMC2775733.
      Citations: 32     Fields:    Translation:Humans
    610. North KE, Franceschini N, Avery CL, Baird L, Graff M, Leppert M, Chung JH, Zhang J, Hanis C, Boerwinkle E, Volcik KA, Grove ML, Mosley TH, Gu C, Heiss G, Pankow JS, Couper DJ, Ballantyne CM, Linda Kao WH, Weder AB, Cooper RS, Ehret GB, O'Connor AA, Chakravarti A, Hunt SC. Variation in the checkpoint kinase 2 gene is associated with type 2 diabetes in multiple populations. Acta Diabetol. 2010 Dec; 47 Suppl 1:199-207. PMID: 19855918; PMCID: PMC2965317.
      Citations: 1     Fields:    Translation:Humans
    611. Belalcazar LM, Reboussin DM, Haffner SM, Reeves RS, Schwenke DC, Hoogeveen RC, Pi-Sunyer FX, Ballantyne CM, Look AHEAD (Action for Health in Diabetes) Obesity, Inflammation, and Thrombosis Research Group. Marine omega-3 fatty acid intake: associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care. 2010 Jan; 33(1):197-9. PMID: 19841042; PMCID: PMC2797972.
      Citations: 8     Fields:    Translation:Humans
    612. Bairey Merz CN, Alberts MJ, Balady GJ, Ballantyne CM, Berra K, Black HR, Blumenthal RS, Davidson MH, Fazio SB, Ferdinand KC, Fine LJ, Fonseca V, Franklin BA, McBride PE, Mensah GA, Merli GJ, O'Gara PT, Thompson PD, Underberg JA, American College of Cardiology Foundation, American Heart Association, American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a, American Academy of Neurology, American Association of Cardiovascular and Pulmonary Rehabilitation, American College of Preventive Medicine, American Diabetes Association, American Society of Hypertension, Association of Black Cardiologists, National Lipid Association, Preventive Cardiovascular Nurses Association. ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association. J Am Coll Cardiol. 2009 Sep 29; 54(14):1336-63. PMID: 19778678; PMCID: PMC2782747.
      Citations: 12     Fields:    Translation:Humans
    613. Bairey Merz CN, Alberts MJ, Balady GJ, Ballantyne CM, Berra K, Black HR, Blumenthal RS, Davidson MH, Fazio SB, Ferdinand KC, Fine LJ, Fonseca V, Franklin BA, McBride PE, Mensah GA, Merli GJ, O'Gara PT, Thompson PD, Underberg JA, American Academy of Neurology, American Association of Cardiovascular and Pulmonary Rehabilitation, American College of Preventive Medicine, American College of Sports Medicine, American Diabetes Association, American Society of Hypertension, Association of Black Cardiologists, Centers for Disease Control and Prevention, National Heart, Lung, and Blood Institute, National Lipid Association, Preventive Cardiovascular Nurses Association. ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association. Circulation. 2009 Sep 29; 120(13):e100-26. PMID: 19770387.
      Citations: 9     Fields:    Translation:Humans
    614. Polsani VR, Nambi V, Virani SS, Yang EY, Jones PH, Ballantyne CM, Zoch D. Efficacy and tolerability of multidrug therapy for hypertriglyceridemia. J Clin Lipidol. 2009 Oct; 3(5):341-4. PMID: 21291832.
      Citations:    Fields:    
    615. Davidson MH, Maki KC, Bays H, Carter R, Ballantyne CM. Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A(2) mass in statin-treated subjects with hypertriglyceridemia. J Clin Lipidol. 2009 Oct; 3(5):332-40. PMID: 21291831.
      Citations: 17     Fields:    
    616. Wu H, Ballantyne CM. Inflammation, adipose tissue, and T cells: what is the "straight skinny" on lean versus fat mice? Circ Res. 2009 Jul 17; 105(2):e3-4; author reply e5. PMID: 19608985; PMCID: PMC2740980.
      Citations:    Fields:    Translation:HumansAnimalsCells
    617. Shiffman D, Chasman DI, Ballantyne CM, Nambi V, Devlin JJ, Boerwinkle E. Coronary heart disease risk, aspirin use, and apolipoprotein(a) 4399Met allele in the Atherosclerosis Risk in Communities (ARIC) study. Thromb Haemost. 2009 Jul; 102(1):179-80. PMID: 19572086; PMCID: PMC4351745.
      Citations: 2     Fields:    Translation:Humans
    618. Robinson JG, Ballantyne CM, Grundy SM, Hsueh WA, Parving HH, Rosen JB, Adewale AJ, Polis AB, Tomassini JE, Tershakovec AM. Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study). Am J Cardiol. 2009 Jun 15; 103(12):1694-702. PMID: 19539078.
      Citations: 17     Fields:    Translation:Humans
    619. Wagenknecht L, Wasserman B, Chambless L, Coresh J, Folsom A, Mosley T, Ballantyne C, Sharrett R, Boerwinkle E. Correlates of carotid plaque presence and composition as measured by MRI: the Atherosclerosis Risk in Communities Study. Circ Cardiovasc Imaging. 2009 Jul; 2(4):314-22. PMID: 19808612; PMCID: PMC2747117.
      Citations: 42     Fields:    Translation:HumansPHPublic Health
    620. Wu H, Gower RM, Wang H, Perrard XY, Ma R, Bullard DC, Burns AR, Paul A, Smith CW, Simon SI, Ballantyne CM. Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia. Circulation. 2009 May 26; 119(20):2708-17. PMID: 19433759; PMCID: PMC2716173.
      Citations: 125     Fields:    Translation:AnimalsCells
    621. Nambi V, Kimball KT, Bray PF, Bergeron AL, Johnson SL, Morrisett JD, Chen C, Lin PH, Lumsden AB, Ballantyne CM, Dong JF. Differences in responses of platelets to fluid shear stress in patients with peripheral artery disease (PAD) and coronary artery disease (CAD). Platelets. 2009 May; 20(3):199-205. PMID: 19437338; PMCID: PMC2869211.
      Citations: 5     Fields:    Translation:Humans
    622. Brautbar A, Ballantyne CM, Lawson K, Nambi V, Chambless L, Folsom AR, Willerson JT, Boerwinkle E. Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the Atherosclerosis Risk in Communities study. Circ Cardiovasc Genet. 2009 Jun; 2(3):279-85. PMID: 20031596; PMCID: PMC2771929.
      Citations: 44     Fields:    Translation:HumansCells
    623. Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, Go AS, Harrell FE, Hong Y, Howard BV, Howard VJ, Hsue PY, Kramer CM, McConnell JP, Normand SL, O'Donnell CJ, Smith SC, Wilson PW, American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Fa. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009 May 05; 119(17):2408-16. PMID: 19364974; PMCID: PMC2956982.
      Citations: 362     Fields:    Translation:Humans
    624. Monda KL, Ballantyne CM, North KE. Longitudinal impact of physical activity on lipid profiles in middle-aged adults: the Atherosclerosis Risk in Communities Study. J Lipid Res. 2009 Aug; 50(8):1685-91. PMID: 19346332; PMCID: PMC2724055.
      Citations: 38     Fields:    Translation:Humans
    625. Chen SN, Ballantyne CM, Gotto AM, Marian AJ. The 9p21 susceptibility locus for coronary artery disease and the severity of coronary atherosclerosis. BMC Cardiovasc Disord. 2009 Jan 27; 9:3. PMID: 19173706; PMCID: PMC2637231.
      Citations: 20     Fields:    Translation:HumansCellsCTClinical Trials
    626. Virani SS, Nambi V, Lee VV, Elayda MA, Pan W, Petersen LA, Wilson JM, Willerson JT, Ballantyne CM. Obesity: an independent predictor of in-hospital postoperative renal insufficiency among patients undergoing cardiac surgery? Tex Heart Inst J. 2009; 36(6):540-5. PMID: 20069078; PMCID: PMC2801932.
      Citations: 4     Fields:    Translation:Humans
    627. Goldberg AC, Bays HE, Ballantyne CM, Kelly MT, Buttler SM, Setze CM, Sleep DJ, Stolzenbach JC. Efficacy and safety of ABT-335 (fenofibric acid) in combination with atorvastatin in patients with mixed dyslipidemia. Am J Cardiol. 2009 Feb 15; 103(4):515-22. PMID: 19195513.
      Citations: 21     Fields:    Translation:Humans
    628. NACB LMPG Committee Members, Myers GL, Christenson RH, Cushman M, Ballantyne CM, Cooper GR, Pfeiffer CM, Grundy SM, Labarthe DR, Levy D, Rifai N, Wilson PW. National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease. Clin Chem. 2009 Feb; 55(2):378-84. PMID: 19106185.
      Citations: 47     Fields:    Translation:HumansPHPublic Health
    629. Nambi V, Hoogeveen RC, Chambless L, Hu Y, Bang H, Coresh J, Ni H, Boerwinkle E, Mosley T, Sharrett R, Folsom AR, Ballantyne CM. Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2009 Feb; 40(2):376-81. PMID: 19095974; PMCID: PMC2711777.
      Citations: 19     Fields:    Translation:Humans
    630. Paolini JF, Bays HE, Ballantyne CM, Davidson M, Pasternak R, Maccubbin D, Norquist JM, Lai E, Waters MG, Kuznetsova O, Sisk CM, Mitchel YB. Extended-release niacin/laropiprant: reducing niacin-induced flushing to better realize the benefit of niacin in improving cardiovascular risk factors. Cardiol Clin. 2008 Nov; 26(4):547-60. PMID: 19031552.
      Citations: 6     Fields:    Translation:HumansAnimals
    631. Vaduganathan M, Alviar CL, Arikan ME, Tellez A, Guthikonda S, DeLao T, Granada JF, Kleiman NS, Ballantyne CM, Lev EI. Platelet reactivity and response to aspirin in subjects with the metabolic syndrome. Am Heart J. 2008 Nov; 156(5):1002.e1-1002.e7. PMID: 19061719.
      Citations: 20     Fields:    Translation:HumansCells
    632. Pearson TA, Ballantyne CM, Veltri E, Shah A, Bird S, Lin J, Rosenberg E, Tershakovec AM. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy. Am J Cardiol. 2009 Feb 01; 103(3):369-74. PMID: 19166691.
      Citations: 24     Fields:    Translation:Humans
    633. Thakker GD, Frangogiannis NG, Zymek PT, Sharma S, Raya JL, Barger PM, Taegtmeyer H, Entman ML, Ballantyne CM. Increased myocardial susceptibility to repetitive ischemia with high-fat diet-induced obesity. Obesity (Silver Spring). 2008 Dec; 16(12):2593-600. PMID: 18833212; PMCID: PMC3049112.
      Citations: 15     Fields:    Translation:Animals
    634. Virani SS, Nambi V, Lee VV, Elayda M, Reul RM, Wilson JM, Ballantyne CM. Does preoperative statin therapy improve outcomes in patients undergoing isolated cardiac valve surgery? Am J Cardiol. 2008 Nov 01; 102(9):1235-9. PMID: 18940299.
      Citations: 6     Fields:    Translation:Humans
    635. Ballantyne CM, Raichlen JS, Cain VA. Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial. J Am Coll Cardiol. 2008 Aug 19; 52(8):626-32. PMID: 18702965.
      Citations: 29     Fields:    Translation:Humans
    636. Steinberg BA, Bhatt DL, Mehta S, Poole-Wilson PA, O'Hagan P, Montalescot G, Ballantyne CM, Cannon CP. Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease. Am Heart J. 2008 Oct; 156(4):719-27. PMID: 18926153.
      Citations: 25     Fields:    Translation:Humans
    637. Pluskota E, Woody NM, Szpak D, Ballantyne CM, Soloviev DA, Simon DI, Plow EF. Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticles. Blood. 2008 Sep 15; 112(6):2327-35. PMID: 18509085; PMCID: PMC2532806.
      Citations: 85     Fields:    Translation:HumansAnimalsCells
    638. Ballantyne CM, Davidson MH, McKenney J, Keller LH, Bajorunas DR, Karas RH. Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study). Am J Cardiol. 2008 May 15; 101(10):1428-36. PMID: 18471454.
      Citations: 31     Fields:    Translation:HumansCTClinical Trials
    639. Mohler ER, Ballantyne CM, Davidson MH, Hanefeld M, Ruilope LM, Johnson JL, Zalewski A, Darapladib Investigators. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study. J Am Coll Cardiol. 2008 Apr 29; 51(17):1632-41. PMID: 18436114.
      Citations: 72     Fields:    Translation:HumansCTClinical Trials
    640. Lee SH, Prince JE, Rais M, Kheradmand F, Ballantyne CM, Weitz-Schmidt G, Smith CW, Corry DB. Developmental control of integrin expression regulates Th2 effector homing. J Immunol. 2008 Apr 01; 180(7):4656-67. PMID: 18354189.
      Citations: 8     Fields:    Translation:AnimalsCells
    641. Klos K, Shimmin L, Ballantyne C, Boerwinkle E, Clark A, Coresh J, Hanis C, Liu K, Sayre S, Hixson J. APOE/C1/C4/C2 hepatic control region polymorphism influences plasma apoE and LDL cholesterol levels. Hum Mol Genet. 2008 Jul 01; 17(13):2039-46. PMID: 18378515; PMCID: PMC2900905.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    642. Ballantyne CM, Raichlen JS, Nicholls SJ, Erbel R, Tardif JC, Brener SJ, Cain VA, Nissen SE, ASTEROID Investigators. Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden. Circulation. 2008 May 13; 117(19):2458-66. PMID: 18378607.
      Citations: 46     Fields:    Translation:HumansCTClinical Trials
    643. Volcik KA, Ballantyne CM, Braun MC, Coresh J, Mosley TH, Boerwinkle E. Association of the complement factor H Y402H polymorphism with cardiovascular disease is dependent upon hypertension status: The ARIC study. Am J Hypertens. 2008 May; 21(5):533-8. PMID: 18292760; PMCID: PMC2674647.
      Citations: 11     Fields:    Translation:Humans
    644. Ballantyne CM, Davidson MH, McKenney JM, Keller LH, Bajorunas DR, Karas RH. Comparison of the efficacy and safety of a combination tablet of niacin extended-release and simvastatin with simvastatin 80 mg monotherapy: the SEACOAST II (high-dose) study. J Clin Lipidol. 2008 Apr; 2(2):79-90. PMID: 21291724.
      Citations: 13     Fields:    
    645. Chamberlain AM, Folsom AR, Schreiner PJ, Boerwinkle E, Ballantyne CM. Low-density lipoprotein and high-density lipoprotein cholesterol levels in relation to genetic polymorphisms and menopausal status: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 2008 Oct; 200(2):322-8. PMID: 18275964; PMCID: PMC2583258.
      Citations: 7     Fields:    Translation:Humans
    646. Nambi V, Morrison AC, Hoogeveen RC, Coresh J, Miles S, Rhodes CE, Sharrett AR, Boerwinkle BE, Ballantyne CM. Matrix metalloproteinase-1 and tissue inhibitors do not predict incident coronary artery disease in the atherosclerosis risk in communities (ARIC) study. Tex Heart Inst J. 2008; 35(4):388-94. PMID: 19156230; PMCID: PMC2607088.
      Citations: 5     Fields:    Translation:Humans
    647. Kshirsagar AV, Bomback AS, Bang H, Gerber LM, Vupputuri S, Shoham DA, Mazumdar M, Ballantyne CM, Paparello JJ, Klemmer PJ. Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004). Am J Cardiol. 2008 Feb 01; 101(3):401-6. PMID: 18237609; PMCID: PMC2848170.
      Citations: 28     Fields:    Translation:Humans
    648. Paolini JF, Mitchel YB, Reyes R, Kher U, Lai E, Watson DJ, Norquist JM, Meehan AG, Bays HE, Davidson M, Ballantyne CM. Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia. Am J Cardiol. 2008 Mar 01; 101(5):625-30. PMID: 18308010.
      Citations: 43     Fields:    Translation:HumansCTClinical Trials
    649. Stein EA, Ballantyne CM, Windler E, Sirnes PA, Sussekov A, Yigit Z, Seper C, Gimpelewicz CR. Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins. Am J Cardiol. 2008 Feb 15; 101(4):490-6. PMID: 18312764.
      Citations: 14     Fields:    Translation:Humans
    650. Virani SS, Nambi V, Razavi M, Lee VV, Elayda M, Wilson JM, Ballantyne CM. Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery. Am Heart J. 2008 Mar; 155(3):541-6. PMID: 18294494.
      Citations: 16     Fields:    Translation:Humans
    651. Virani SS, Ballantyne CM. How to identify patients with vulnerable plaques. Diabetes Obes Metab. 2008 Sep; 10(10):824-33. PMID: 17970757.
      Citations: 1     Fields:    Translation:Humans
    652. Volcik KA, Ballantyne CM, Fuchs FD, Sharrett AR, Boerwinkle E. Relationship of alcohol consumption and type of alcoholic beverage consumed with plasma lipid levels: differences between Whites and African Americans of the ARIC study. Ann Epidemiol. 2008 Feb; 18(2):101-7. PMID: 17855114; PMCID: PMC2819069.
      Citations: 29     Fields:    Translation:Humans
    653. Stein EA, Amerena J, Ballantyne CM, Brice E, Farnier M, Guthrie RM, Harats D, Ma PT, Le Maulf F, Gold A, Sager P, Melez?nkov? H. Long-term efficacy and safety of rosuvastatin 40 mg in patients with severe hypercholesterolemia. Am J Cardiol. 2007 Nov 01; 100(9):1387-96. PMID: 17950795.
      Citations: 12     Fields:    Translation:Humans
    654. Mikhailidis DP, Sibbring GC, Ballantyne CM, Davies GM, Catapano AL. Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy. Curr Med Res Opin. 2007 Aug; 23(8):2009-26. PMID: 17659159.
      Citations: 32     Fields:    Translation:Humans
    655. Volcik K, Ballantyne CM, Pownall HJ, Sharrett AR, Boerwinkle E. Interaction effects of high-density lipoprotein metabolism gene variation and alcohol consumption on coronary heart disease risk: the atherosclerosis risk in communities study. J Stud Alcohol Drugs. 2007 Jul; 68(4):485-92. PMID: 17568951; PMCID: PMC2731423.
      Citations: 6     Fields:    Translation:Humans
    656. Hart Sailors ML, Folsom AR, Ballantyne CM, Hoelscher DM, Jackson AS, Linda Kao WH, Pankow JS, Bray MS. Genetic variation and decreased risk for obesity in the Atherosclerosis Risk in Communities Study. Diabetes Obes Metab. 2007 Jul; 9(4):548-57. PMID: 17587397.
      Citations: 5     Fields:    Translation:Humans
    657. Ballantyne CM. Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends? Crit Pathw Cardiol. 2007 Jun; 6(2):41-5. PMID: 17667863.
      Citations: 2     Fields:    Translation:Humans
    658. Steinberg BA, Ballantyne CM, Bhatt DL, Montalescot G, Mehta S, O'Hagan P, Poole-Wilson PA, Cannon CP. An annual, prospective, international study of outpatients with cardiovascular disease or risk factors: design and methods of the CardioMonitor registry. Crit Pathw Cardiol. 2007 Jun; 6(2):72-5. PMID: 17667869.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    659. Pearson T, Ballantyne C, Sisk C, Shah A, Veltri E, Maccubbin D. Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels. Am J Cardiol. 2007 Jun 15; 99(12):1706-1713. PMID: 17560879.
      Citations: 21     Fields:    Translation:Humans
    660. Volcik KA, Ballantyne CM, Coresh J, Folsom AR, Boerwinkle E. Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis. 2007 Nov; 195(1):e76-82. PMID: 17420019; PMCID: PMC2175083.
      Citations: 21     Fields:    Translation:Humans
    661. Lumsden AB, Rice TW, Chen C, Zhou W, Lin PH, Bray P, Morrisett J, Nambi V, Ballantyne C. Peripheral arterial occlusive disease: magnetic resonance imaging and the role of aggressive medical management. World J Surg. 2007 Apr; 31(4):695-704. PMID: 17345122.
      Citations: 12     Fields:    Translation:Humans
    662. Kohsaka S, Volcik KA, Folsom AR, Wu KK, Ballantyne CM, Willerson JT, Boerwinkle E. Increased risk of incident stroke associated with the cyclooxygenase 2 (COX-2) G-765C polymorphism in African-Americans: the Atherosclerosis Risk in Communities Study. Atherosclerosis. 2008 Feb; 196(2):926-30. PMID: 17350020.
      Citations: 21     Fields:    Translation:Humans
    663. Wu H, Ghosh S, Perrard XD, Feng L, Garcia GE, Perrard JL, Sweeney JF, Peterson LE, Chan L, Smith CW, Ballantyne CM. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation. 2007 Feb 27; 115(8):1029-38. PMID: 17296858.
      Citations: 311     Fields:    Translation:HumansAnimalsCells
    664. Ballantyne CM, Weiss R, Moccetti T, Vogt A, Eber B, Sosef F, Duffield E, EXPLORER Study Investigators. Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study). Am J Cardiol. 2007 Mar 01; 99(5):673-80. PMID: 17317370.
      Citations: 37     Fields:    Translation:Humans
    665. Nettleton JA, Steffen LM, Ballantyne CM, Boerwinkle E, Folsom AR. Associations between HDL-cholesterol and polymorphisms in hepatic lipase and lipoprotein lipase genes are modified by dietary fat intake in African American and White adults. Atherosclerosis. 2007 Oct; 194(2):e131-40. PMID: 17157861; PMCID: PMC2248232.
      Citations: 31     Fields:    Translation:Humans
    666. Hoogeveen RC, Ballantyne CM, Bang H, Heiss G, Duncan BB, Folsom AR, Pankow JS. Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Diabetologia. 2007 Jan; 50(1):36-42. PMID: 17136392.
      Citations: 20     Fields:    Translation:Humans
    667. Yang CY, Chen HH, Huang MT, Raya JL, Yang JH, Chen CH, Gaubatz JW, Pownall HJ, Taylor AA, Ballantyne CM, Jenniskens FA, Smith CV. Pro-apoptotic low-density lipoprotein subfractions in type II diabetes. Atherosclerosis. 2007 Aug; 193(2):283-91. PMID: 17030034.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    668. Abe Y, Fornage M, Yang CY, Bui-Thanh NA, Wise V, Chen HH, Rangaraj G, Ballantyne CM. L5, the most electronegative subfraction of plasma LDL, induces endothelial vascular cell adhesion molecule 1 and CXC chemokines, which mediate mononuclear leukocyte adhesion. Atherosclerosis. 2007 May; 192(1):56-66. PMID: 17022986.
      Citations: 12     Fields:    Translation:HumansCells
    669. Catapano AL, Davidson MH, Ballantyne CM, Brady WE, Gazzara RA, Tomassini JE, Tershakovec AM. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients. Curr Med Res Opin. 2006 Oct; 22(10):2041-53. PMID: 17022864.
      Citations: 19     Fields:    Translation:Humans
    670. Samson SL, Pownall HJ, Scott LW, Ballantyne CM, Smith EO, Sekhar RV, Balasubramanyam A. Heart positive: design of a randomized controlled clinical trial of intensive lifestyle intervention, niacin and fenofibrate for HIV lipodystrophy/dyslipidemia. Contemp Clin Trials. 2006 Dec; 27(6):518-30. PMID: 16914390.
      Citations: 6     Fields:    Translation:Humans
    671. Folsom AR, Chambless LE, Ballantyne CM, Coresh J, Heiss G, Wu KK, Boerwinkle E, Mosley TH, Sorlie P, Diao G, Sharrett AR. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med. 2006 Jul 10; 166(13):1368-73. PMID: 16832001.
      Citations: 103     Fields:    Translation:Humans
    672. Volcik KA, Barkley RA, Hutchinson RG, Mosley TH, Heiss G, Sharrett AR, Ballantyne CM, Boerwinkle E. Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants. Am J Epidemiol. 2006 Aug 15; 164(4):342-8. PMID: 16760224.
      Citations: 52     Fields:    Translation:Humans
    673. Thakker GD, Frangogiannis NG, Bujak M, Zymek P, Gaubatz JW, Reddy AK, Taffet G, Michael LH, Entman ML, Ballantyne CM. Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction. Am J Physiol Heart Circ Physiol. 2006 Nov; 291(5):H2504-14. PMID: 16731644.
      Citations: 49     Fields:    Translation:Animals
    674. Ballantyne CM, Bertolami M, Hernandez Garcia HR, Nul D, Stein EA, Theroux P, Weiss R, Cain VA, Raichlen JS. Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II. Am Heart J. 2006 May; 151(5):975.e1-9. PMID: 16644314.
      Citations: 21     Fields:    Translation:Humans
    675. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM, ASTEROID Investigators. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA. 2006 Apr 05; 295(13):1556-65. PMID: 16533939.
      Citations: 452     Fields:    Translation:HumansCTClinical Trials
    676. Jelesoff NE, Ballantyne CM, Xydakis AM, Chiou P, Jones PH, Guyton JR. Effectiveness and tolerability of adding ezetimibe to niacin-based regimens for treatment of primary hyperlipidemia. Endocr Pract. 2006 Mar-Apr; 12(2):159-64. PMID: 16690463.
      Citations: 1     Fields:    Translation:Humans
    677. Barter PJ, Ballantyne CM, Carmena R, Castro Cabezas M, Chapman MJ, Couture P, de Graaf J, Durrington PN, Faergeman O, Frohlich J, Furberg CD, Gagne C, Haffner SM, Humphries SE, Jungner I, Krauss RM, Kwiterovich P, Marcovina S, Packard CJ, Pearson TA, Reddy KS, Rosenson R, Sarrafzadegan N, Sniderman AD, Stalenhoef AF, Stein E, Talmud PJ, Tonkin AM, Walldius G, Williams KM. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med. 2006 Mar; 259(3):247-58. PMID: 16476102.
      Citations: 115     Fields:    Translation:Humans
    678. Ballantyne CM, Hoogeveen RC, Bang H, Coresh J, Folsom AR, Chambless LE, Myerson M, Wu KK, Sharrett AR, Boerwinkle E. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med. 2005 Nov 28; 165(21):2479-84. PMID: 16314544.
      Citations: 91     Fields:    Translation:Humans
    679. Abe Y, Bui-Thanh NA, Ballantyne CM, Burns AR. Extra domain A and type III connecting segment of fibronectin in assembly and cleavage. Biochem Biophys Res Commun. 2005 Dec 23; 338(3):1640-7. PMID: 16277979.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    680. Vasudevan AR, Wu H, Xydakis AM, Jones PH, Smith EO, Sweeney JF, Corry DB, Ballantyne CM. Eotaxin and obesity. J Clin Endocrinol Metab. 2006 Jan; 91(1):256-61. PMID: 16263831.
      Citations: 50     Fields:    Translation:HumansAnimalsCells
    681. Fordis M, King JE, Ballantyne CM, Jones PH, Schneider KH, Spann SJ, Greenberg SB, Greisinger AJ. Comparison of the instructional efficacy of Internet-based CME with live interactive CME workshops: a randomized controlled trial. JAMA. 2005 Sep 07; 294(9):1043-51. PMID: 16145024.
      Citations: 125     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    682. Stalenhoef AF, Ballantyne CM, Sarti C, Murin J, Tonstad S, Rose H, Wilpshaar W. A comparative study with rosuvastatin in subjects with metabolic syndrome: results of the COMETS study. Eur Heart J. 2005 Dec; 26(24):2664-72. PMID: 16143705.
      Citations: 22     Fields:    Translation:Humans
    683. Volcik KA, Ballantyne CM, Coresh J, Folsom AR, Wu KK, Boerwinkle E. P-selectin Thr715Pro polymorphism predicts P-selectin levels but not risk of incident coronary heart disease or ischemic stroke in a cohort of 14595 participants: the Atherosclerosis Risk in Communities Study. Atherosclerosis. 2006 May; 186(1):74-9. PMID: 16125711.
      Citations: 21     Fields:    Translation:Humans
    684. Davidson MH, Maki KC, Pearson TA, Pasternak RC, Deedwania PC, McKenney JM, Fonarow GC, Maron DJ, Ansell BJ, Clark LT, Ballantyne CM. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. Am J Cardiol. 2005 Aug 15; 96(4):556-63. PMID: 16098311.
      Citations: 67     Fields:    Translation:Humans
    685. Liu MY, Xydakis AM, Hoogeveen RC, Jones PH, Smith EO, Nelson KW, Ballantyne CM. Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system. Clin Chem. 2005 Jul; 51(7):1102-9. PMID: 15976097.
      Citations: 44     Fields:    Translation:Humans
    686. Ballantyne C, Arroll B, Shepherd J. Lipids and CVD management: towards a global consensus. Eur Heart J. 2005 Nov; 26(21):2224-31. PMID: 15972289.
      Citations: 16     Fields:    Translation:HumansPHPublic Health
    687. Chen SN, Ballantyne CM, Gotto AM, Tan Y, Willerson JT, Marian AJ. A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis. J Am Coll Cardiol. 2005 May 17; 45(10):1611-9. PMID: 15893176; PMCID: PMC2910256.
      Citations: 55     Fields:    Translation:HumansCTClinical Trials
    688. Hoogeveen RC, Morrison A, Boerwinkle E, Miles JS, Rhodes CE, Sharrett AR, Ballantyne CM. Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study. Atherosclerosis. 2005 Dec; 183(2):301-7. PMID: 16285993.
      Citations: 45     Fields:    Translation:HumansPHPublic Health
    689. Ballantyne CM, Abate N, Yuan Z, King TR, Palmisano J. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) study. Am Heart J. 2005 Mar; 149(3):464-73. PMID: 15864235.
      Citations: 51     Fields:    Translation:HumansCTClinical Trials
    690. Wu AH, Ballantyne CM, Short BC, Torre-Amione G, Young JB, Ventura HO, Eisen HJ, Radovancevic B, Rayburn BK, Lake KD, Yancy CW, Taylor DO, Mehra MR, Kubo SH, Fishbein DP, Zhao XQ, O'Brien KD. Statin use and risks of death or fatal rejection in the Heart Transplant Lipid Registry. Am J Cardiol. 2005 Feb 01; 95(3):367-72. PMID: 15670546.
      Citations: 8     Fields:    Translation:Humans
    691. Hoogeveen RC, Ballantyne CM. PLAC test for identification of individuals at increased risk for coronary heart disease. Expert Rev Mol Diagn. 2005 Jan; 5(1):9-14. PMID: 15723587.
      Citations: 7     Fields:    Translation:Humans
    692. McNeill AM, Rosamond WD, Girman CJ, Heiss G, Golden SH, Duncan BB, East HE, Ballantyne C. Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study). Am J Cardiol. 2004 Nov 15; 94(10):1249-54. PMID: 15541239.
      Citations: 40     Fields:    Translation:Humans
    693. Adams GJ, Greene J, Vick GW, Harrist R, Kimball KT, Karmonik C, Ballantyne CM, Insull W, Morrisett JD. Tracking regression and progression of atherosclerosis in human carotid arteries using high-resolution magnetic resonance imaging. Magn Reson Imaging. 2004 Nov; 22(9):1249-58. PMID: 15607096.
      Citations: 17     Fields:    Translation:HumansCTClinical Trials
    694. Ballantyne CM, Miller E, Chitra R. Efficacy and safety of rosuvastatin alone and in combination with cholestyramine in patients with severe hypercholesterolemia: a randomized, open-label, multicenter trial. Clin Ther. 2004 Nov; 26(11):1855-64. PMID: 15639697.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    695. Xydakis AM, Guyton JR, Chiou P, Stein JL, Jones PH, Ballantyne CM. Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia. Am J Cardiol. 2004 Sep 15; 94(6):795-7. PMID: 15374793.
      Citations: 5     Fields:    Translation:Humans
    696. Jacobson TA, Case CC, Roberts S, Buckley A, Murtaugh KM, Sung JC, Gause D, Varas C, Ballantyne CM. Characteristics of US adults with the metabolic syndrome and therapeutic implications. Diabetes Obes Metab. 2004 Sep; 6(5):353-62. PMID: 15287928.
      Citations: 8     Fields:    Translation:Humans
    697. Davidson MH, Ballantyne CM, Kerzner B, Melani L, Sager PT, Lipka L, Strony J, Suresh R, Veltri E, Ezetimibe Study Group. Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia. Int J Clin Pract. 2004 Aug; 58(8):746-55. PMID: 15372846.
      Citations: 20     Fields:    Translation:HumansCTClinical Trials
    698. Wu H, Rodgers JR, Perrard XY, Perrard JL, Prince JE, Abe Y, Davis BK, Dietsch G, Smith CW, Ballantyne CM. Deficiency of CD11b or CD11d results in reduced staphylococcal enterotoxin-induced T cell response and T cell phenotypic changes. J Immunol. 2004 Jul 01; 173(1):297-306. PMID: 15210787.
      Citations: 41     Fields:    Translation:AnimalsCells
    699. Ballantyne CM, Lipka LJ, Sager PT, Strony J, Alizadeh J, Suresh R, Veltri EP. Long-term safety and tolerability profile of ezetimibe and atorvastatin coadministration therapy in patients with primary hypercholesterolaemia. Int J Clin Pract. 2004 Jul; 58(7):653-8. PMID: 15311720.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    700. Ballantyne CM, Blazing MA, King TR, Brady WE, Palmisano J. Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia. Am J Cardiol. 2004 Jun 15; 93(12):1487-94. PMID: 15194018.
      Citations: 47     Fields:    Translation:HumansCTClinical Trials
    701. Xydakis AM, Case CC, Jones PH, Hoogeveen RC, Liu MY, Smith EO, Nelson KW, Ballantyne CM. Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J Clin Endocrinol Metab. 2004 Jun; 89(6):2697-703. PMID: 15181044.
      Citations: 68     Fields:    Translation:Humans
    702. Hallman DM, Brown SA, Ballantyne CM, Sharrett AR, Boerwinkle E. Relationship between low-density lipoprotein subclasses and asymptomatic atherosclerosis in subjects from the Atherosclerosis Risk in Communities (ARIC) Study. Biomarkers. 2004 Mar-Apr; 9(2):190-202. PMID: 15370875.
      Citations: 4     Fields:    Translation:Humans
    703. Ballantyne CM, Moore N, Saia F, Serruys PW, Riegger G. Fluvastatin reduces cardiac mortality in patients with coronary heart disease. Cardiovasc Drugs Ther. 2004 Jan; 18(1):67-75. PMID: 15115905.
      Citations: 1     Fields:    Translation:Humans
    704. Chen S, Tsybouleva N, Ballantyne CM, Gotto AM, Marian AJ. Effects of PPARalpha, gamma and delta haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary atherosclerosis study. Pharmacogenetics. 2004 Jan; 14(1):61-71. PMID: 15128052.
      Citations: 13     Fields:    
    705. Miller EA, Pankow JS, Millikan RC, Bray MS, Ballantyne CM, Bell DA, Heiss G, Li R. Glutathione-S-transferase genotypes, smoking, and their association with markers of inflammation, hemostasis, and endothelial function: the atherosclerosis risk in communities (ARIC) study. Atherosclerosis. 2003 Dec; 171(2):265-72. PMID: 14644396.
      Citations: 26     Fields:    Translation:Humans
    706. Ballantyne CM, Blazing MA, Hunninghake DB, Davidson MH, Yuan Z, DeLucca P, Ramsey KE, Hustad CM, Palmisano J. Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: results of the Comparative HDL Efficacy and Safety Study (CHESS). Am Heart J. 2003 Nov; 146(5):862-9. PMID: 14597936.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    707. Ballantyne CM, Davidson MH. Possible differences between fibrates in pharmacokinetic interactions with statins. Arch Intern Med. 2003 Oct 27; 163(19):2394-5. PMID: 14581261.
      Citations: 4     Fields:    Translation:Humans
    708. Wu H, Prince JE, Brayton CF, Shah C, Zeve D, Gregory SH, Smith CW, Ballantyne CM. Host resistance of CD18 knockout mice against systemic infection with Listeria monocytogenes. Infect Immun. 2003 Oct; 71(10):5986-93. PMID: 14500519; PMCID: PMC201099.
      Citations: 6     Fields:    Translation:AnimalsCells
    709. Folsom AR, Nieto FJ, Boland LL, Ballantyne CM, Chambless LE, Desvarieux M. B vitamin status and inflammatory markers. Atherosclerosis. 2003 Jul; 169(1):169-74. PMID: 12860264.
      Citations: 19     Fields:    Translation:Humans
    710. Hunninghake DB, Ballantyne CM, Maccubbin DL, Shah AK, Gumbiner B, Mitchel YB. Comparative effects of simvastatin and atorvastatin in hypercholesterolemic patients with characteristics of metabolic syndrome. Clin Ther. 2003 Jun; 25(6):1670-86. PMID: 12860491.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    711. Case CC, Jacobson TA, Roberts S, Buckley A, Murtaugh KM, Sung JC, Gause D, Varas C, Ballantyne CM. Management of persons with high risk of coronary heart disease but low serum low-density lipoprotein cholesterol. Am J Cardiol. 2003 May 01; 91(9):1134-6. PMID: 12714165.
      Citations: 2     Fields:    Translation:Humans
    712. Ballantyne CM, Houri J, Notarbartolo A, Melani L, Lipka LJ, Suresh R, Sun S, LeBeaut AP, Sager PT, Veltri EP, Ezetimibe Study Group. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial. Circulation. 2003 May 20; 107(19):2409-15. PMID: 12719279.
      Citations: 113     Fields:    Translation:HumansCTClinical Trials
    713. Chen CH, Jiang T, Yang JH, Jiang W, Lu J, Marathe GK, Pownall HJ, Ballantyne CM, McIntyre TM, Henry PD, Yang CY. Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription. Circulation. 2003 Apr 29; 107(16):2102-8. PMID: 12695302.
      Citations: 50     Fields:    Translation:HumansAnimalsCells
    714. Wu KK, Aleksic N, Ballantyne CM, Ahn C, Juneja H, Boerwinkle E. Interaction between soluble thrombomodulin and intercellular adhesion molecule-1 in predicting risk of coronary heart disease. Circulation. 2003 Apr 08; 107(13):1729-32. PMID: 12668515.
      Citations: 18     Fields:    Translation:Humans
    715. Ballantyne CM, Corsini A, Davidson MH, Holdaas H, Jacobson TA, Leitersdorf E, Reckless JP, Stein EA, M?rz W. Risk for myopathy with statin therapy in high-risk patients. Arch Intern Med. 2003 Mar 10; 163(5):553-64. PMID: 12622602.
      Citations: 92     Fields:    Translation:Humans
    716. Ballantyne CM, Stein EA, Paoletti R, Southworth H, Blasetto JW. Efficacy of rosuvastatin 10 mg in patients with the metabolic syndrome. Am J Cardiol. 2003 Mar 06; 91(5A):25C-27C; discussion 28C. PMID: 12646342.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    717. Ma K, Cilingiroglu M, Otvos JD, Ballantyne CM, Marian AJ, Chan L. Endothelial lipase is a major genetic determinant for high-density lipoprotein concentration, structure, and metabolism. Proc Natl Acad Sci U S A. 2003 Mar 04; 100(5):2748-53. PMID: 12601178; PMCID: PMC151412.
      Citations: 77     Fields:    Translation:HumansAnimalsCells
    718. Shahar E, Chambless LE, Rosamond WD, Boland LL, Ballantyne CM, McGovern PG, Sharrett AR, Atherosclerosis Risk in Communities Study. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2003 Mar; 34(3):623-31. PMID: 12624282.
      Citations: 95     Fields:    Translation:Humans
    719. Schneck DW, Knopp RH, Ballantyne CM, McPherson R, Chitra RR, Simonson SG. Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease. Am J Cardiol. 2003 Jan 01; 91(1):33-41. PMID: 12505568.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    720. Fernandes LS, Conde ID, Wayne Smith C, Kansas GS, Snapp KR, Bennet N, Ballantyne C, McIntire LV, O'Brian Smith E, Klem JA, Mathew S, Frangogiannis N, Turner NA, Maresh KJ, Kleiman NS. Platelet-monocyte complex formation: effect of blocking PSGL-1 alone, and in combination with alphaIIbbeta3 and alphaMbeta2, in coronary stenting. Thromb Res. 2003; 111(3):171-7. PMID: 14678816.
      Citations: 13     Fields:    Translation:HumansCells
    721. Xydakis AM, Ballantyne CM. Combination therapy for combined dyslipidemia. Am J Cardiol. 2002 Nov 20; 90(10B):21K-29K. PMID: 12467937.
      Citations: 14     Fields:    Translation:Humans
    722. Koenig JM, Ballantyne CM, Kumar AG, Smith CW, Yoder MC. Vascular cell adhesion molecule-1 expression and hematopoietic supportive capacity of immortalized murine stromal cell lines derived from fetal liver and adult bone marrow. In Vitro Cell Dev Biol Anim. 2002 Oct; 38(9):538-43. PMID: 12703982.
      Citations: 2     Fields:    Translation:AnimalsCells
    723. Morrisett JD, Abdel-Fattah G, Hoogeveen R, Mitchell E, Ballantyne CM, Pownall HJ, Opekun AR, Jaffe JS, Oppermann S, Kahan BD. Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients. J Lipid Res. 2002 Aug; 43(8):1170-80. PMID: 12177161.
      Citations: 93     Fields:    Translation:Humans
    724. Bowden RA, Ding ZM, Donnachie EM, Petersen TK, Michael LH, Ballantyne CM, Burns AR. Role of alpha4 integrin and VCAM-1 in CD18-independent neutrophil migration across mouse cardiac endothelium. Circ Res. 2002 Mar 22; 90(5):562-9. PMID: 11909820.
      Citations: 42     Fields:    Translation:AnimalsCells
    725. Morrison AC, Ballantyne CM, Bray M, Chambless LE, Sharrett AR, Boerwinkle E. LPL polymorphism predicts stroke risk in men. Genet Epidemiol. 2002 Mar; 22(3):233-42. PMID: 11921083.
      Citations: 11     Fields:    Translation:Humans
    726. Case CC, Ballantyne CM. Statins and inflammatory markers. Curr Atheroscler Rep. 2002 Jan; 4(1):42-7. PMID: 11772421.
      Citations: 3     Fields:    Translation:Humans
    727. Ballantyne CM, Olsson AG, Cook TJ, Mercuri MF, Pedersen TR, Kjekshus J. Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S. Circulation. 2001 Dec 18; 104(25):3046-51. PMID: 11748098.
      Citations: 83     Fields:    Translation:HumansCTClinical Trials
    728. Hoogeveen RC, Ballantyne CM, Pownall HJ, Opekun AR, Hachey DL, Jaffe JS, Oppermann S, Kahan BD, Morrisett JD. Effect of sirolimus on the metabolism of apoB100- containing lipoproteins in renal transplant patients. Transplantation. 2001 Oct 15; 72(7):1244-50. PMID: 11602850.
      Citations: 23     Fields:    Translation:Humans
    729. Lutucuta S, Ballantyne CM, Elghannam H, Gotto AM, Marian AJ. Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ Res. 2001 May 11; 88(9):969-73. PMID: 11349008.
      Citations: 30     Fields:    Translation:HumansCells
    730. Turban S, Fuentes F, Ferlic L, Brugada R, Gotto AM, Ballantyne CM, Marian AJ. A prospective study of paraoxonase gene Q/R192 polymorphism and severity, progression and regression of coronary atherosclerosis, plasma lipid levels, clinical events and response to fluvastatin. Atherosclerosis. 2001 Feb 15; 154(3):633-40. PMID: 11257264.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    731. Ballantyne CM, Pazzucconi F, Reckless JP, Stein E, McKenney J, Bortolini M, Chiang YT, Pint? X. Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis. Clin Ther. 2001 Feb; 23(2):177-92. PMID: 11293552.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    732. Briaud SA, Ding ZM, Michael LH, Entman ML, Daniel S, Ballantyne CM. Leukocyte trafficking and myocardial reperfusion injury in ICAM-1/P-selectin-knockout mice. Am J Physiol Heart Circ Physiol. 2001 Jan; 280(1):H60-7. PMID: 11123218.
      Citations: 24     Fields:    Translation:Animals
    733. Ballantyne CM, Herd JA, Stein EA, Ferlic LL, Dunn JK, Gotto AM, Marian AJ. Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy. J Am Coll Cardiol. 2000 Nov 01; 36(5):1572-8. PMID: 11079660.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    734. Choi YJ, Baranowska-Daca E, Nguyen V, Koji T, Ballantyne CM, Sheikh-Hamad D, Suki WN, Truong LD. Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules. Kidney Int. 2000 Oct; 58(4):1481-91. PMID: 11012883.
      Citations: 17     Fields:    Translation:Animals
    735. Ballantyne CM, McKenney J, Trippe BS. Efficacy and safety of an extended-release formulation of fluvastatin for once-daily treatment of primary hypercholesterolemia. Am J Cardiol. 2000 Oct 01; 86(7):759-63. PMID: 11018196.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    736. Frangogiannis NG, Mendoza LH, Lindsey ML, Ballantyne CM, Michael LH, Smith CW, Entman ML. IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. J Immunol. 2000 Sep 01; 165(5):2798-808. PMID: 10946312.
      Citations: 100     Fields:    Translation:AnimalsCells
    737. Ballantyne CM. Development and assessment of antiatherosclerotic therapies beyond low-density lipoprotein cholesterol and blood pressure. Curr Atheroscler Rep. 2000 Jul; 2(4):281-3. PMID: 11122754.
      Citations:    Fields:    Translation:HumansCells
    738. Jacobson TA, Griffiths GG, Varas C, Gause D, Sung JC, Ballantyne CM. Impact of evidence-based "clinical judgment" on the number of American adults requiring lipid-lowering therapy based on updated NHANES III data. National Health and Nutrition Examination Survey. Arch Intern Med. 2000 May 08; 160(9):1361-9. PMID: 10809042.
      Citations: 12     Fields:    Translation:Humans
    739. Nossuli TO, Lakshminarayanan V, Baumgarten G, Taffet GE, Ballantyne CM, Michael LH, Entman ML. A chronic mouse model of myocardial ischemia-reperfusion: essential in cytokine studies. Am J Physiol Heart Circ Physiol. 2000 Apr; 278(4):H1049-55. PMID: 10749697.
      Citations: 67     Fields:    Translation:Animals
    740. Cahilly C, Ballantyne CM, Lim DS, Gotto A, Marian AJ. A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ Res. 2000 Mar 03; 86(4):391-5. PMID: 10700443.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    741. Lu H, Youker K, Ballantyne C, Entman M, Smith CW. Hydrogen peroxide induces LFA-1-dependent neutrophil adherence to cardiac myocytes. Am J Physiol Heart Circ Physiol. 2000 Mar; 278(3):H835-42. PMID: 10710352.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    742. Marian AJ, Safavi F, Ferlic L, Dunn JK, Gotto AM, Ballantyne CM. Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin: the lipoprotein and coronary atherosclerosis study. J Am Coll Cardiol. 2000 Jan; 35(1):89-95. PMID: 10636265.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    743. Ding ZM, Babensee JE, Simon SI, Lu H, Perrard JL, Bullard DC, Dai XY, Bromley SK, Dustin ML, Entman ML, Smith CW, Ballantyne CM. Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration. J Immunol. 1999 Nov 01; 163(9):5029-38. PMID: 10528208.
      Citations: 197     Fields:    Translation:AnimalsCells
    744. Abe Y, Smith CW, Katkin JP, Thurmon LM, Xu X, Mendoza LH, Ballantyne CM. Endothelial alpha 2,6-linked sialic acid inhibits VCAM-1-dependent adhesion under flow conditions. J Immunol. 1999 Sep 01; 163(5):2867-76. PMID: 10453033.
      Citations: 17     Fields:    Translation:HumansCells
    745. Michael LH, Ballantyne CM, Zachariah JP, Gould KE, Pocius JS, Taffet GE, Hartley CJ, Pham TT, Daniel SL, Funk E, Entman ML. Myocardial infarction and remodeling in mice: effect of reperfusion. Am J Physiol. 1999 08; 277(2 Pt 2):H660-8. PMID: 10444492.
      Citations: 54     Fields:    Translation:Animals
    746. Ballantyne CM. Reducing atherothrombotic events in high-risk patients: recent data on therapy with statins and fatty acids. Curr Atheroscler Rep. 1999 Jul; 1(1):6-8. PMID: 11122685.
      Citations: 1     Fields:    Translation:Humans
    747. Sing K, Ballantyne CM, Ferlic L, Brugada R, Cushman I, Dunn JK, Herd JA, Pownall HJ, Gotto AM, Marian AJ. Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Lipoproteins and Coronary Atherosclerosis Study. Atherosclerosis. 1999 Jun; 144(2):435-42. PMID: 10407505.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    748. Pownall HJ, Ballantyne CM, Kimball KT, Simpson SL, Yeshurun D, Gotto AM. Effect of moderate alcohol consumption on hypertriglyceridemia: a study in the fasting state. Arch Intern Med. 1999 May 10; 159(9):981-7. PMID: 10326940.
      Citations: 15     Fields:    Translation:Humans
    749. Pownall HJ, Brauchi D, Osmundsen K, Pao Q, Payton-Ross C, Gotto AM, Ballantyne CM, Kilin? C. Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins. Atherosclerosis. 1999 Apr; 143(2):285-97. PMID: 10217357.
      Citations: 49     Fields:    Translation:HumansCTClinical Trials
    750. Frangogiannis NG, Youker KA, Rossen RD, Gwechenberger M, Lindsey MH, Mendoza LH, Michael LH, Ballantyne CM, Smith CW, Entman ML. Cytokines and the microcirculation in ischemia and reperfusion. J Mol Cell Cardiol. 1998 Dec; 30(12):2567-76. PMID: 9990529.
      Citations: 41     Fields:    Translation:AnimalsCells
    751. Ballantyne CM. Low-density lipoproteins and risk for coronary artery disease. Am J Cardiol. 1998 Nov 05; 82(9A):3Q-12Q. PMID: 9819098.
      Citations: 25     Fields:    Translation:Humans
    752. Jacobson TA, Schein JR, Williamson A, Ballantyne CM. Maximizing the cost-effectiveness of lipid-lowering therapy. Arch Intern Med. 1998 Oct 12; 158(18):1977-89. PMID: 9778197.
      Citations: 12     Fields:    Translation:Humans
    753. Abe Y, El-Masri B, Kimball KT, Pownall H, Reilly CF, Osmundsen K, Smith CW, Ballantyne CM. Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion. Arterioscler Thromb Vasc Biol. 1998 May; 18(5):723-31. PMID: 9598830.
      Citations: 34     Fields:    Translation:HumansCells
    754. Youker KA, Birdsall HH, Frangogiannis NG, Kumar AG, Lindsey ML, Ballantyne CM, Smith CW, Rossen RD, Entman ML. Phagocytes in ischemia injury. Ann N Y Acad Sci. 1997 Dec 15; 832:243-65. PMID: 9704052.
      Citations: 2     Fields:    Translation:AnimalsCells
    755. Ballantyne CM, Herd JA, Dunn JK, Jones PH, Farmer JA, Gotto AM. Effects of lipid lowering therapy on progression of coronary and carotid artery disease. Curr Opin Lipidol. 1997 Dec; 8(6):354-61. PMID: 9412776.
      Citations: 6     Fields:    Translation:Humans
    756. Herd JA, Ballantyne CM, Farmer JA, Ferguson JJ, Jones PH, West MS, Gould KL, Gotto AM. Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS]). Am J Cardiol. 1997 Aug 01; 80(3):278-86. PMID: 9264419.
      Citations: 41     Fields:    Translation:HumansCTClinical Trials
    757. Lu H, Smith CW, Perrard J, Bullard D, Tang L, Shappell SB, Entman ML, Beaudet AL, Ballantyne CM. LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice. J Clin Invest. 1997 Mar 15; 99(6):1340-50. PMID: 9077544; PMCID: PMC507950.
      Citations: 94     Fields:    Translation:AnimalsCells
    758. Ballantyne CM, el Masri B, Morrisett JD, Torre-Amione G. Pathophysiology and treatment of lipid perturbation after cardiac transplantation. Curr Opin Cardiol. 1997 Mar; 12(2):153-60. PMID: 9192484.
      Citations: 1     Fields:    Translation:HumansAnimals
    759. Kumar AG, Ballantyne CM, Michael LH, Kukielka GL, Youker KA, Lindsey ML, Hawkins HK, Birdsall HH, MacKay CR, LaRosa GJ, Rossen RD, Smith CW, Entman ML. Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation. 1997 Feb 04; 95(3):693-700. PMID: 9024159.
      Citations: 54     Fields:    Translation:HumansAnimalsCells
    760. Abe Y, Ballantyne CM, Smith CW. Functions of domain 1 and 4 of vascular cell adhesion molecule-1 in alpha4 integrin-dependent adhesion under static and flow conditions are differentially regulated. J Immunol. 1996 Dec 01; 157(11):5061-9. PMID: 8943415.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    761. West MS, Herd JA, Ballantyne CM, Pownall HJ, Simpson S, Gould L, Gotto AM. The Lipoprotein and Coronary Atherosclerosis Study (LCAS): design, methods, and baseline data of a trial of fluvastatin in patients without severe hypercholesterolemia. Control Clin Trials. 1996 Dec; 17(6):550-83. PMID: 8974213.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    762. Ballantyne CM, Bourge RC, Domalik LJ, Eisen HJ, Fishbein DP, Kubo SH, Lake KD, Radovancevic B, Taylor DO, Ventura HO, Yancy CW, Young JB. Treatment of hyperlipidemia after heart transplantation and rationale for the Heart Transplant Lipid Registry. Am J Cardiol. 1996 Sep 01; 78(5):532-5. PMID: 8806337.
      Citations: 2     Fields:    Translation:Humans
    763. Hackman A, Abe Y, Insull W, Pownall H, Smith L, Dunn K, Gotto AM, Ballantyne CM. Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation. 1996 Apr 01; 93(7):1334-8. PMID: 8641021.
      Citations: 43     Fields:    Translation:Humans
    764. Ballantyne CM, Masri BM, Clubb FJ, Radovancevic B, Smith CW, Hawkins HK, Frazier OH, Willerson JT. Increased expression of ICAM-1 in a case of accelerated coronary artery disease after heart transplantation. Tex Heart Inst J. 1996; 23(4):293-5. PMID: 8969030; PMCID: PMC325374.
      Citations:    Fields:    Translation:Humans
    765. Michael LH, Entman ML, Hartley CJ, Youker KA, Zhu J, Hall SR, Hawkins HK, Berens K, Ballantyne CM. Myocardial ischemia and reperfusion: a murine model. Am J Physiol. 1995 Dec; 269(6 Pt 2):H2147-54. PMID: 8594926.
      Citations: 154     Fields:    Translation:Animals
    766. Schowengerdt KO, Zhu JY, Stepkowski SM, Tu Y, Entman ML, Ballantyne CM. Cardiac allograft survival in mice deficient in intercellular adhesion molecule-1. Circulation. 1995 Jul 01; 92(1):82-7. PMID: 7788921.
      Citations: 1     Fields:    Translation:Animals
    767. Kukielka GL, Youker KA, Michael LH, Kumar AG, Ballantyne CM, Smith CW, Entman ML. Role of early reperfusion in the induction of adhesion molecules and cytokines in previously ischemic myocardium. Mol Cell Biochem. 1995 Jun 7-21; 147(1-2):5-12. PMID: 7494554.
      Citations: 12     Fields:    Translation:AnimalsCells
    768. Kumar AG, Dai XY, Kozak CA, Mims MP, Gotto AM, Ballantyne CM. Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. J Immunol. 1994 Nov 01; 153(9):4088-98. PMID: 7523515.
      Citations: 10     Fields:    Translation:AnimalsCells
    769. Schowengerdt KO, Ballantyne CM. Key references on transplant coronary artery disease. Circulation. 1994 Jul; 90(1):632-5. PMID: 8026051.
      Citations:    Fields:    Translation:Humans
    770. Kukielka GL, Youker KA, Hawkins HK, Perrard JL, Michael LH, Ballantyne CM, Smith CW, Entman ML. Regulation of ICAM-1 and IL-6 in myocardial ischemia: effect of reperfusion. Ann N Y Acad Sci. 1994 Jun 17; 723:258-70. PMID: 7913298.
      Citations: 10     Fields:    Translation:AnimalsCells
    771. Youker KA, Hawkins HK, Kukielka GL, Perrard JL, Michael LH, Ballantyne CM, Smith CW, Entman ML. Molecular evidence for induction of intracellular adhesion molecule-1 in the viable border zone associated with ischemia-reperfusion injury of the dog heart. Circulation. 1994 Jun; 89(6):2736-46. PMID: 7911404.
      Citations: 15     Fields:    Translation:Animals
    772. Welty SE, Rivera JL, Elliston JF, Smith CV, Zeb T, Ballantyne CM, Montgomery CA, Hansen TN. Increases in lung tissue expression of intercellular adhesion molecule-1 are associated with hyperoxic lung injury and inflammation in mice. Am J Respir Cell Mol Biol. 1993 Oct; 9(4):393-400. PMID: 8104435.
      Citations: 12     Fields:    Translation:Animals
    773. Sligh JE, Ballantyne CM, Rich SS, Hawkins HK, Smith CW, Bradley A, Beaudet AL. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc Natl Acad Sci U S A. 1993 Sep 15; 90(18):8529-33. PMID: 8104338; PMCID: PMC47390.
      Citations: 122     Fields:    Translation:AnimalsCells
    774. Wilson RW, Ballantyne CM, Smith CW, Montgomery C, Bradley A, O'Brien WE, Beaudet AL. Gene targeting yields a CD18-mutant mouse for study of inflammation. J Immunol. 1993 Aug 01; 151(3):1571-8. PMID: 8101543.
      Citations: 76     Fields:    Translation:AnimalsCells
    775. Cocanougher B, Ballantyne CM, Pollack MS, Payton-Ross C, Lowry R, Kleiman NS, Farmer JA, Noon GP, Short HD, Young JB. Degree of HLA mismatch as a predictor of death from allograft arteriopathy after heart transplant. Transplant Proc. 1993 Feb; 25(1 Pt 1):233-6. PMID: 8438282.
      Citations: 3     Fields:    Translation:Humans
    776. Youker KA, Hawkins HK, Kukielka GL, Perrard JL, Michael LH, Ballantyne CM, Smith CW, Entman ML. Molecular evidence for a border zone vulnerable to inflammatory reperfusion injury. Trans Assoc Am Physicians. 1993; 106:145-54. PMID: 7913564.
      Citations: 1     Fields:    Translation:AnimalsCells
    777. Ballantyne CM, Sligh JE, Dai XY, Beaudet AL. Characterization of the murine Icam-1 gene. Genomics. 1992 Dec; 14(4):1076-80. PMID: 1362180.
      Citations: 7     Fields:    Translation:AnimalsCells
    778. Sanders WE, Wilson RW, Ballantyne CM, Beaudet AL. Molecular cloning and analysis of in vivo expression of murine P-selectin. Blood. 1992 Aug 01; 80(3):795-800. PMID: 1379089.
      Citations: 38     Fields:    Translation:HumansAnimalsCells
    779. Ballantyne CM, Radovancevic B, Farmer JA, Frazier OH, Chandler L, Payton-Ross C, Cocanougher B, Jones PH, Young JB, Gotto AM. Hyperlipidemia after heart transplantation: report of a 6-year experience, with treatment recommendations. J Am Coll Cardiol. 1992 May; 19(6):1315-21. PMID: 1564233.
      Citations: 14     Fields:    Translation:Humans
    780. Farmer JA, Ballantyne CM, Frazier OH, Radovancevic B, Payton-Ross C, Patsch W, Morrisett JD, Gotto AM, Young JB. Lipoprotein(a) and apolipoprotein changes after cardiac transplantation. J Am Coll Cardiol. 1991 Oct; 18(4):926-30. PMID: 1832699.
      Citations: 3     Fields:    Translation:Humans
    781. Ballantyne CM, Kozak CA, O'Brien WE, Beaudet AL. Assignment of the gene for intercellular adhesion molecule-1 (Icam-1) to proximal mouse chromosome 9. Genomics. 1991 Mar; 9(3):547-50. PMID: 1674500.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    782. Smart FW, Ballantyne CM, Cocanougher B, Farmer JA, Sekela ME, Noon GP, Young JB. Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplant. Am J Cardiol. 1991 Feb 01; 67(4):243-7. PMID: 1990786.
      Citations: 22     Fields:    Translation:Humans
    783. Smart FW, Grinstead WC, Cocanougher B, Ballantyne CM, Farmer JA, Kleiman N, Young JB. Detection of transplant arteriopathy: does exercise thallium scintigraphy improve noninvasive diagnostic capabilities? Transplant Proc. 1991 Feb; 23(1 Pt 2):1189-92. PMID: 1989183.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    784. Zoghbi HY, Ballantyne CM, O'Brien WE, McCall AE, Kwiatkowski TJ, Ledbetter SA, Beaudet AL. Deletion and linkage mapping of eight markers from the proximal short arm of chromosome 6. Genomics. 1990 Feb; 6(2):352-7. PMID: 1968423.
      Citations: 5     Fields:    Translation:HumansCells
    785. Ballantyne CM, O'Brien WE, Beaudet AL. Nucleotide sequence of the cDNA for murine intercellular adhesion molecule-1 (ICAM-1). Nucleic Acids Res. 1989 Jul 25; 17(14):5853. PMID: 2762164; PMCID: PMC318216.
      Citations: 13     Fields:    Translation:AnimalsCells
    786. Ballantyne CM, Podet EJ, Patsch WP, Harati Y, Appel V, Gotto AM, Young JB. Effects of cyclosporine therapy on plasma lipoprotein levels. JAMA. 1989 Jul 07; 262(1):53-6. PMID: 2733125.
      Citations: 31     Fields:    Translation:HumansCTClinical Trials
    787. Ballantyne CM, Zoghbi HY, Grzeschik KH, O'Brien WE, Beaudet AL. A human single copy DNA probe (ZB6-1) detects multiple polymorphisms on 6q. Nucleic Acids Res. 1988 Feb 25; 16(4):1650. PMID: 2894640; PMCID: PMC336370.
      Citations:    Fields:    Translation:HumansCells
    788. Ballantyne CM, Verani MS, Short HD, Hyatt C, Noon GP. Delayed recovery of severely "stunned" myocardium with the support of a left ventricular assist device after coronary artery bypass graft surgery. J Am Coll Cardiol. 1987 Sep; 10(3):710-2. PMID: 3497967.
      Citations: 7     Fields:    Translation:Humans
    789. Ballantyne CM, Jones PH, Payton-Ross C, Patsch W, Short HD, Noon GP, Gotto AM, DeBakey ME, Young JB. Hyperlipidemia following heart transplantation: natural history and intervention with mevinolin (lovastatin). Transplant Proc. 1987 Aug; 19(4 Suppl 5):60-2. PMID: 3303569.
      Citations: 4     Fields:    Translation:Humans
    790. Ballantyne CM, Vega GL, East C, Richards G, Grundy SM. Low-density lipoprotein metabolism in cerebrotendinous xanthomatosis. Metabolism. 1987 Mar; 36(3):270-6. PMID: 3821507.
      Citations: 6     Fields:    Translation:Humans
    BALLANTYNE's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (1283)
    Explore
    _
    Co-Authors (134)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _